
<html lang="en"     class="pb-page"  data-request-id="c937f561-1543-40dc-af80-e4bff3c2e4c7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-19;website:website:acspubs;article:article:10.1021/jm101144f;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Qingsong  Liu" /></meta><meta name="dc.Creator" content="Jae Won  Chang" /></meta><meta name="dc.Creator" content="Jinhua  Wang" /></meta><meta name="dc.Creator" content="Seong A.  Kang" /></meta><meta name="dc.Creator" content="Carson C.  Thoreen" /></meta><meta name="dc.Creator" content="Andrew  Markhard" /></meta><meta name="dc.Creator" content="Wooyoung  Hur" /></meta><meta name="dc.Creator" content="Jianming  Zhang" /></meta><meta name="dc.Creator" content="Taebo  Sim" /></meta><meta name="dc.Creator" content="David M.  Sabatini" /></meta><meta name="dc.Creator" content="Nathanael S.  Gray" /></meta><meta name="dc.Description" content="The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anticancer drugs. Starting from quinoline 1,..." /></meta><meta name="Description" content="The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anticancer drugs. Starting from quinoline 1,..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 22, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101144f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101144f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101144f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101144f" /></link>
        
    
    

<title>Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101144f" /></meta><meta property="og:title" content="Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0001.jpeg" /></meta><meta property="og:description" content="The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anticancer drugs. Starting from quinoline 1, which was identified in a biochemical mTOR assay, we developed a tricyclic benzonaphthyridinone inhibitor 37 (Torin1), which inhibited phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Torin1 was efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrated good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. These results demonstrate that Torin1 is a useful probe of mTOR-dependent phenomena and that benzonaphthridinones represent a promising scaffold for the further development of mTOR-specific inhibitors with the potential for clinical utility." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101144f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101144f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101144f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101144f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101144f&amp;href=/doi/10.1021/jm101144f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7146-7155</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100763j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100803c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1<i>H</i>)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingsong++Liu">Qingsong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jae+Won++Chang">Jae Won Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinhua++Wang">Jinhua Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seong+A.++Kang">Seong A. Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carson+C.++Thoreen">Carson C. Thoreen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Markhard">Andrew Markhard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wooyoung++Hur">Wooyoung Hur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianming++Zhang">Jianming Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taebo++Sim">Taebo Sim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Sabatini">David M. Sabatini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathanael+S.++Gray">Nathanael S. Gray</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Koch Center for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 1-617-582-8590. Fax: 1-617-582-8615. E-mail: <a href="/cdn-cgi/l/email-protection#86c8e7f2eee7e8e7e3ead9e1f4e7ffc6e2e0e5efa8eee7f4f0e7f4e2a8e3e2f3"><span class="__cf_email__" data-cfemail="4a042b3e222b242b2f26152d382b330a2e2c292364222b383c2b382e642f2e3f">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101144f&amp;href=/doi/10.1021%2Fjm101144f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7146â7155</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 22, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 June 2010</li><li><span class="item_label"><b>Published</b> online</span>22 September 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101144f" title="DOI URL">https://doi.org/10.1021/jm101144f</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7146%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQingsong%2BLiu%252C%2BJae%2BWon%2BChang%252C%2BJinhua%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D19%26contentID%3Djm101144f%26title%3DDiscovery%2Bof%2B1-%25284-%25284-Propionylpiperazin-1-yl%2529-3-%2528trifluoromethyl%2529phenyl%2529-9-%2528quinolin-3-yl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2Bas%2Ba%2BHighly%2BPotent%252C%2BSelective%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7155%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101144f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5251</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">145</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101144f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qingsong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;Won Chang&quot;},{&quot;first_name&quot;:&quot;Jinhua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Seong&quot;,&quot;last_name&quot;:&quot;A. Kang&quot;},{&quot;first_name&quot;:&quot;Carson&quot;,&quot;last_name&quot;:&quot;C. Thoreen&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Markhard&quot;},{&quot;first_name&quot;:&quot;Wooyoung&quot;,&quot;last_name&quot;:&quot;Hur&quot;},{&quot;first_name&quot;:&quot;Jianming&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Taebo&quot;,&quot;last_name&quot;:&quot;Sim&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Sabatini&quot;},{&quot;first_name&quot;:&quot;Nathanael&quot;,&quot;last_name&quot;:&quot;S. Gray&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7146-7155&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101144f&quot;},&quot;abstract&quot;:&quot;The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anticancer drugs. Starting from quinoline 1, which was identified in a biochemical mTOR assay, we developed a tricyclic benzonaphthyridinone inhibitor 37 (Torin1), which inhibited phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Torin1 was efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrated good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. These results demonstrate that Torin1 is a useful probe of mTOR-dependent phenomena and that benzonaphthridinones represent a promising scaffold for the further development of mTOR-specific inhibitors with the potential for clinical ut&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101144f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101144f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101144f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101144f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101144f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101144f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101144f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101144f&amp;href=/doi/10.1021/jm101144f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101144f" /></input><a href="/doi/pdf/10.1021/jm101144f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101144f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101144f%26sid%3Dliteratum%253Aachs%26pmid%3D20860370%26genre%3Darticle%26aulast%3DLiu%26date%3D2010%26atitle%3DDiscovery%2Bof%2B1-%25284-%25284-Propionylpiperazin-1-yl%2529-3-%2528trifluoromethyl%2529phenyl%2529-9-%2528quinolin-3-yl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2Bas%2Ba%2BHighly%2BPotent%252C%2BSelective%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D19%26spage%3D7146%26epage%3D7155%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jmcmar.2010.53.issue-19/production/jmcmar.2010.53.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anticancer drugs. Starting from quinoline <b>1</b>, which was identified in a biochemical mTOR assay, we developed a tricyclic benzonaphthyridinone inhibitor <b>37</b> (Torin1), which inhibited phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC<sub>50</sub> = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Torin1 was efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrated good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. These results demonstrate that Torin1 is a useful probe of mTOR-dependent phenomena and that benzonaphthridinones represent a promising scaffold for the further development of mTOR-specific inhibitors with the potential for clinical utility.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian target of rapamycin (mTOR<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: mTOR, mammalian target of rapamycin; Akt, v-akt murine thymoma viral oncogene homologue 1; ATP, adenosine triphosphate; PIKKs, PI3K related kinases; DNA-PK, DNA activated protein kinase; ATM, ataxia telangiectasia mutated kinase; ATR, ataxia telangiectasia and Rad-3-related kinase; SMG-1, serine/threonine protine kinase-1; 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; PK, pharmacokinetics; PD, pharmacodynamics; ADME, absorption, distribution, metabolism, excretion; MEFs, mouse embryo fibroblasts.</p></div>) is a key node in the PI3K/Akt/mTOR signaling pathway that is often deregulated in human cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In conjunction with PI3K and Akt/PKB, mTOR integrates signals derived from extracellular cues, such as growth factors, energy, stress, and nutrients, and regulates growth-related cellular processes, including mRNA translation, ribosome biogenesis, autophagy, and metabolism. The mTOR serine/threonine protein kinase shares a structurally similar catalytic domain with other PIKK family members, including PI3Ks, DNA-PK, ATM, ATR, and SMG-1.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> mTOR exists in at least two distinct protein complexes in cells: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 regulates mRNA translation through the phosphorylation of S6K1 and 4EBP1, while mTORC2 regulates cell survival through the phosphorylation of Akt/PKB and other AGC-family kinases, such as SGK. Hyperactivation of the mTOR signaling pathway is often implicated in cellular growth deregulation in cancer, and therefore there has been a substantial effort to develop mTOR inhibitors for potential clinical application.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">The development of ATP-competitive mTOR inhibitors was not viewed as a priority until recently because of rapamycin and its analogues (known as rapalogues), which were widely considered highly potent and selective allosteric inhibitors of mTORC1. In some cell types, rapamycin can also inhibit mTORC2.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Unfortunately, clinical success of these compounds has been limited to a small number of relatively rare cancers, including mantle cell lymphoma, renal cell carcinoma, and endometrial cancer.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Several explanations for this limited efficacy have been proposed: (1) rapamycin may only be effective in tumors where it is also capable of inhibiting mTORC2, (2) the induction by rapamycin of a feedback signal that leads to the hyperactivation of PI3K signaling might undermine the antiproliferative effect of mTORC1 inhibition, or (3) in many cell types, rapamycin fails to significantly inhibit mTORC1 kinase activity toward substrates, such as 4E-BP1, that are major regulators of proliferation.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> It is currently unknown whether any or all of these explanations account for the apparently limited clinical efficacy of rapamycin and its derivatives. Nonetheless, these potential deficiencies in rapamycin-based therapies have spurred the rapid development of ATP-competitive mTOR inhibitors that target both mTOR complexes. Recently, a number of selective ATP-competitive mTOR inhibitors have been reported, including <b>37</b> (Torin1),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a><b>1</b> (PP242),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><b>2</b> (KU-0063794),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><b>3</b> (WYE-354),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><b>4</b> (OSI-027),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><b>5</b> (AZD-8055),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>6</b> (KU-BMCL-200908069-1),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and <b>7</b> (Wyeth-BMCL-200910096-27),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> as well as a number of compounds that are capable of inhibiting both PI3K and mTOR and other PIKK-family kinases such as <b>8</b> (PI-103),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>9</b> (NVP-BEZ235),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><b>10</b> (GNE-493),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and <b>11</b> (GSK2126458)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Here we describe our screening and medicinal chemistry efforts that resulted in the identification of benzonapthridinones exemplified by <b>37</b> as highly potent and selective mTOR inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of reported ATP-competitive mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To identify compounds capable of inhibiting mTOR kinase activity, we established a medium-throughput biochemical assay utilizing purified mTORC1 from mammalian cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We screened a compound library consisting of both known kinase inhibitors as well as heterocycles that would be anticipated to have the propensity to bind to the ATP binding pocket of kinases.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This screening effort resulted in the identification of several classes of compounds; however, based on the criteria of the scaffold selectivity, we focused our attention on quinoline hit compound <b>12</b>. Although compound <b>12</b> exhibited only moderate biochemical inhibitory activity (mTORC1 IC<sub>50</sub> = 5 Î¼M) and was unable to inhibit phosphorylation of the cellular mTORC1 substrate S6K at a concentration of 10 Î¼M, it did exhibit selectivity for PIKK-family kinases when screened in binding assays against a panel of approximately 400 kinases at a concentration of 10 Î¼M (KinomeScan). In addition, the quinoline and isosteric quinazoline scaffolds are âprivilegedâ ATP-site binders and several highly selective kinase inhibitors such as HKI-272<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and lapatinib<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> are built from these heterocyclic cores.</div><div class="NLM_p">To optimize the cellular potency and selectivity of âhitâ compound <b>12</b>, we established a streamlined flowchart of biochemical and cellular assays to explore the structureâactivity relationship (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Newly synthesized compounds were initially screened for their ability to inhibit mTORC1 activity by monitoring the inhibition of phosphorylation of T389 of S6K1 by immunoblot analyses in mouse embryonic fibroblasts (MEFs). The cellular assay was primarily used to prioritize compounds and, in parallel, compounds were also tested using an in vitro mTORC1 kinase assay. Compounds that exhibited promising cellular mTORC1 activity were assessed for selectivity versus inhibition of cellular PI3K activity by monitoring inhibition of Akt T308 in PC-3 cells that stably express the phosphomimetic S473D mutant of Akt.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The S473D mutant of Akt was used to achieve a more pure PI3K-dependent phosphorylation read-out by eliminating the effect of mTORC2 phosphorylation at that site, which normally facilitates phosphorylation at T308 by PDK1.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The most potent and selective candidates to emerge from this reiterative process between the chemical modification and biological evaluation were subject to broad kinase selectivity profiling using the Ambit KinomeScan and LifeTechnologies LanthaScreen platforms. Compounds that passed our criteria for triage were further profiled for their in vitro and in vivo drug metabolism and pharmacokinetic properties (DMPK) and finally tested in a U87MG tumor xenograft model.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening flowchart for development of mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To begin the SAR exploration of compound <b>12</b>, we generated a number of analogues by varying the side chains at 4- and 6-positions of the quinoline (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). A few representative compounds that emerged from this effort are illustrated by compounds <b>15</b>, <b>16</b>, and <b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Unfortunately, these substitutions generally resulted in very minor changes in biochemical IC<sub>50</sub> values and none of the compounds inhibited mTOR or PI3K activity in cellular assays at submicromolar concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (1) appropriate aniline, 1,4-dioxane, 100 Â°C, 4â12 h; (2) appropriate boronic acid, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, <i>t</i>-Bu-Xphos, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 Â°C, 6 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic and Cellular Activities Profile of Acyclic Quinoline Series<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0011.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The IC<sub>50</sub> determinations are the mean of two of independent measurement with standard error of <20%. For cellular assay, 300 nM was the highest concentration tested</p></div></div></div><div class="NLM_p">A substructure search of compound <b>12</b> identified a broad class of tricyclic quinoline-derived dual PI3K/mTOR inhibitors exemplified by <b>9</b> as containing a similar substructure<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Tricylic core structure have been exploited in the development of numerous other kinase inhibitors targeting EGFR,<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> PDGFR,<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a> Aurora,<a onclick="showRef(event, 'cit26c'); return false;" href="javascript:void(0);" class="ref cit26c">(26c)</a> CK2,<a onclick="showRef(event, 'cit26d'); return false;" href="javascript:void(0);" class="ref cit26d">(26d)</a> and IKK.<a onclick="showRef(event, 'cit26e'); return false;" href="javascript:void(0);" class="ref cit26e">(26e)</a><b>9</b> was predicted to bind to PI3K using the quinoline nitrogen to form a key hydrogen bond to the kinase âhinge regionâ.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The cyclic urea moiety was predicted to be important for constraining the pendant phenyl ring to the presumed bioactive conformation. We decided to introduce a similar constraint by introducing a six-membered lactam that would result in a tricyclic scaffold which would facilitate additional diversification points as well as introduce the potentially important carbonyl oxygen for the potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic and Cellular Activities Profile of Compound <b>18</b></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0012.gif" alt="" id="_i5" /></img></td></tr></tbody></table></div></div><div class="NLM_p">The introduction of this additional ring constraint resulted in benzonaphthridinone compound <b>18</b>, which exhibited a dramatic 1000-fold improved mTOR cellular potency compared to that of the screening hit compound <b>12</b>. Compound <b>18</b> possessed a biochemical IC<sub>50</sub> of 5.4 nM against mTORC1 enzyme and an IC<sub>50</sub> of 3 nM for inhibition of S6K phosphorylation in cells without any detectable inhibitory activity on PI3K up to a concentration of 300 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">To rationalize the potency of <b>18</b> in a structural context, we docked compound <b>18</b> into the ATP-binding site of an mTOR homology model built using the related Pi3KÎ³ crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Similar to the published homology model of <b>9</b> with Pi3KÎ³,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> a hydrogen bond was predicted to form between the quinolione nitrogen of compound <b>18</b> and Val2240 within the kinase hinge region.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A comparison to the proposed binding mode of morpholine-derived mTOR inhibitors such as <b>8</b> suggests that the morpholine oxygen makes a similar hydrogen bond. The quinoline moiety of compound <b>18</b> was predicted to reside within the inner hydrophobic pocket formed by Glu2190, Leu2192, Asp2195, Tyr2225, Asp2357, Phe2358, Gly2359, and Asp2360. The phenyl piperazine side chain was oriented below a loop defined by residues from Ile2183 to Gln2187, which occupy a similar region of the ATP-binding site as the âP-loopâ of protein kinases. Using this homology model as a guide, we embarked on a further elaboration of the benzonaphthridione scaffold at the quinoline (<b>R1</b>) and lactam phenyl (<b>R2</b>) positions. Previous efforts to optimize PI3K inhibitors have suggested that modification at either of these positions could modulate potency, while the <b>R1</b> position may provide a stronger contribution to specificity versus other PIKK-family kinases.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, to improve the extremely poor water-solubility of this compound class, we continued our SAR exploration with <b>R2</b> fixed as a phenyl piperazine, which introduces a water solubility enhancing basic secondary nitrogen versus the acyl piperazine present in our library compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The target compounds were synthesized using a four-step sequence starting from dichloroquinoline scaffold <b>S1</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Introduction of substituted anilines in the first step was followed by construction of the six-membered lactam using a HornerâWadsworthâEmmons reaction. The <b>R1</b> side chain was then introduced via palladium-mediated coupling with the desired boronic acid. The biological activities of the compounds that resulted from this effort are illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model demonstration of compound <b>18</b> binding with mTOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (1) aniline (R<sub>2</sub>NH<sub>2</sub>), 1,4-dioxane, 100 Â°C, 4 h; (2) LAH, THF, 0 Â°Cârt, 4 h; (3) (a) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 6 h, (b) triethyl phosphonoacetate, K<sub>2</sub>CO<sub>3</sub>, EtOH, 100 Â°C, 12 h; (4) R<sub>1</sub>B(OH)<sub>2</sub>, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, <i>t</i>-Bu-Xphos, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 Â°C, 12 h.</p></p></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative structures of variations of R1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzymatic and Cellular Activities Profile of Compounds Varying R1<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0013.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determinations are the mean of two of independent measurement with standard error of <20%. None of the tested compounds exhibited IC<sub>50</sub> for inhibition of cellular PI3K activity of less than 300 nM.</p></div></div></div><div class="NLM_p">Removal of the acyl group of compound <b>18</b> to yield compound <b>19</b> resulted in a 2â10-fold reduction in potency in both biochemical and cellular assays. On the basis of the homology model, this could be rationalized by the potential loss of a hydrogen bond between the amide carbonyl oxygen and epsilon amine of Lys2186. Removal of the quinoline nitrogen of compound <b>19</b> to yield compound <b>25</b> resulted in more than a 10-fold loss in cellular mTOR potency, which may be attributable to the loss of a hydrogen bond between the quinoline N and the phenol of Tyr2225. Introduction of the tricyclic thianthrene side chain (<b>22</b>) significantly reduced the cellular mTOR potency, providing a potential upper limit on the size of the functionality that can be accommodated within the inner hydrophobic pocket. Most of the bicyclic side chains such as benzothiophene (<b>21</b>), isoquinoline (<b>23</b>), naphthalene (<b>25</b>), benzodioxane (<b>26</b>), and benzodioxole (<b>27</b>) maintained reasonable enzymatic activities, but only those with appropriately placed hydrogen-bond accepting potential (<b>26</b>, <b>27</b>) displayed good cellular activity. Monocyclic <b>R1</b> groups with substitution at the para-position (<b>20</b>) possessed activity in the same range as the bicyclic ring systems. The dramatic loss of activity observed between compound <b>24</b> and <b>20</b> may be attributed to the lack of tolerance for Î±-substitution, which is consistent with the observations made for the compound <b>10</b> series.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Cumulatively, these data suggest that a combination of hydrophobic and hydrogen bonding interactions are critical for achieving potent cellular inhibition of mTOR and that the quinoline moiety was the preferred core for this pharmacophore. None of the compounds in this series displayed cellular activity against PI3K up to a concentration of 300 nM. A number of discordances were observed between the biochemical and cellular IC<sub>50</sub> measurements that may be attributed to differential cellular permeability and/or the inability of the biochemical assay to accurately reflect the functionally relevant intracellular mTOR. On the basis of this observation, the cell based IC<sub>50</sub> was used as a guide for the chemical optimization process.</div><div class="NLM_p">Following the initial optimization steps, we introduced a variety of side chains to the R2 position while fixing the <b>R1</b> side chain as a quinoline (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Introducing sulfonyl (<b>31</b>) or methylene spacer (<b>33</b>) before the piperazine functionality resulted in a loss in mTOR potency. Introducing an <i>ortho</i>-methoxy substitution (<b>32</b> versus <b>19</b>) resulted in a 5-fold loss in cellular mTOR inhibition. Replacement of an <b>R2</b> phenyl moiety with small aliphatic side chains (represented by <b>38</b>) resulted in inactive compounds. Most compounds that retained the <i>meta</i>-CF<sub>3</sub> substituted aniline and also those derivatized at the para-position with piperazinyl, phenyl, and piperidinyl groups retained similar or superior potency relative to compound <b>18</b>. Introducing a carbonyl moiety in the form of an acetyl group to the piperazine nitrogen (<b>18</b> versus <b>19</b>) resulted in a 13-fold improvement in cellular potency, potentially due to the introduction of a hydrogen bond with Lys2186. (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) To avoid an 1,4-dianiline moiety that could potentially represent a metabolic liability in compound <b>18</b>, several piperazine replacements were explored such as reversed piperidine (<b>41</b>), unsaturated piperidine (<b>40</b>), or phenyl (<b>39</b>) linkage; however, they all resulted in weaker biochemical and cellular mTOR inhibition. Further exploration of the piperazine acyl moiety, which the modeling predicted to be directed toward the solvent area, resulted in the identification of the propyl amide (<b>37</b>, named Torin1) as conferring the greatest potency and selectivity. Compound <b>37</b> is a picomolar inhibitor of mTORC1 enzymatic activity and single digit nanomolar inhibitor of cellular mTOR activity. Although most compounds in this series have over 100-fold selectivity relative to inhibition of cellular PI3K activity, a more detailed study of <b>37</b> revealed that it has more than 800-fold selectivity between mTOR and PI3K.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative structures of variations of R2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Enzymatic and Cellular Activities Profile of Compounds Varying R2<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0014.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determinations are the mean of two of independent measurement with standard error of <20%. None of the tested compounds exhibited an IC<sub>50</sub> for inhibition of cellular PI3K activity of less than 300 nM.</p></div></div></div><div class="NLM_p">We next investigated the SAR of the lactam ring using Torin1 as a staring point. The resultant SAR indicated that the rigid six-membered lactam was preferred, as urea, carbamate, and pyrimidinedione analogues lost more than 500-fold activity against the mTORC1 complex (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Introduction of a methyl group to either the Î± (<b>42</b>) or Î² position (<b>43</b>) of the lactam ring significantly diminished potency in both the biochemical and cellular assays, suggesting these positions make a close contact to the ATP-binding site.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Enzymatic and Cellular Activities Profile of Fixed Conformation Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0015.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determinations are the mean of two of independent measurements with standard error of <20%. <b>37</b> has a cellular IC<sub>50</sub> of 1800 nM for PI3K. None of other compounds exhibited a cellular IC<sub>50</sub> for PI3K of less than 300 nM.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Kinase Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Biochemical characterization of <b>37</b> at varying ATP concentrations demonstrated that it is an ATP competitive inhibitor of mTOR. The selectivity of <b>37</b> was assessed using the KinomeScan methodology across a panel of 442 human kinases at a concentration of 10 Î¼M. Only three kinases displayed tight binding to <b>37</b> (Ambit scores of less than 2), and dissociation constants were determined for mTOR, PI3KÎ±, and PI3KÎ± (I800L) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). This analysis revealed that <b>37</b> is extremely selective for PIKK family kinases relative to all other serine/threonine and tyrosine kinases. To further investigate these observed binding events, we performed enzymatic assays across most of the known PIKK family kinases using the LanthaScreen technology. This analysis revealed that <b>37</b> is very selective relative to other PIKK family kinases with the exception of DNA-PK (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The activity against DNA-PK was further characterized using a radiometric kinase assay where the compound exhibited an IC<sub>50</sub> of approximately 1 Î¼M.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The origin of the 150-fold discrepancy between the LanthaScreen IC<sub>50</sub> for DNA-PK versus the radiometric assay is currently unknown.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. KinomeScan Profile of <b>37</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">% control</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">% control</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>d</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mTOR</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">PIK3CA(E545K)</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PIK3CA(C420R)</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">PIK3CA(I800L)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PIK3CA</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">MRCKA</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="left">10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Compound <b>37</b> was profiled at a concentration of 10 Î¼M against a diverse panel of 442 kinases by Ambit Biosciences.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. LanthaScreen Profile of <b>37</b> in Invitrogen Lipid Kinase Panel<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI4K Î±</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="left">P110 Î±/p85Î±</td><td class="colsep0 rowsep0" align="char" char=".">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI4K Î²</td><td class="colsep0 rowsep0" align="char" char=".">6680</td><td class="colsep0 rowsep0" align="left">P110Î´/P85Î±</td><td class="colsep0 rowsep0" align="char" char=".">564</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3KâC2 Î±</td><td class="colsep0 rowsep0" align="char" char=".">176</td><td class="colsep0 rowsep0" align="left">P110Î³</td><td class="colsep0 rowsep0" align="char" char=".">171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3KâC2Î²</td><td class="colsep0 rowsep0" align="char" char=".">549</td><td class="colsep0 rowsep0" align="left">DNA-PK</td><td class="colsep0 rowsep0" align="char" char=".">6.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hVPS34</td><td class="colsep0 rowsep0" align="char" char=".">533</td><td class="colsep0 rowsep0" align="left">mTOR</td><td class="colsep0 rowsep0" align="char" char=".">4.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Kinase targets were tested with biochemical enzymatic kinase assays using the SelectScreen Kinase Profiling Service (Life Technologies Corporation, Madison, WI) to determine IC<sub>50</sub> values as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. The compounds were assayed at 10 concentrations (3-fold serial dilutions starting from 1 Î¼M) at an ATP concentration equal to the ATP <i>K</i><sub>m,app</sub> for the assay following the detailed procedures described in the SelectScreen Customer Protocol and Assay Conditions documents located at <a href="http://www.invitrogen.com/kinaseprofiling" class="extLink">www.invitrogen.com/kinaseprofiling</a>.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Pharmacokinetic Data</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmacokinetic properties of <b>37</b> were next evaluated both in vitro and in vivo. In both human and mouse liver microsome stability studies, <b>37</b> was rapidly consumed with a half-life of 4 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The significant difference in human liver microsome metabolism observed in the presence and absence of NADPH indicates a NADPH dependent metabolism mechanism. The in vivo pharmacokinetic parameters of <b>37</b> in mice were determined following the intravenous administration of 1 mg/kg, oral administration of 10 mg/kg, or intraperitoneal administration of 10 mg/kg of <b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). As expected from the in vitro studies, <b>37</b> exhibited a short <i>T</i><sub>1/2</sub> of 0.5 h that may partially due to the rapid first-pass metabolism. <b>37</b> also exhibited low exposure and limited bioavailability following the oral administration, possibly suggestive of low absorption or high first pass metabolism. The better exposure and much longer half-life achieved following intraperitoneal administration further confirmed the instability of <b>37</b> to the liver metabolism.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Human and Mouse Liver Microsome Stability Data of <b>37</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">MR (nmol/min/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>R</i> at 60 min</th><th class="colsep0 rowsep0" align="center" char=".">%<i>R</i> at 60 min (âNADPH)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">1.53</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Human liver microsome (7 males + 2 females, cat. 452165) and male mouse liver microsomes (cat. 452220) from BD Gentest.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Mouse PK Data of <b>37</b><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (hÂ·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">MRT (h)</th><th class="colsep0 rowsep0" align="center">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="char" char=".">2757</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">720</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">23.0</td><td class="colsep0 rowsep0" align="left">0.59</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="char" char=".">223</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">396</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="left">1.51</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">5.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IP</td><td class="colsep0 rowsep0" align="char" char=".">5121</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="char" char=".">5718</td><td class="colsep0 rowsep0" align="char" char=".">4.52</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">C57BL/6 male mouse was dosed at 1 mg/kg for the intravenous (IV), 10 mg/kg for the oral (PO), and 10 mg for the intraperitoneal  (IP: Swiss albino mice) studies. IV formulation used 10% <i>N</i>-methyl pyrrolidone (NMP) and 50% polyethylene glycol (PEG-200) in water. PO formulation used 0.5% w/v NaCMC with 0.1% w/v Tween-80. IP administration formulation was 10% v/v dimethylacetamide (DMA), 20% v/v polyethylene glycol (PEG-200), 20% v/v PG in water.</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Pharmacodynamic Data</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To assess the pharmacodynamic effects of <b>37</b>, mice were treated with a single intraperitoneal dose of 20 mg/kg <b>37</b>, and the phosphorylation of S6 at S235/236 and of Akt1 at S473 were measured by Western blot in lysates derived from liver and lung. <b>37</b> suppressed Akt1 phosphorylation at S473, the phosphorylation site of mTORC2, for approximately 2â3 h, after which the phosphorylation gradually returned to baseline levels. Inhibition of S6 at S235/236, an indirect substrate of mTORC1, was more markedly suppressed with complete inhibition of phosphorylation observed up to 6 h in the lung and to greater than 10 h in the liver (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). These pharmacodynamic studies indicate that despite the poor pharmacological properties of <b>37</b>, suppression of both mTORC1 and mTORC2 dependent outputs can be achieved in mice.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic inhibition of Akt S473 and S6 S235/236 phosphorylation in lung and liver of mice treated with a single intraperitoneal dose of 20 mg/kg <b>37</b>. Six-week-old male C57BL/6 mice were fasted overnight prior to treatment with <b>37</b> as a suspension in 20% <i>N</i>-methyl-2-pyrrolidone/40% PEG400/40% water or with vehicle by IP injection. Tissues were collected and analyzed at 2, 6, and 10 h after dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Antitumor in Vivo Efficacy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The results from the pharmacodynamic studies encouraged us to investigate whether <b>37</b> would inhibit growth in a U87MG xenograft model. U87MG is a PTEN<i>null</i> glioblastoma cell line that exhibits strong activation of the PI3K-mTOR-Akt pathway and has been commonly used for xenograft experiments to evaluate the efficacy of PI3K and mTOR kinase inhibitors.<a onclick="showRef(event, 'ref11 ref28'); return false;" href="javascript:void(0);" class="ref ref11 ref28">(11, 28)</a> Because of the relatively poor pharmacokinetic properties, we decided to perform once daily IP dosing of 20 mg/kg of <b>37</b>. Continuous dosing for 10 days resulted in greater than 99% inhibition of tumor growth as assessed by caliper measurements. (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) Upon cessation of drug treatment, the tumors continued to grow, suggesting that <b>37</b> treatment is primarily cytostatic and that a significant number of tumor cells remain viable during treatment (data not shown).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo efficacy of <b>37</b> in U87MG xenografts. Mice model was established with six-week-old immunodeficient mice by subcutaneous injection of U87MG cells. <b>37</b> as a solution/suspension in vehicle (20% <i>N</i>-methyl-2-pyrrolidone, 40% PEG400, and 40% water) or vehicle was delivered by intraperitoneal injection once daily after the tumor reached 1 cm<sup>3</sup> in size and continued for 10 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from a quinoline screening âhitâ compound <b>12</b> discovered using a medium-throughput biochemical mTORC1 assay, a focused medicinal chemistry effort facilitated by molecular modeling and other known PIKK-family inhibitors resulted in the identification of a novel benzonaphthridinone scaffold exemplified by <b>37</b>. Compound <b>37</b> inhibits phosphorylation of both mTORC1 and mTORC2 at single-digit nanomolar concentrations while exhibiting 800-fold selectivity relative to cellular PI3K inhibitory activity. Compound <b>37</b> exhibited a short in vivo half-life and low oral bioavailability but displayed pharmacodynamic inhibition of both mTORC1 and mTORC2 outputs in lung and liver. Compound <b>37</b> dosed once a day at 20 mg/kg for 10 days demonstrated efficacy in a U87MG xenograft mouse model. Compound <b>37</b> is a valuable tool for investigating mTOR mediated signal pathways and provides a valuable starting point for identification of compounds with improved âdrug-likeâ properties.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">All solvents and reagents were used as obtained. <sup>1</sup>HNMR spectra were recorded with a Varian Inova 600 NMR spectrometer and referenced to dimethyl sulfoxide. Chemical shifts are expressed in ppm. In the NMR tabulation, s indicates singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak. Mass spectra were measured with Waters Micromass ZQ using an ESI source coupled to a Waters 2525 HPLC system operating in reverse mode with an Waters Sunfire C18 5 Î¼m 4.6 mm Ã 50 mm column. Purification of compounds was performed with either a Teledyne ISCO combiflash Rf system or a Waters Micromass ZQ preparative system. The purity of all compounds was â¥95%. The purity was analyzed on an above-mentioned Waters LC-MS Symmetry (C18 column, 4.6 mm Ã 50 mm, 5 Î¼M) using a gradient of 5â95% acetonitrile in water containing 0.05% trifluoacetic acid (TFA) over 8 min (10 min run time) at a flow rate of 2 mL/min.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Preparation of Compounds <b>15</b>â<b>17</b></h3><div class="NLM_p">To a solution of compound <b>14</b> (4,6-dichloroquinoline, 1 equiv) in 1,4-dioxane at room temperature in a sealed tube was added aniline (1 equiv). The resultant solution was heated to 100â120 Â°C for 4â12 h. After cooling to room temperature, a solution of NaOH (1 N) was added to neutralize the solution followed by dilution with water and extraction with ethyl acetate. After drying with Na<sub>2</sub>SO<sub>4</sub>, the solvents were removed and the residue was purified by ISCO to furnish compound <b>13</b>.</div><div class="NLM_p last">To a solution of compound <b>13</b> (1 equiv) in 1,4-dioxane at room temperature was added PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (0.1 equiv), <i>t</i>-Bu-Xphos (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (3 equiv, 1 N), and quinoline-3-boronic acid. After degassing, the resultant mixture was heated to 100 Â°C for 6 h before cooling down to room temperature and filtration through Celite. Upon removal of the solvents, the residue was purified by column chromatography to furnish compounds <b>15</b>â<b>17</b>.</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(4-(4-([3,6â²-Biquinolin]-4â²-ylamino)-2-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone (<b>15</b>)</h3><div class="NLM_p last">Yield 20% overall from <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.12 (s, 1H), 9.49 (d, <i>J</i> = 2.4 Hz, 1H), 9.05 (d, <i>J</i> = 1.8 Hz, 1H), 8.84 (d, <i>J</i> = 2.4 Hz, 1H), 8.67 (s, 1H), 8.42 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 8.26 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 8.19 (d, <i>J</i> = 2.4 Hz, 1H), 8.10â8.12 (m, 2H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.82 (ddd, <i>J</i> = 7.2, 6.6, 1.8 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.4, 7.8, 1.2 Hz, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 3.54â3.56 (m, 4H), 2.87 (t, <i>J</i> = 4.8 Hz, 2H), 2.81 (t, <i>J</i> = 4.8 Hz, 2H), 2.04 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 542.87.</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Compounds <b>18</b>â<b>42</b></h3><div class="NLM_p">To a solution of compound <b>S1</b> (ethyl 4,6-dichloroquinoline-3-carboxylate, 1 equiv) in 1,4-dioxane at room temperature was added aniline (1 equiv) at room temperature. The reaction mixture was heated to 100 Â°C for 4 h, followed by cooling to room temperature and the addition of NaOH (1 N) to neutralize the solution. The resultant solution was diluted with water and extracted with ethyl acetate. After removal of the solvents, the residue was purified by flash chromatography to afford compound <b>S2</b>.</div><div class="NLM_p">To a solution of compound <b>S2</b> (1 equiv) in THF at 0 Â°C was added LAH (3 equiv). After 15 min, the solution was warmed to room temperature and stirred for 1â4 h before carefully quenching with methanol and water. Subsequent filtration through Celite furnished crude <b>S3</b>, which was used in the next step without further purification.</div><div class="NLM_p">To a solution of compound <b>S3</b> in CH<sub>2</sub>Cl<sub>2</sub> (1 equiv) at room temperature was added MnO<sub>2</sub> (10 equiv mass). After 4 h, the reaction mixture was filtered through Celite. The filtrate was concentrated in a sealed tube and dissolved in dry EtOH, after which K<sub>2</sub>CO<sub>3</sub> (3 equiv) and triethyl phosphonoacetate (triethyl 2-phosphonopropionate for compound (<b>42</b>) were added. The resultant mixture was heated to 100 Â°C for 12 h before cooling to room temperature. Upon removal of the solvents under vacuum, the residue was diluted with water following by extraction with ethyl acetate. Purification of the residue by column chromatography provided compound <b>S4</b>.</div><div class="NLM_p last">To a solution of compound <b>S4</b> in 1,4-dioxane at room temperature was added subsequently PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (0.1 equiv), <i>t</i>-Bu-Xphos (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (3 equiv, 1 N), and boronic acids or boronate pinacol esters. After degassing, the resultant mixture was heated to 100 Â°C for 6 h before cooling to room temperature and filtration through Celite. Upon removal of the solvents, the residue was subjected to column purification to furnish the desired compounds (<b>18</b>â<b>42</b>).</div></div><div id="sec8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(4-(4-Acetylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">Yield 15% overall from <b>S1</b>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) Î´ 9.20 (s, 1H), 8.58 (d, <i>J</i> = 1.8 Hz, 1H), 8.34 (d, <i>J</i> = 9.6 Hz, 1H), 8.27 (s, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 8.16 (d, <i>J</i> = 7.2 Hz, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.97â7.98 (m, 2H), 7.79â7.82 (m, 2H), 7.67â7.71 (m, 2H), 7.11 (s, 1H), 6.95 (d, <i>J</i> = 9.0 Hz, 1H), 3.28 (m, 4H), 2.65â2.70 (m, 2H), 2.59 (m, 2H), 1.98 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 594.81.</div></div><div id="sec8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1<i>H</i>)-one (<b>37</b>)</h3><div class="NLM_p last">Overall yield 7% from <b>S1</b>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) Î´ 9.19 (s, 1H), 8.58 (d, <i>J</i> = 2.4 Hz, 1H), 8.34 (d, <i>J</i> = 9.6 Hz, 1H), 8.26 (d, <i>J</i> = 1.8 Hz, 1H), 8.19 (d, <i>J</i> = 9.0 Hz, 1H), 8.14 (dd, <i>J</i> = 9.0, 1.8 Hz, 1H), 8.03 (d, <i>J</i> = 9.0 Hz, 1H), 7.96â7.98 (m, 2H), 7.77â7.82 (m, 2H), 7.66â7.70 (m, 2H), 7.09 (d, <i>J</i> = 1.8 Hz, 1H), 6.94 (d, <i>J</i> = 9.6 Hz, 1H), 3.40â3.42 (m, 4H), 2.60â2.65 (m, 4H), 2.28 (q, <i>J</i> = 7.8 Hz, 2H), 0.98 (t, <i>J</i> = 7.8 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 608.23.</div></div><div id="sec8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for the Preparation of Compounds <b>43</b>â<b>47</b></h3><div class="NLM_p">Compound <b>S2</b> was subjected to Pd mediated coupling with quinoline 3-boronic acid under the conditions mentioned above to furnish compound <b>S2a</b> (ethyl 4-(3-(trifluoromethyl)-4-(4-propionylpiperazin-1-yl)phenylamino)-6-(quinolin-3-yl)quinoline-3-carboxylate). Compound <b>S2a</b> was dissolved in a mixture of MeOH/H<sub>2</sub>O (1:1) and treated with NaOH (1 N, 5 equiv) at room temperature. The reaction mixture was then stirred overnight. The pH of the solution was adjusted to 4, followed by extraction with ethyl acetate to afford the crude carboxylic acid <b>S2b</b>. Acid <b>S2b</b> (1 equiv) was dissolved in THF at room temperature and treated with triphosgene (0.4 equiv). After 2 h, methylamine (2 equiv) was added and the resulting mixture was heated at 40 Â°C for 1 h before quenching with saturated Na<sub>2</sub>CO<sub>3</sub>. Extraction with ethyl acetate followed by column chromatography afforded compound <b>44</b>.</div><div class="NLM_p">To a solution of compound <b>S2b</b> in THF was added methyl methoxyamine (2 equiv), Et<sub>3</sub>N (3 equiv), and HATU (2 equiv). The resultant solution was stirred at room temperature for 4 h before extraction with ethyl acetate. Column purification afforded Weinreb amide <b>S2c</b>, which was then dissolved in THF and treated with methyl magnesium bromide (3 equiv) at room temperature. The resulting solution was stirred for 4 h before quenching with satd Na<sub>2</sub>CO<sub>3</sub>. Column chromatography afforded methyl ketone <b>S2d</b>, which was further elaborated to compound <b>43</b> in the same fashion as the synthesis of compound <b>18</b>.</div><div class="NLM_p">To a solution of compound <b>S3</b> (1 equiv) in THF at room temperature was added triphosgene (0.4 equiv). The resultant solution was stirred at room temperature for 2 h before it was quenched with satd Na<sub>2</sub>CO<sub>3</sub>. Column chromatography afforded compound <b>47</b>.</div><div class="NLM_p last">To a solution of compound <b>S3</b> in CH<sub>2</sub>Cl<sub>2</sub> (1 equiv) at room temperature was added MnO<sub>2</sub> (10 equiv mass). The mixture was stirred for 4 h before being filtered through Celite. The filtrate was concentrated, dissolved in THF, and treated with methyl amine (2 equiv for compound <b>46</b>) or 2,4-dimethoxylbenzylamine (2 equiv for compound <b>45</b>), NaBH(OAc)<sub>3</sub> (5 equiv), and AcOH (1 drop) at room temperature. The reaction mixture was stirred for 4 h before it was quenched with satd Na<sub>2</sub>CO<sub>3</sub>. After compound purification, the corresponding product was subjected to the same procedure as in the preparation of compound <b>43</b> to afford compounds <b>45</b> and <b>46</b>.</div></div><div id="sec8_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Characterization of in Vitro Biochemical Activity with the mTORC1 Complex</h3><div class="NLM_p last">Human mTORC1 complex was obtained as previously described.<a onclick="showRef(event, 'ref7 ref29'); return false;" href="javascript:void(0);" class="ref ref7 ref29">(7, 29)</a> In vitro mTORC1 activity was assayed using the Lanthascreen time-resolved FRET assay (Invitrogen). Briefly, mTORC1 (0.1 Î¼g each) was incubated with serially diluted inhibitors (3-fold, 11 points) for 30 min in 5 Î¼L of kinase buffer (25 mM HEPES, pH 7.4, 10 mM MgCl<sub>2</sub>, 4 mM MnCl<sub>2</sub>, 50 mM KCl) in a 384-well low-volume plate (Corning). The kinase reaction was initiated by the addition of an equal volume of kinase buffer containing 0.8 Î¼M GFP-labeled 4E-BP1 and 100 Î¼M ATP at room temperature and, after 1 h, the reaction was stopped with 10 Î¼L of solution containing 20 mM EDTA and 4 nM Tb-labeled antiphospho 4E-BP1 (T46) antibody. After incubation for 30 min, the FRET signal between Tb and GFP within the immune complex was read using an Envision plate reader (PerkinElmer). Each data point was duplicated and IC<sub>50</sub> values were calculated using Prism4 software (GraphPad).</div></div><div id="sec8_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> mTOR and PI3K Cellular Assays</h3><div class="NLM_p last">Cellular IC<sub>50</sub> values for mTOR were determined using p53<sup>â/â</sup> MEFs. Cells were treated with vehicle or increasing concentrations of compound for 1 h and then lysed. Phosphorylation of S6K1 Thr-389 was monitored by immunoblotting using a phospho-specific antibody. Meanwhile, cellular IC<sub>50</sub> values for PI3Ka were determined based on phosphorylation of Akt Thr-308 in p53<sup>â/â</sup>/mLST8<sup>â/â</sup> MEFs or human PC3 cells expressing the S473D mutant of Akt1 as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec8_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Ambit in Vitro KinomeScan Kinase Selectivity Profile</h3><div class="NLM_p last"><b>37</b> was profiled at a concentration of 10 Î¼M against a diverse panel of 442 kinases by Ambit Biosciences. Scores for primary screen hits are reported as a percent of the DMSO control (% control). For kinases where no score is shown, no measurable binding was detected. The lower the score, the lower the <i>K</i><sub>d</sub> is likely to be, such that scores of zero represent strong hits. Scores are related to the probability of a hit but are not strictly an affinity measurement. At a screening concentration of 10 Î¼M, a score of less than 10% implies that the false positive probability is less than 20% and the <i>K</i><sub>d</sub> is most likely less than 1 Î¼M. A score between 1% and 10% implies that the false positive probability is less than 10%, although it is difficult to assign a quantitative affinity from a single-point primary screen. A score of less than 1% implies that the false positive probability is less than 5% and the <i>K</i><sub>d</sub> is most likely less than 1 Î¼M.</div></div><div id="sec8_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">The study was performed at the Sai Advantium Pharma Limited Company (India) with male Swiss albino mice following single intravenous bolus and oral administration. A group of 18 male mice were divided into two groups (group 1, IV; group 2, PO), with each group comprised of nine mice. Animals in group 1 were dosed intravenously via the tail vein at 1 mg/kg of <b>37</b> solution (10% v/v <i>N</i>-methyl pyrrolidone and 50% v/v polyethylene glycol-200 in normal saline). Group 2 animals were dosed orally at 10 mg/kg with a suspension formulation (0.5% w/v Na CMC with 0.1% v/v Tween-80 in water) of <b>37</b>. Blood samples were collected at 0, 0.08 (for IV only), 0.25, 0.5, 1, 2, 4, 6 (For PO only), 8, 12, and 24 h for the IV and PO groups. IP experiment was one with Swiss albino mice using formulation as 10% v/v dimethylacetamide(DMA), 20% v/v polyethylene glycol(PEG-200), 20% v/v PG in water. The blood samples were collected from sets of three mice at each time point in labeled microcentrifuge tubes containing K2EDTA as an anticoagulant. Plasma samples were separated by centrifugation and stored below â70 Â°C until bioanalysis. All samples were processed for analysis by precipitation using acetonitrile and analyzed with a partially validated LC/MS/MS method (LLOQ, 1.138 ng/mL). Pharmacokinetic parameters were calculated using the noncompartmental analysis tool of WinNonlin Enterprise software (version 5.2).</div></div><div id="sec8_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Antitumor (U87MG model) Efficacy Studies</h3><div class="NLM_p last">Immunodeficient mice (NCR nude, nu/nu; Taconic Laboratories) were maintained in a pathogen-free facility and were given autoclaved food and water ad libitum. U87-MG glioblastoma cells were xenografted into six-week-old immunodeficient mice. Briefly, 2 Ã 10<sup>6</sup> U87MG cells were resuspended in 100 Î¼L of media that had been premixed with Matrigel and was injected subcutaneously in the upper flank region of mice that had been anaesthetized with isoflurane. Tumors were allowed to grow to 1 cm<sup>3</sup> in size, and the animals were randomized into two treatment groups: vehicle and <b>37</b>. For <b>37</b> injections, <b>37</b> powder was first dissolved at 25 mg/mL in 100% <i>N</i>-methyl-2-pyrrolidone and subsequently diluted 1:4 with sterile 50% PEG400 to a final concentration of 5 mg/mL <b>37</b>. Vehicle or <b>37</b> was delivered by IP injection at the indicated dosage once daily. Tumors were measured with calipers in two dimensions every other day. Tumor volumes were estimated with the formula: volume = (2<i>a</i> Ã <i>b</i>)/2, where <i>a</i> = short and <i>b</i> = long tumor axes, respectively, in millimeters. All animal studies were performed according to the official guidelines from the MIT Committee on Animal Care and the American Association of Laboratory Animal Care.</div></div><div id="sec8_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> In Vivo Pharmacodynamic Studies</h3><div class="NLM_p last">For pharmacodynamic experiments, <b>37</b> powder was first dissolved at 25 mg/mL in 100% <i>N</i>-methyl-2-pyrrolidone and then diluted 1:4 with sterile 50% PEG400 prior to injection. Six-week old male C57BL/6 mice were fasted overnight prior to drug treatment. The mice were treated with vehicle (for 10 h) or <b>37</b> (20 mg/kg for 2, 6, or 10 h) by IP injection and then re-fed 1 h prior to sacrifice (CO<sub>2</sub> asphyxiation). Tissues were collected and frozen on dry ice. The frozen tissue was thawed on ice and lysed by sonication in tissue lysis buffer (50 mM HEPES, pH 7.4, 40 mM NaCL, 2 mM EDTA, 1.5 mM sodium orthovanadate, 50 mM sodium fluoride, 10 mM sodium pyrophosphate, 10 mM sodium Î²-glycerophosphate, 0.1% SDS, 1.0% sodium deoxycholate, and 1.0% Triton, supplemented with protease inhibitor cocktail tablets (Roche)). The concentration of clear lysate was measured using the Bradford assay and samples were subsequently normalized by protein content and analyzed by SDS-PAGE and immunoblotting.</div></div><div id="sec8_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Molecular Modeling</h3><div class="NLM_p last">An mTOR homology model was built with Modeler(9v6) based on a published PI3KÎ³ crystal structure complexed with GDC-0941 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>). <b>37</b> was docked into the model with Pair fitting, followed by energy minimization with Discovery Studio II.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm101144f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Spectral data of <b>16</b>â<b>17</b>, <b>19</b>â<b>36</b>, <b>38</b>â<b>47</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101144f/suppl_file/jm101144f_si_001.pdf">jm101144f_si_001.pdf (76.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm101144f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathanael S. Gray</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d49ab5a0bcb5bab5b1b88bb3a6b5ad94b0b2b7bdfabcb5a6a2b5a6b0fab1b0a1"><span class="__cf_email__" data-cfemail="2967485d414847484c45764e5b4850694d4f4a400741485b5f485b4d074c4d5c">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingsong Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae Won Chang</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinhua Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seong A. Kang</span> - <span class="hlFld-Affiliation affiliation">Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carson C. Thoreen</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Markhard</span> - <span class="hlFld-Affiliation affiliation">Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wooyoung Hur</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianming Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taebo Sim</span> - <span class="hlFld-Affiliation affiliation">Department of Cancer Biology, Dana Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Sabatini</span> - <span class="hlFld-Affiliation affiliation">Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142</span>;Â 
    <span class="hlFld-Affiliation affiliation">Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139</span>;Â 
    <span class="hlFld-Affiliation affiliation">Koch Center for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Life Technologies Corporation, SelectScreen Kinase Profiling Service for performing enzymatic biochemical kinase profiling. We also thank Ambit Bioscience for performing KinomeScan profiling and Dr. David Waller (Dana Farber Cancer Institute) for the useful proofreading.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-kinase related kinases: âbigâ players in stress-induced signaling pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-kinase+related+kinases%3A+%E2%80%9Cbig%E2%80%9D+players+in+stress-induced+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-kinase%2520related%2520kinases%253A%2520%25E2%2580%259Cbig%25E2%2580%259D%2520players%2520in%2520stress-induced%2520signaling%2520pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Targeting mTOR globally in cancer: thinking beyond rapamycin</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3831</span><span class="NLM_x">â</span> <span class="NLM_lpage">3837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.4161%2Fcc.8.23.10070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19901542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlWrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3831-3837&author=B.+Shorauthor=J%2C+J.+Gibbonsauthor=R%2C+T.+Abrahamauthor=K.+Yu&title=Targeting+mTOR+globally+in+cancer%3A+thinking+beyond+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mTOR globally in cancer: thinking beyond rapamycin</span></div><div class="casAuthors">Shor, Boris; Gibbons, James J.; Abraham, Robert T.; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3831-3837</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is centrally involved in growth, survival and metab.  In cancer, mTOR is frequently hyperactivated and is a clin. validated target for drug development.  Until recently, we have relied largely on the use of rapamycin to study mTOR function and its anticancer potential.  Recent insights now indicate that rapamycin is a partial inhibitor of mTOR through allosteric inhibition of mTOR complex-1 (mTORC1) but not mTOR complex-2 (mTORC2).  Both the mechanism of action and the cellular response to mTORC1 inhibition by rapamycin and related drugs may limit the effectiveness of these compds. as antitumor agents.  We and others have recently reported the discovery of second-generation ATP-competitive mTOR kinase inhibitors (TKIs) that bind to the active sites of mTORC1 and mTORC2, thereby targeting mTOR signaling function globally (reviewed in refs. 1-4).  The discovery of specific, active-site mTOR inhibitors has opened a new chapter in the 40-plus year old odyssey that began with the discovery of rapamycin from a soil sample collected on Easter Island.  Here, we discuss recent studies that highlight the emergence of rapamycin-resistant mTOR function in protein synthesis, cell growth, survival and metab.  It is shown that these rapamycin-resistant mTOR functions are profoundly inhibited by TKIs.  A more complete suppression of mTOR global signaling network by the new inhibitors is expected to yield a deeper and broader antitumor response in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9EP_1DwoGrVg90H21EOLACvtfcHk0lg9m4LeQ-LmWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlWrtL4%253D&md5=4dab0a66742fadd9087aa2c439704f27</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.23.10070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.23.10070%26sid%3Dliteratum%253Aachs%26aulast%3DShor%26aufirst%3DB.%26aulast%3DGibbons%26aufirst%3DJ%252C%2BJ.%26aulast%3DAbraham%26aufirst%3DR%252C%2BT.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DTargeting%2520mTOR%2520globally%2520in%2520cancer%253A%2520thinking%2520beyond%2520rapamycin%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D3831%26epage%3D3837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">mTOR mediated anti-cancer drug discovery</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.ddstr.2009.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=20622997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=47-55&author=Q.+Liuauthor=C.+Thoreenauthor=J.+Wangauthor=D.+Sabatiniauthor=N.+S.+Gray&title=mTOR+mediated+anti-cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR mediated anti-cancer drug discovery</span></div><div class="casAuthors">Liu, Qingsong; Thoreen, Carson; Wang, Jinhua; Sabatini, David; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase and the founding member of a signaling pathway that regulates many fundamental features of cell growth and division.  In cells, mTOR acts as the catalytic subunit of two functionally distinct complexes, called mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2).  Together, these complexes coordinate a variety of processes that include protein translation, autophagy, proliferation, survival and metab. in response to nutrient, energy and growth factor signals.  Consistent with its role as a growth-promoting pathway, numerous studies have found that mTOR signaling is hyper-activated in a broad spectrum of human cancers.  In particular, mTORC2 is considered a primary effector of the phosphatidylinositol-3-kinase (PI3K) signaling pathway, which is mutated in a majority of human cancers, in part through its ability to phosphorylate and regulate the proto-oncogene Akt/PKB.  Many biol. functions of mTOR have been pharmacol. explored using the natural product rapamycin, an allosteric inhibitor that has been reviewed extensively elsewhere.  This review will focus specifically on the development of small mol. ATP-competitive inhibitors of mTOR and their prospects as a targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo708zVFEp5VLVg90H21EOLACvtfcHk0liwTIdVgebFEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D&md5=93364d568c3a23dd0fcf0c3980841e7e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2009.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2009.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DThoreen%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSabatini%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DmTOR%2520mediated%2520anti-cancer%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2009%26volume%3D6%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">â</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-168&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=S.+Senguptaauthor=J.+H.+Sheenauthor=P.+P.+Hsuauthor=A.+F.+Bagleyauthor=A.+L.+Markhardauthor=D.+M.+Sabatini&title=Prolonged+rapamycin+treatment+inhibits+mTORC2+assembly+and+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSheen%26aufirst%3DJ.%2BH.%26aulast%3DHsu%26aufirst%3DP.%2BP.%26aulast%3DBagley%26aufirst%3DA.%2BF.%26aulast%3DMarkhard%26aufirst%3DA.%2BL.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DProlonged%2520rapamycin%2520treatment%2520inhibits%2520mTORC2%2520assembly%2520and%2520Akt%252FPKB%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuleux, M.</span><span> </span><span class="NLM_article-title">Optimal targeting of the mTORC1 kinase in human cancer</span> <span class="citation_source-journal">Curr. Opin. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.ceb.2009.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19233631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=219-229&author=H.+A.+Laneauthor=M.+Breuleux&title=Optimal+targeting+of+the+mTORC1+kinase+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal targeting of the mTORC1 kinase in human cancer</span></div><div class="casAuthors">Lane, Heidi A.; Breuleux, Madlaina</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A central sensor of the availability of growth factors, nutrients, and energy sources, the mammalian target of rapamycin complex 1 (mTORC1) kinase plays a key role in tumor biol.  Consequently, mTORC1 inhibitors were shown to have broad antitumor activity pre-clin. in exptl. tumor models as well as clin. in cancer patients.  Strikingly, certain tumor types appear to be predisposed to respond to mTORC1 inhibition, a phenomenon related to deregulation of crit. elements of the PI3K/mTORC1 pathway.  In this review we address optimization of clin. development in the context of mTORC1 inhibitor-induced activation of survival pathways, crosstalk between different signaling modules involved in malignant transformation, definition of rational target combination scenarios and biol. based dosing and patient stratification strategies.  Emphasis is given where possible to mTORC1 drug development decisions based on full clin. publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kA5ODdrLmrVg90H21EOLACvtfcHk0liwTIdVgebFEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7o%253D&md5=cdacb3486d406d929dc4d1a0d06478c8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DBreuleux%26aufirst%3DM.%26atitle%3DOptimal%2520targeting%2520of%2520the%2520mTORC1%2520kinase%2520in%2520human%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">â</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-Competitive+Mammalian+Target+of+Rapamycin+Inhibitor+Reveals+Rapamycin-Resistant+Functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0liwTIdVgebFEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Inhibitor%2520Reveals%2520Rapamycin-Resistant%2520Functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinght, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of  mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Kinghtauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-Site+Inhibitors+of+mTOR+Target+Rapamycin-Resistant+Outputs+of++mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKinght%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-Site%2520Inhibitors%2520of%2520mTOR%2520Target%2520Rapamycin-Resistant%2520Outputs%2520of%2520%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Garcia-martinez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garcia-martinezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-martinez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T., S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">â</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-kaloustianauthor=T.%2C+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+Cellular%2C+and+in+Vivo+Activity+of+Novel+ATP-Competitive+and+Selective+Inhibitors+of+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%252C%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520Cellular%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Novel%2520ATP-Competitive%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DCancer.%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Barr, S.; Russo, S.; Buck, E.; Epstein, D.; Miglarese, M.</span><span> </span><span class="NLM_article-title">Co-targeting mTOR and IGF-1R/IR results in synergistic activity against a broad array of tumor cell lines, independent of KRAS mutation status</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington, DC</span>, <span class="NLM_conf-date">April, 2010</span>, p  <span class="NLM_fpage">1632</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Barr%2C+S.%3B+Russo%2C+S.%3B+Buck%2C+E.%3B+Epstein%2C+D.%3B+Miglarese%2C+M.+Co-targeting+mTOR+and+IGF-1R%2FIR+results+in+synergistic+activity+against+a+broad+array+of+tumor+cell+lines%2C+independent+of+KRAS+mutation+status.+AACR+101st+Annual+Meeting%2C+Washington%2C+DC%2C+April%2C+2010%2C+p+1632."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DS.%26atitle%3DCo-targeting%2520mTOR%2520and%2520IGF-1R%252FIR%2520results%2520in%2520synergistic%2520activity%2520against%2520a%2520broad%2520array%2520of%2520tumor%2520cell%2520lines%252C%2520independent%2520of%2520KRAS%2520mutation%2520status%26spage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellsonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+Is+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+ATP-Competitive+Mammalian+Target+of+Rapamycin+Kinase+Inhibitor+with+in+Vitro+and+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllson%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520Is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Kinase%2520Inhibitor%2520with%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and optimization of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">â</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+optimization+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6830</span><span class="NLM_x">â</span> <span class="NLM_lpage">6835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6830-6835&author=D.+J.+Richardauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=J.+Lucasauthor=K.+Yuauthor=A.+Zask&title=Incorporation+of+water-solubilizing+groups+in+pyrazolopyrimidine+mTOR+inhibitors%3A+discovery+of+highly+potent+and+selective+analogs+with+improved+human+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DIncorporation%2520of%2520water-solubilizing%2520groups%2520in%2520pyrazolopyrimidine%2520mTOR%2520inhibitors%253A%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520analogs%2520with%2520improved%2520human%2520microsomal%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6830%26epage%3D6835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viguie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">PI-103, a dual inhibitor of class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">â</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1698-1706&author=S.+Parkauthor=N.+Chapuisauthor=V.+Bardetauthor=J.+Tamburiniauthor=N.+Gallayauthor=L.+Willemsauthor=Z.+A.+Knightauthor=K.+M.+Shokatauthor=N.+Azarauthor=F.+Viguieauthor=N.+Ifrahauthor=F+Dreyfusauthor=P.+Mayeuxauthor=C.+Lacombeauthor=D.+Bouscary&title=PI-103%2C+a+dual+inhibitor+of+class+IA+phosphatidylinositide+3-kinase+and+mTOR%2C+has+antileukemic+activity+in+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DN.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DAzar%26aufirst%3DN.%26aulast%3DViguie%26aufirst%3DF.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DPI-103%252C%2520a%2520dual%2520inhibitor%2520of%2520class%2520IA%2520phosphatidylinositide%25203-kinase%2520and%2520mTOR%252C%2520has%2520antileukemic%2520activity%2520in%2520AML%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1698%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llonch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8022</span><span class="NLM_x">â</span> <span class="NLM_lpage">8030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F0008-5472.CAN-08-1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18829560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8022-8030&author=V.+Serraauthor=B.+Markmanauthor=M.+Scaltritiauthor=P.+J.+A.+Eichhornauthor=V.+Valeroauthor=M.+Guzmanauthor=M.+L.+Boteroauthor=E.+Llonchauthor=F.+Atzoriauthor=S.+D.+Cosimoauthor=M.+Mairaauthor=C.+Garcia-Echeverriaauthor=J.+L.+Parraauthor=J.+Arribasauthor=J.+Baselga&title=NVP-BEZ235%2C+a+Dual+PI3K%2FmTOR+Inhibitor%2C+Prevents+PI3K+Signaling+and+Inhibits+the+Growth+of+Cancer+Cells+with+Activating+PI3K+Mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span></div><div class="casAuthors">Serra, Violeta; Markman, Ben; Scaltriti, Maurizio; Eichhorn, Pieter J. A.; Valero, Vanesa; Guzman, Marta; Botero, Maria Luisa; Llonch, Elisabeth; Atzori, Francesco; Di Cosimo, Serena; Maira, Michel; Garcia-Echeverria, Carlos; Parra, Josep Lluis; Arribas, Joaquin; Baselga, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8022-8030</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homolog deleted from chromosome 10 or activating mutations of p110-Î±.  These hotspot mutations result in oncogenic activity of the enzyme and contribute to therapeutic resistance to the anti-HER2 antibody trastuzumab.  The PI3K pathway is, therefore, an attractive target for cancer therapy.  We have studied NVP-BEZ235, a dual inhibitor of the PI3K and the downstream mammalian target of rapamycin (mTOR).  NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breast cancer cells.  The antiproliferative activity of NVP-BEZ235 was superior to the allosteric selective mTOR complex inhibitor everolimus in a panel of 21 cancer cell lines of different origin and mutation status.  The described Akt activation due to mTOR inhibition was prevented by higher doses of NVP-BEZ235.  NVP-BEZ235 reversed the hyperactivation of the PI3K/mTOR pathway caused by the oncogenic mutations of p110-Î±, E545K, and H1047R, and inhibited the proliferation of HER2-amplified BT474 cells exogenously expressing these mutations that render them resistant to trastuzumab.  In trastuzumab-resistant BT474 H1047R breast cancer xenografts, NVP-BEZ235 inhibited PI3K signaling and had potent antitumor activity.  In treated animals, there was complete inhibition of PI3K signaling in the skin at pharmacol. active doses, suggesting that skin may serve as surrogate tissue for pharmacodynamic studies.  In summary, NVP-BEZ235 inhibits the PI3K/mTOR axis and results in antiproliferative and antitumoral activity in cancer cells with both wild-type and mutated p110-Î±.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlC_vqzWMDk7Vg90H21EOLACvtfcHk0lj8Nslrua0LUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK&md5=b5d08e989c1b619e3c0ee9437002afd7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1385%26sid%3Dliteratum%253Aachs%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DBotero%26aufirst%3DM.%2BL.%26aulast%3DLlonch%26aufirst%3DE.%26aulast%3DAtzori%26aufirst%3DF.%26aulast%3DCosimo%26aufirst%3DS.%2BD.%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DNVP-BEZ235%252C%2520a%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%252C%2520Prevents%2520PI3K%2520Signaling%2520and%2520Inhibits%2520the%2520Growth%2520of%2520Cancer%2520Cells%2520with%2520Activating%2520PI3K%2520Mutations%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8022%26epage%3D8030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span> </span><span class="NLM_article-title">Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dostonauthor=A.+Folkesauthor=L.+Freidmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.+Zhu&title=Discovery+of+%28Thienopyrimidin-2-yl%29aminopyrimidines+as+Potent%2C+Selective%2C+and+Orally+Available+Pan-PI3-Kinase+and+Dual+Pan-PI3-Kinase%2FmTOR+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDoston%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFreidman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Pan-PI3-Kinase%2520and%2520Dual%2520Pan-PI3-Kinase%252FmTOR%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">â</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase Î± (PI3KÎ±) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3KÎ± and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0ljeX6EnAmZ-nQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sancak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaul, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peled, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1496</span><span class="NLM_x">â</span> <span class="NLM_lpage">1501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1126%2Fscience.1157535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18497260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVWqsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2008&pages=1496-1501&author=Y.+Sancakauthor=T.+R.+Petersonauthor=Y.+D.+Shaulauthor=R.+A.+Lindquistauthor=C.+C.+Thoreenauthor=L.+B.+Peledauthor=D.+M.+Sabatini&title=The+Rag+GTPases+Bind+Raptor+and+Mediate+Amino+Acid+Signaling+to+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1</span></div><div class="casAuthors">Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Bar-Peled, Liron; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">5882</span>),
    <span class="NLM_cas:pages">1496-1501</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The multiprotein mTORC1 protein kinase complex is the central component of a pathway that promotes growth in response to insulin, energy levels, and amino acids and is deregulated in common cancers.  We find that the Rag proteins-a family of four related small guanosine triphosphatases (GTPases)-interact with mTORC1 in an amino acid-sensitive manner and are necessary for the activation of the mTORC1 pathway by amino acids.  A Rag mutant that is constitutively bound to guanosine triphosphate interacted strongly with mTORC1, and its expression within cells made the mTORC1 pathway resistant to amino acid deprivation.  Conversely, expression of a guanosine diphosphate-bound Rag mutant prevented stimulation of mTORC1 by amino acids.  The Rag proteins do not directly stimulate the kinase activity of mTORC1, but, like amino acids, promote the intracellular localization of mTOR to a compartment that also contains its activator Rheb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmWxESH6HwgLVg90H21EOLACvtfcHk0ljeX6EnAmZ-nQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVWqsr4%253D&md5=e5df88ef594f04671eb9cc61a602e6f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1157535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1157535%26sid%3Dliteratum%253Aachs%26aulast%3DSancak%26aufirst%3DY.%26aulast%3DPeterson%26aufirst%3DT.%2BR.%26aulast%3DShaul%26aufirst%3DY.%2BD.%26aulast%3DLindquist%26aufirst%3DR.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DPeled%26aufirst%3DL.%2BB.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Rag%2520GTPases%2520Bind%2520Raptor%2520and%2520Mediate%2520Amino%2520Acid%2520Signaling%2520to%2520mTORC1%26jtitle%3DScience%26date%3D2008%26volume%3D320%26spage%3D1496%26epage%3D1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A combinatorial scaffold approach toward kinase-directed heterocycle libraries</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1594</span><span class="NLM_x">â</span> <span class="NLM_lpage">1596</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0170302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1594-1596&author=S.+Dingauthor=N.+S.+Grayauthor=X.+Wuauthor=Q.+Dingauthor=P.+G.+Schultz&title=A+combinatorial+scaffold+approach+toward+kinase-directed+heterocycle+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja0170302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0170302%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520combinatorial%2520scaffold%2520approach%2520toward%2520kinase-directed%2520heterocycle%2520libraries%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1594%26epage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord., E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F0008-5472.CAN-03-2868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=15173008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3958-3965&author=S.+K.+Rabindranauthor=C.+M.+Discafaniauthor=E.+C.+Rosfjord.author=M+Baxterauthor=M.+B.+Floydauthor=J.+Golasauthor=W.+A.+Hallettauthor=B.+D.+Johnsonauthor=R.+Nilakantanauthor=E.+Overbeekauthor=M.+F.+Reichauthor=R.+Shenauthor=X.+Shiauthor=H.+R.+Tsouauthor=Y.+F.+Wangauthor=A.+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase</span></div><div class="casAuthors">Rabindran, Sridhar K.; Discafani, Carolyn M.; Rosfjord, Edward C.; Baxter, Michelle; Floyd, M. Brawner; Golas, Jonathan; Hallett, William A.; Johnson, Bernard D.; Nilakantan, Ramaswamy; Overbeek, Elsebe; Reich, Marvin F.; Shen, Ru; Shi, Xiaoqing; Tsou, Hwei-Ru; Wang, Yu-Fen; Wissner, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3958-3965</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HER-2 belongs to the ErbB family of receptor tyrosine kinases, which has been implicated in a variety of cancers.  Overexpression of HER-2 is seen in 25-30% of breast cancer patients and predicts a poor outcome in patients with primary disease.  Trastuzumab (Herceptin), a monoclonal antibody to HER-2, is specifically approved for HER-2-pos. breast cancer but is active only in a subset of these tumors.  Blocking HER-2 function by a small mol. kinase inhibitor, therefore, represents an attractive alternate strategy to inhibit the growth of HER-2-pos. tumors.  HKI-272 is a potent inhibitor of HER-2 and is highly active against HER-2-overexpressing human breast cancer cell lines in vitro.  It also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.  HKI-272 reduces HER-2 receptor autophosphorylation in cells at doses consistent with inhibition of cell proliferation and functions as an irreversible binding inhibitor, most likely by targeting a cysteine residue in the ATP-binding pocket of the receptor.  In agreement with the predicted effects of HER-2 inactivation, HKI-272 treatment of cells results in inhibition of downstream signal transduction events and cell cycle regulatory pathways.  This leads to arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle, ultimately resulting in decreased cell proliferation.  In vivo, HKI-272 is active in HER-2- and EGFR-dependent tumor xenograft models when dosed orally on a once daily schedule.  On the basis of its favorable preclin. pharmacol. profile, HKI-272 has been selected as a candidate for addnl. development as an antitumor agent in breast and other HER-2-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xeLXlAwWvbVg90H21EOLACvtfcHk0ljeX6EnAmZ-nQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D&md5=60accd0599b7c489e4c3753d4f39cab4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-2868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-2868%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DRosfjord.%26aufirst%3DE.%2BC.%26aulast%3DBaxter%26aufirst%3DM%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3958%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusanak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">â</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusanakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0libVkj2iX6F4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusanak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">The Akt kinase: molecular determinants of oncogenicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">14950</span><span class="NLM_x">â</span> <span class="NLM_lpage">14955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=14950-14955&author=M.+Aokiauthor=O.+Batistaauthor=A.+Bellacosaauthor=P.+Tsichlisauthor=P.+K.+Vogt&title=The+Akt+kinase%3A+molecular+determinants+of+oncogenicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DO.%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DTsichlis%26aufirst%3DP.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DThe%2520Akt%2520kinase%253A%2520molecular%2520determinants%2520of%2520oncogenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D14950%26epage%3D14955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stowasser, F.; Banziger, M.; Garad, S. D.</span><span> </span><span class="NLM_article-title">Salts and crystalline forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydroimidazo[4,5-<i>c</i>]quinolin-1-yl)-phenyl]propionitrile</span>. PCT. Int. Appl. WO2008064093,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+Stowasser&author=M.+Banziger&author=S.+D.+Garad&title=Salts+and+crystalline+forms+of+2-methyl-2-%5B4-%283-methyl-2-oxo-8-quinolin-3-yl-2%2C3-dihydroimidazo%5B4%2C5-c%5Dquinolin-1-yl%29-phenyl%5Dpropionitrile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStowasser%26aufirst%3DF.%26atitle%3DSalts%2520and%2520crystalline%2520forms%2520of%25202-methyl-2-%255B4-%25283-methyl-2-oxo-8-quinolin-3-yl-2%252C3-dihydroimidazo%255B4%252C5-c%255Dquinolin-1-yl%2529-phenyl%255Dpropionitrile%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Capraro, H.; Furet, P.</span><span> </span><span class="NLM_article-title">1H-imidazo[4,5-<i>c</i>]quinoline derivatives in the treatment of protein kinase dependent diseases.</span> PCT. Int. Appl. WO03097641,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Garcia-Echeverria&author=H.+Capraro&author=P.+Furet&title=1H-imidazo%5B4%2C5-c%5Dquinoline+derivatives+in+the+treatment+of+protein+kinase+dependent+diseases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D1H-imidazo%255B4%252C5-c%255Dquinoline%2520derivatives%2520in%2520the%2520treatment%2520of%2520protein%2520kinase%2520dependent%2520diseases.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Let.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">â</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.bmcl.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18248814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathway</span></div><div class="casAuthors">Stauffer, Frederic; Maira, Sauveur-Michel; Furet, Pascal; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1027-1030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Imidazo[4,5-c]quinoline derivs. have been discovered and developed as potent and effective modulators of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) pathway to lead to clin. development candidates.  The SAR data of representative examples of this compd. class and their biol. profiling in cellular and in vivo settings are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGWVPHweBID7Vg90H21EOLACvtfcHk0libVkj2iX6F4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWlsbw%253D&md5=1266a6fd4ee3e6cd57eb34b84713a3ae</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Let.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Blocking the PI3K/PKB pathway in tumor cells.</span> <span class="citation_source-journal">Curr. Med. Chem.âAnti-Cancer Agents.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">â</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.2174%2F1568011054866937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=16178772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovV2rsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=449-462&author=F.+Staufferauthor=P.+Holzerauthor=C.+Garcia-Echeverria&title=Blocking+the+PI3K%2FPKB+pathway+in+tumor+cells."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking the PI3K/PKB pathway in tumor cells</span></div><div class="casAuthors">Stauffer, Frederic; Holzer, Philipp; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-462</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A substantial no. of exptl. and epidemiol. studies support an important role for the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) pathway in the biol. of human cancers.  Components of this signaling cascade have been deregulated in a wide range of solid tumors and hematol. malignancies, and extensive anti-cancer therapeutic programs are now devoted to the identification of agents that specifically block this mol. pathway.  This article focuses on the current knowledge of the alterations of the PI3K/PKB pathway in cancer cells and ongoing drug discovery efforts to therapeutically target it.  Particular emphasis is placed on medicinal chem. activities to identify and develop compds. able to modulate the kinase activity of its main mol. components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDY3kHBWG1bVg90H21EOLACvtfcHk0libVkj2iX6F4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovV2rsrk%253D&md5=d05e06c8872a3a868b26844ad918d148</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.2174%2F1568011054866937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011054866937%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DBlocking%2520the%2520PI3K%252FPKB%2520pathway%2520in%2520tumor%2520cells.%26jtitle%3DCurr.%2520Med.%2520Chem.%25E2%2588%2592Anti-Cancer%2520Agents.%26date%3D2005%26volume%3D5%26spage%3D449%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950692f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=918-928&author=G.+W.+Rewcastleauthor=B.+D.+Palmerauthor=A.+J.+Bridgesauthor=H.+D.+H.+Showalterauthor=L.+Sunauthor=J.+Nelsonauthor=A.+McMichaelauthor=A.+J.+Krakerauthor=D.+W.+Fryauthor=W.+A.+Denny&title=Tyrosine+Kinase+Inhibitors.+9.+Synthesis+and+Evaluation+of+Fused+Tricyclic+Quinazoline+Analogues+as+ATP+Site+Inhibitors+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm950692f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950692f%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DJ.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%25209.%2520Synthesis%2520and%2520Evaluation%2520of%2520Fused%2520Tricyclic%2520Quinazoline%2520Analogues%2520as%2520ATP%2520Site%2520Inhibitors%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D918%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gazit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohmer, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoblom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golomb, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tricyclic Quinoxalines as Potent Kinase Inhibitors of PDGFR Kinase, Flt3 and Kit</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">â</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2007-2018&author=A.+Gazitauthor=K.+Yeeauthor=A.+Ueckerauthor=F.+D.+Bohmerauthor=T.+Sjoblomauthor=A.+Ostmanauthor=J.+Waltenbergerauthor=G.+Golombauthor=S.+Banaiauthor=M.+C.+Heinrichauthor=A.+Levitzki&title=Tricyclic+Quinoxalines+as+Potent+Kinase+Inhibitors+of+PDGFR+Kinase%2C+Flt3+and+Kit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DYee%26aufirst%3DK.%26aulast%3DUecker%26aufirst%3DA.%26aulast%3DBohmer%26aufirst%3DF.%2BD.%26aulast%3DSjoblom%26aufirst%3DT.%26aulast%3DOstman%26aufirst%3DA.%26aulast%3DWaltenberger%26aufirst%3DJ.%26aulast%3DGolomb%26aufirst%3DG.%26aulast%3DBanai%26aufirst%3DS.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTricyclic%2520Quinoxalines%2520as%2520Potent%2520Kinase%2520Inhibitors%2520of%2520PDGFR%2520Kinase%252C%2520Flt3%2520and%2520Kit%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2007%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H.</span><span> </span><span class="NLM_article-title">Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4<i>H</i>-pyrazolo-[1,5-<i>a</i>]pyrrolo[3,4-<i>d</i>]pyrimidine-5,8-dione scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">â</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1623-1627&author=M.+S.+Coumarauthor=J.+Wuauthor=J.+Leouauthor=U.+Tanauthor=C.+Changauthor=T.+Changauthor=W.+Linauthor=J.+T.+Hsuauthor=Y.+Chaoauthor=S.+Wuauthor=H.+Hsieh&title=Aurora+kinase+A+inhibitors%3A+identification%2C+SAR+exploration+and+molecular+modeling+of+6%2C7-dihydro-4H-pyrazolo-%5B1%2C5-a%5Dpyrrolo%5B3%2C4-d%5Dpyrimidine-5%2C8-dione+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLeou%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DU.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DH.%26atitle%3DAurora%2520kinase%2520A%2520inhibitors%253A%2520identification%252C%2520SAR%2520exploration%2520and%2520molecular%2520modeling%2520of%25206%252C7-dihydro-4H-pyrazolo-%255B1%252C5-a%255Dpyrrolo%255B3%252C4-d%255Dpyrimidine-5%252C8-dione%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1623%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span> </span><span class="NLM_article-title">Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 inhibitors</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=281-284&author=S.+Moroauthor=F.+Varanoauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=G.+Zagottoauthor=A.+Chilinauthor=A.+Guiottoauthor=D.+Catarziauthor=V.+Calottaauthor=L.+A.+Pinnaauthor=F.+Meggio&title=Pyrazoloquinazoline+Tricyclic+System+as+Novel+Scaffold+to+Design+New+Kinase+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DChilin%26aufirst%3DA.%26aulast%3DGuiotto%26aufirst%3DA.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DCalotta%26aufirst%3DV.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26atitle%3DPyrazoloquinazoline%2520Tricyclic%2520System%2520as%2520Novel%2520Scaffold%2520to%2520Design%2520New%2520Kinase%2520CK2%2520inhibitors%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2006%26volume%3D3%26spage%3D281%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kempson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesnelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevine, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattoli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang-Iverson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Inhibitors of IKB Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">â</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8015816" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1994-2005&author=J.+Kempsonauthor=S.+H.+Spergelauthor=J.+Guoauthor=C.+Quesnelleauthor=P.+Gillauthor=D.+Belangerauthor=A.+J.+Dyckmanauthor=T.+Liauthor=S.+H.+Wattersonauthor=C.+M.+Langevineauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+A.+Furchauthor=A.+Marinierauthor=M.+Dodierauthor=A.+Martelauthor=D.+Nirschlauthor=K.+V.+Kirkauthor=J.+R.+Burkeauthor=M.+A.+Pattoliauthor=K.+Gilloolyauthor=K.+W.+McIntyreauthor=L.+Chenauthor=Z.+Yangauthor=P.+H.+Maratheauthor=D.+Wang-Iversonauthor=H.+H.+Doddauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=W.+J.+Pitts&title=Novel+Tricyclic+Inhibitors+of+IKB+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1021%2Fjm8015816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8015816%26sid%3Dliteratum%253Aachs%26aulast%3DKempson%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DQuesnelle%26aufirst%3DC.%26aulast%3DGill%26aufirst%3DP.%26aulast%3DBelanger%26aufirst%3DD.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DMarinier%26aufirst%3DA.%26aulast%3DDodier%26aufirst%3DM.%26aulast%3DMartel%26aufirst%3DA.%26aulast%3DNirschl%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DK.%2BV.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DWang-Iverson%26aufirst%3DD.%26aulast%3DDodd%26aufirst%3DH.%2BH.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26atitle%3DNovel%2520Tricyclic%2520Inhibitors%2520of%2520IKB%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1994%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Maira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pover, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C. G.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">â</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+D.+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+G.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lj3JNMSi_iDQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DPover%26aufirst%3DA.%2BD.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%2BG.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110Î± in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110Î± in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110Î³ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110Î± is the primary insulin-responsive PI3-K in cultured cells, whereas p110Î² is dispensable but sets a phenotypic threshold for p110Î± activity.  Compds. targeting p110Î± block the acute effects of insulin treatment in vivo, whereas a p110Î² inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lj3JNMSi_iDQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yip, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span> </span><span class="NLM_article-title">Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=768-774&author=C.+K.+Yipauthor=K.+Murataauthor=T.+Walzauthor=D.+M.+Sabatiniauthor=S.+A.+Kang&title=Structure+of+the+Human+mTOR+Complex+I+and+Its+Implications+for+Rapamycin+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DC.%2BK.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DKang%26aufirst%3DS.%2BA.%26atitle%3DStructure%2520of%2520the%2520Human%2520mTOR%2520Complex%2520I%2520and%2520Its%2520Implications%2520for%2520Rapamycin%2520Inhibition%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D5%26spage%3D768%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b'],'ref26':['cit26a','cit26b','cit26c','cit26d','cit26e'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 145 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Karthik Krishnan, Peter Ziniel, Hao Li, Xiuli Huang, Daniel Hupalo, Nita Gombakomba, Sandra Mendoza Guerrero, Thoai Dotrang, Xiao Lu, Diana Caridha, Anna R. Sternberg, Emma Hughes, Wei Sun, Daniel Y. Bargieri, Paul D. Roepe, Richard J. Sciotti, Matthew D. Wilkerson, Clifton L. Dalgard, Gregory J. Tawa, Amy Q. Wang, Xin Xu, Wei Zheng, Philip E. Sanderson, Wenwei Huang, <span class="NLM_string-name hlFld-ContribAuthor">Kim C. Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Torin 2 Derivative, NCATS-SM3710, Has Potent Multistage Antimalarial Activity through Inhibition of P. falciparum Phosphatidylinositol 4-Kinase (Pfâ¯PI4KIIIÎ²). </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (5)
                                     , 948-964. <a href="https://doi.org/10.1021/acsptsci.0c00078" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00078%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTorin%252B2%252BDerivative%25252C%252BNCATS-SM3710%25252C%252BHas%252BPotent%252BMultistage%252BAntimalarial%252BActivity%252Bthrough%252BInhibition%252Bof%252BP.%252Bfalciparum%252BPhosphatidylinositol%252B4-Kinase%252B%252528Pf%2525E2%252580%2525AFPI4KIII%2525CE%2525B2%252529%26aulast%3DKrishnan%26aufirst%3DKarthik%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02072020%26date%3D30092020%26date%3D11092020%26volume%3D3%26issue%3D5%26spage%3D948%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ming-Shu Wang, Hong-Chuang Xu, Yi Gong, Ren-Yu Qu, Lin-Sheng Zhuo, <span class="NLM_string-name hlFld-ContribAuthor">Wei Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 457-467. <a href="https://doi.org/10.1021/acscombsci.0c00074" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BArylation%252Bof%252B2%25252C7-Naphthyridin-1%2525282H%252529-one%252Bwith%252BDiaryliodonium%252BSalts%252Band%252BDiscovery%252Bof%252Ba%252BNew%252BSelective%252BMET%25252FAXL%252BKinase%252BInhibitor%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D22062020%26date%3D10072020%26date%3D26062020%26volume%3D22%26issue%3D9%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohamed
S. A. Elsayed, Brittany Griggs, <span class="NLM_string-name hlFld-ContribAuthor">Mark Cushman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (17)
                                     , 5228-5232. <a href="https://doi.org/10.1021/acs.orglett.8b02171" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02171%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BBenzo%25255B1%25252C6%25255Dnaphthyridinones%252BUsing%252Bthe%252BCatellani%252BReaction%26aulast%3DElsayed%26aufirst%3DMohamed%2BS.%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D13082018%26volume%3D20%26issue%3D17%26spage%3D5228%26epage%3D5232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Xiuli  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao  Lu</span>, <span class="hlFld-ContribAuthor ">Paresma R.  Patel</span>, <span class="hlFld-ContribAuthor ">Myunghoon  Kim</span>, <span class="hlFld-ContribAuthor ">Meghan J.  Orr</span>, <span class="hlFld-ContribAuthor ">Richard M.  Fisher</span>, <span class="hlFld-ContribAuthor ">Takeshi Q  Tanaka</span>, <span class="hlFld-ContribAuthor ">John C.  McKew</span>, <span class="hlFld-ContribAuthor ">Anton  Simeonov</span>, <span class="hlFld-ContribAuthor ">Philip E.  Sanderson</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">Kim C.  Williamson</span>, and <span class="hlFld-ContribAuthor ">Wenwei  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2017,</strong> <em>19 </em>
                                    (12)
                                     , 748-754. <a href="https://doi.org/10.1021/acscombsci.7b00119" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00119%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BSynthesis%252Bof%252B1%25252C9-Substituted%252BBenzo%25255Bh%25255D%25255B1%25252C6%25255Dnaphthyridin-2%2525281H%252529-ones%252Band%252BEvaluation%252Bof%252Btheir%252BPlasmodium%252Bfalciparum%252BGametocytocidal%252BActivities%26aulast%3DLi%26aufirst%3DHao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31072017%26date%3D29092017%26date%3D27102017%26date%3D11122017%26date%3D12102017%26volume%3D19%26issue%3D12%26spage%3D748%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew R.  Hassett</span>, <span class="hlFld-ContribAuthor ">Anna R.  Sternberg</span>, and <span class="hlFld-ContribAuthor ">Paul D.  Roepe</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Human Class I vs Class III Phosphatidylinositol 3â²-Kinases. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2017,</strong> <em>56 </em>
                                    (33)
                                     , 4326-4334. <a href="https://doi.org/10.1021/acs.biochem.7b00413" title="DOI URL">https://doi.org/10.1021/acs.biochem.7b00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.7b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.7b00413%26sid%3Dliteratum%253Aachs%26date%3D2011%26jtitle%3DJ.%2520Med.%2520Chem.%26volume%3D54%26spage%3D1473%26epage%3D1480%26jtitle%3DBiochemistry%26atitle%3DInhibition%252Bof%252BHuman%252BClass%252BI%252Bvs%252BClass%252BIII%252BPhosphatidylinositol%252B3%2525E2%252580%2525B2-Kinases%26aulast%3DHassett%26aufirst%3DMatthew%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02052017%26date%3D11072017%26date%3D08082017%26date%3D22082017%26date%3D18072017%26volume%3D56%26issue%3D33%26spage%3D4326%26epage%3D4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanke  Liang</span>, <span class="hlFld-ContribAuthor ">Melissanne  de Wispelaere</span>, <span class="hlFld-ContribAuthor ">Margot  Carocci</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Priscilla L.  Yang</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">StructureâActivity Relationship Study of QL47: A Broad-Spectrum Antiviral Agent. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 344-349. <a href="https://doi.org/10.1021/acsmedchemlett.7b00008" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00008%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BQL47%25253A%252BA%252BBroad-Spectrum%252BAntiviral%252BAgent%26aulast%3DLiang%26aufirst%3DYanke%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D03022017%26date%3D21022017%26date%3D09032017%26date%3D03022017%26volume%3D8%26issue%3D3%26spage%3D344%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Zi  Wang</span>, <span class="hlFld-ContribAuthor ">Linhua  Song</span>, and <span class="hlFld-ContribAuthor ">Youhong  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Tandem HeckâSonogashira Reactions of N,N-Di-Boc-Protected 6-Amino-5-iodo-2-methyl Pyrimidin-4-ol in An Efficient Approach to Functionalized Pyrido[2,3-d]Pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (13)
                                     , 3524-3527. <a href="https://doi.org/10.1021/ol501459e" title="DOI URL">https://doi.org/10.1021/ol501459e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501459e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501459e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DMicrowave%252BAssisted%252BTandem%252BHeck%2525E2%252580%252593Sonogashira%252BReactions%252Bof%252BN%25252CN-Di-Boc-Protected%252B6-Amino-5-iodo-2-methyl%252BPyrimidin-4-ol%252Bin%252BAn%252BEfficient%252BApproach%252Bto%252BFunctionalized%252BPyrido%25255B2%25252C3-d%25255DPyrimidines%26aulast%3DLiu%26aufirst%3DYang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D22052014%26date%3D23062014%26date%3D03072014%26volume%3D16%26issue%3D13%26spage%3D3524%26epage%3D3527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Feiyang  Liu</span>, <span class="hlFld-ContribAuthor ">Ellen L.  Weisberg</span>, <span class="hlFld-ContribAuthor ">Bei  Tian</span>, <span class="hlFld-ContribAuthor ">Yongfei  Chen</span>, <span class="hlFld-ContribAuthor ">Binhua  Li</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Douglas W.  McMillin</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Yanke  Liang</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>, <span class="hlFld-ContribAuthor ">Junting  Liang</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Brown</span>, <span class="hlFld-ContribAuthor ">Steven P.  Treon</span>, <span class="hlFld-ContribAuthor ">Constantine S.  Mitsiades</span>, <span class="hlFld-ContribAuthor ">James D.  Griffin</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (5)
                                     , 1086-1091. <a href="https://doi.org/10.1021/cb4008524" title="DOI URL">https://doi.org/10.1021/cb4008524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb4008524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb4008524%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BCovalent%252BBTK%252BInhibitor%252Bfor%252BB-Cell%252BLymphoma%26aulast%3DWu%26aufirst%3DHong%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D20022014%26date%3D17032014%26date%3D16052014%26date%3D20022014%26volume%3D9%26issue%3D5%26spage%3D1086%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feiyang  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ellen  Weisberg</span>, <span class="hlFld-ContribAuthor ">Sen  Chen</span>, <span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Mao  Mao</span>, <span class="hlFld-ContribAuthor ">Changmeng  Cai</span>, <span class="hlFld-ContribAuthor ">Nicholas I.  Simon</span>, <span class="hlFld-ContribAuthor ">Takaomi  Sanda</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">A. Thomas  Look</span>, <span class="hlFld-ContribAuthor ">James D.  Griffin</span>, <span class="hlFld-ContribAuthor ">Steven P.  Balk</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (7)
                                     , 1423-1428. <a href="https://doi.org/10.1021/cb4000629" title="DOI URL">https://doi.org/10.1021/cb4000629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb4000629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb4000629%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252BSelective%252BIrreversible%252BBMX%252BInhibitor%252Bfor%252BProstate%252BCancer%26aulast%3DLiu%26aufirst%3DFeiyang%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25012013%26date%3D17042013%26date%3D26042013%26date%3D19072013%26date%3D17042013%26volume%3D8%26issue%3D7%26spage%3D1423%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Epler</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Frederic  St-Jean</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 3090-3101. <a href="https://doi.org/10.1021/jm400194n" title="DOI URL">https://doi.org/10.1021/jm400194n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400194n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400194n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrimidoaminotropanes%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BSmall%252BMolecule%252BKinase%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D29032013%26date%3D11042013%26date%3D08032013%26volume%3D56%26issue%3D7%26spage%3D3090%26epage%3D3101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Jennifer  Epler</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cuong  Ly</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10958-10971. <a href="https://doi.org/10.1021/jm301389h" title="DOI URL">https://doi.org/10.1021/jm301389h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301389h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301389h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252BKinase%252BDomain%252BExhibiting%252BSingle%252BAgent%252BAntiproliferative%252BActivity%26aulast%3DKoehler%26aufirst%3DMichael%2BF.%2BT.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D12122012%26date%3D27122012%26date%3D30112012%26volume%3D55%26issue%3D24%26spage%3D10958%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Tao  Ren</span>, <span class="hlFld-ContribAuthor ">Tara  Fresques</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Oppliger</span>, <span class="hlFld-ContribAuthor ">Brad J.  Niles</span>, <span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>, <span class="hlFld-ContribAuthor ">Michael N.  Hall</span>, <span class="hlFld-ContribAuthor ">Ted  Powers</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective ATP-Competitive Inhibitors of TOR Suppress Rapamycin-Insensitive Function of TORC2 in Saccharomyces cerevisiae. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (6)
                                     , 982-987. <a href="https://doi.org/10.1021/cb300058v" title="DOI URL">https://doi.org/10.1021/cb300058v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb300058v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb300058v%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelective%252BATP-Competitive%252BInhibitors%252Bof%252BTOR%252BSuppress%252BRapamycin-Insensitive%252BFunction%252Bof%252BTORC2%252Bin%252BSaccharomyces%252Bcerevisiae%26aulast%3DLiu%26aufirst%3DQingsong%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10022012%26date%3D11042012%26date%3D18042012%26date%3D15062012%26date%3D11042012%26volume%3D7%26issue%3D6%26spage%3D982%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Susan M.  Young</span>, <span class="hlFld-ContribAuthor ">Chris  Allen</span>, <span class="hlFld-ContribAuthor ">Andrew  Seeber</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  PÃ©li-Gulli</span>, <span class="hlFld-ContribAuthor ">Nicolas  Panchaud</span>, <span class="hlFld-ContribAuthor ">Anna  Waller</span>, <span class="hlFld-ContribAuthor ">Oleg  Ursu</span>, <span class="hlFld-ContribAuthor ">Tuanli  Yao</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Golden</span>, <span class="hlFld-ContribAuthor ">J. Jacob  Strouse</span>, <span class="hlFld-ContribAuthor ">Mark B.  Carter</span>, <span class="hlFld-ContribAuthor ">Huining  Kang</span>, <span class="hlFld-ContribAuthor ">Cristian G.  Bologa</span>, <span class="hlFld-ContribAuthor ">Terry D.  Foutz</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Edwards</span>, <span class="hlFld-ContribAuthor ">Blake R.  Peterson</span>, <span class="hlFld-ContribAuthor ">Jeffrey  AubÃ©</span>, <span class="hlFld-ContribAuthor ">Margaret  Werner-Washburne</span>, <span class="hlFld-ContribAuthor ">Robbie J.  Loewith</span>, <span class="hlFld-ContribAuthor ">Claudio  De Virgilio</span>, and <span class="hlFld-ContribAuthor ">Larry A.  Sklar</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Small Molecule Yeast TORC1 Inhibitor with a Multiplex Screen Based on Flow Cytometry. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (4)
                                     , 715-722. <a href="https://doi.org/10.1021/cb200452r" title="DOI URL">https://doi.org/10.1021/cb200452r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200452r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200452r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIdentification%252Bof%252Ba%252BSmall%252BMolecule%252BYeast%252BTORC1%252BInhibitor%252Bwith%252Ba%252BMultiplex%252BScreen%252BBased%252Bon%252BFlow%252BCytometry%26aulast%3DChen%26aufirst%3DJun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D04112011%26date%3D19012012%26date%3D01022012%26date%3D20042012%26date%3D19012012%26volume%3D7%26issue%3D4%26spage%3D715%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Seong A.  Kang</span>, <span class="hlFld-ContribAuthor ">Carson C.  Thoreen</span>, <span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">Tausif  Ahmed</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1473-1480. <a href="https://doi.org/10.1021/jm101520v" title="DOI URL">https://doi.org/10.1021/jm101520v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101520v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B9-%2525286-Aminopyridin-3-yl%252529-1-%2525283-%252528trifluoromethyl%252529phenyl%252529benzo%25255Bh%25255D%25255B1%25252C6%25255Dnaphthyridin-2%2525281H%252529-one%252B%252528Torin2%252529%252Bas%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BInhibitor%252Bfor%252BTreatment%252Bof%252BCancer%26aulast%3DLiu%26aufirst%3DQingsong%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D26112010%26date%3D15022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1473%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longsheng  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Nannan  Wu</span>, <span class="hlFld-ContribAuthor ">Baiyun  Dai</span>, <span class="hlFld-ContribAuthor ">Shuang  Han</span>, <span class="hlFld-ContribAuthor ">Qiaoyun  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Huang</span>, <span class="hlFld-ContribAuthor ">Zhihua  Chen</span>, <span class="hlFld-ContribAuthor ">Weihong  Xu</span>, <span class="hlFld-ContribAuthor ">Dajing  Xia</span>, <span class="hlFld-ContribAuthor ">Cunji  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">mTOR regulates GPVI-mediated platelet activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Translational Medicine</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12967-021-02756-y" title="DOI URL">https://doi.org/10.1186/s12967-021-02756-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12967-021-02756-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12967-021-02756-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Translational%2520Medicine%26atitle%3DmTOR%252Bregulates%252BGPVI-mediated%252Bplatelet%252Bactivation%26aulast%3DWang%26aufirst%3DLongsheng%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramakant A.  Kardile</span>, <span class="hlFld-ContribAuthor ">Aniket P.  Sarkate</span>, <span class="hlFld-ContribAuthor ">Avinash S.  Borude</span>, <span class="hlFld-ContribAuthor ">Rajendra S.  Mane</span>, <span class="hlFld-ContribAuthor ">Deepak K.  Lokwani</span>, <span class="hlFld-ContribAuthor ">Shailee V.  Tiwari</span>, <span class="hlFld-ContribAuthor ">Rajaram  Azad</span>, <span class="hlFld-ContribAuthor ">Prasad V.L.S.  Burra</span>, <span class="hlFld-ContribAuthor ">Shankar R.  Thopate</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>115 </em>, 105174. <a href="https://doi.org/10.1016/j.bioorg.2021.105174" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105174%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bconformationally%252Bconstrained%252B7%25252C12-dihydrodibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255D%252Bnaphthyridine%252Band%252B7H-Chromeno%25255B3%25252C2-c%25255D%252Bquinoline%252Bderivatives%252Bas%252Btopoisomerase%252BI%252Binhibitors%25253A%252BIn%252Bvitro%252Bscreening%25252C%252Bmolecular%252Bdocking%252Band%252BADME%252Bpredictions%26aulast%3DKardile%26aufirst%3DRamakant%2BA.%26date%3D2021%26volume%3D115%26spage%3D105174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naomasa  Fukase</span>, <span class="hlFld-ContribAuthor ">Ingrid  K. Stake</span>, <span class="hlFld-ContribAuthor ">Yoichi  Murata</span>, <span class="hlFld-ContribAuthor ">William  S. Hambright</span>, <span class="hlFld-ContribAuthor ">Sudheer  Ravuri</span>, <span class="hlFld-ContribAuthor ">Marc  J. Philippon</span>, <span class="hlFld-ContribAuthor ">Johnny  Huard</span>. </span><span class="cited-content_cbyCitation_article-title">Interventional Strategies to Delay Aging-Related Dysfunctions of the Musculoskeletal System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.97311" title="DOI URL">https://doi.org/10.5772/intechopen.97311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.97311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.97311%26sid%3Dliteratum%253Aachs%26atitle%3DInterventional%252BStrategies%252Bto%252BDelay%252BAging-Related%252BDysfunctions%252Bof%252Bthe%252BMusculoskeletal%252BSystem%26aulast%3DFukase%26aufirst%3DNaomasa%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DMuscle%252BCell%252Band%252BTissue%252B-%252BNovel%252BMolecular%252BTargets%252Band%252BCurrent%252BAdvances%26aulast%3DSakuma%26aufirst%3DKunihiro%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anaelle  Costa</span>, <span class="hlFld-ContribAuthor ">Thibaud  Metais</span>, <span class="hlFld-ContribAuthor ">Franck  Mouthon</span>, <span class="hlFld-ContribAuthor ">Danielle  Kerkovich</span>, <span class="hlFld-ContribAuthor ">Mathieu  CharvÃ©riat</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders. </span><span class="cited-content_cbyCitation_journal-name">Fundamental & Clinical Pharmacology</span><span> <strong>2021,</strong> <em>35 </em>
                                    (3)
                                     , 539-551. <a href="https://doi.org/10.1111/fcp.12634" title="DOI URL">https://doi.org/10.1111/fcp.12634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/fcp.12634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffcp.12634%26sid%3Dliteratum%253Aachs%26jtitle%3DFundamental%2520%2526%2520Clinical%2520Pharmacology%26atitle%3DEvaluating%252Band%252Bmodulating%252BTFEB%252Bin%252Bthe%252Bcontrol%252Bof%252Bautophagy%25253A%252Btoward%252Bnew%252Btreatments%252Bin%252BCNS%252Bdisorders%26aulast%3DCosta%26aufirst%3DAnaelle%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D3%26spage%3D539%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Whitmarsh-Everiss</span>, <span class="hlFld-ContribAuthor ">Luca  Laraia</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule probes for targeting autophagy. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (6)
                                     , 653-664. <a href="https://doi.org/10.1038/s41589-021-00768-9" title="DOI URL">https://doi.org/10.1038/s41589-021-00768-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-021-00768-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-021-00768-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DSmall%252Bmolecule%252Bprobes%252Bfor%252Btargeting%252Bautophagy%26aulast%3DWhitmarsh-Everiss%26aufirst%3DThomas%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D6%26spage%3D653%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis  Giraud</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Pereira</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2696. <a href="https://doi.org/10.3390/molecules26092696" title="DOI URL">https://doi.org/10.3390/molecules26092696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092696%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BPain%252BManagement%25253A%252BRelevant%252BProtein%252BKinases%252Band%252BTheir%252BInhibitors%26aulast%3DGiraud%26aufirst%3DFrancis%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qitao  Zhang</span>, <span class="hlFld-ContribAuthor ">Feriel  Presswalla</span>, <span class="hlFld-ContribAuthor ">Robin R.  Ali</span>, <span class="hlFld-ContribAuthor ">David N.  Zacks</span>, <span class="hlFld-ContribAuthor ">Debra A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Jason ML.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic activation of autophagy without direct mTOR inhibition as a therapeutic strategy for treating dry macular degeneration. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 10866-10890. <a href="https://doi.org/10.18632/aging.202974" title="DOI URL">https://doi.org/10.18632/aging.202974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.202974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.202974%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DPharmacologic%252Bactivation%252Bof%252Bautophagy%252Bwithout%252Bdirect%252BmTOR%252Binhibition%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Btreating%252Bdry%252Bmacular%252Bdegeneration%26aulast%3DZhang%26aufirst%3DQitao%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D10866%26epage%3D10890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shumin  Zhang</span>, <span class="hlFld-ContribAuthor ">A. Rehman  Khalid</span>, <span class="hlFld-ContribAuthor ">Dongmei  Guo</span>, <span class="hlFld-ContribAuthor ">Jingping  Zhang</span>, <span class="hlFld-ContribAuthor ">Fangjie  Xiong</span>, <span class="hlFld-ContribAuthor ">Maozhi  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">TOR Inhibitors Synergistically Suppress the Growth and Development of Phytophthora infestans, a Highly Destructive Pathogenic Oomycete. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fmicb.2021.596874" title="DOI URL">https://doi.org/10.3389/fmicb.2021.596874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2021.596874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2021.596874%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DTOR%252BInhibitors%252BSynergistically%252BSuppress%252Bthe%252BGrowth%252Band%252BDevelopment%252Bof%252BPhytophthora%252Binfestans%25252C%252Ba%252BHighly%252BDestructive%252BPathogenic%252BOomycete%26aulast%3DZhang%26aufirst%3DShumin%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallu  Lavanya</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Dhakshanamurthy  Thirumalai</span>, <span class="hlFld-ContribAuthor ">Sreenath Reddy  Aabaka</span>, <span class="hlFld-ContribAuthor ">Xiaojiang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Mao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Huang</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00314-6" title="DOI URL">https://doi.org/10.1007/s41061-020-00314-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00314-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BProperties%252Bof%252BFunctionalized%252B1%25252C6-Naphthyridines%26aulast%3DLavanya%26aufirst%3DMallu%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andromachi  Lambrianidou</span>, <span class="hlFld-ContribAuthor ">Evangelia  Sereti</span>, <span class="hlFld-ContribAuthor ">Katerina  Soupsana</span>, <span class="hlFld-ContribAuthor ">Chrysoula  Komini</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Dimas</span>, <span class="hlFld-ContribAuthor ">Theoni  Trangas</span>. </span><span class="cited-content_cbyCitation_article-title">mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2021,</strong> <em>80 </em>, 109912. <a href="https://doi.org/10.1016/j.cellsig.2020.109912" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109912%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DmTORC2%252Bdeploys%252Bthe%252BmRNA%252Bbinding%252Bprotein%252BIGF2BP1%252Bto%252Bregulate%252Bc-MYC%252Bexpression%252Band%252Bpromote%252Bcell%252Bsurvival%26aulast%3DLambrianidou%26aufirst%3DAndromachi%26date%3D2021%26volume%3D80%26spage%3D109912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Briana K.  Shimada</span>, <span class="hlFld-ContribAuthor ">Naaiko  Yorichika</span>, <span class="hlFld-ContribAuthor ">Jason K.  Higa</span>, <span class="hlFld-ContribAuthor ">Yuichi  Baba</span>, <span class="hlFld-ContribAuthor ">Motoi  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Toshinori  Aoyagi</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Suhara</span>, <span class="hlFld-ContribAuthor ">Takashi  Matsui</span>. </span><span class="cited-content_cbyCitation_article-title">mTORâmediated calcium transients affect cardiac function in
              ex vivo
              ischemiaâreperfusion injury. </span><span class="cited-content_cbyCitation_journal-name">Physiological Reports</span><span> <strong>2021,</strong> <em>9 </em>
                                    (6)
                                     <a href="https://doi.org/10.14814/phy2.14807" title="DOI URL">https://doi.org/10.14814/phy2.14807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14814/phy2.14807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14814%2Fphy2.14807%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Reports%26atitle%3DmTOR%2525E2%252580%252590mediated%252Bcalcium%252Btransients%252Baffect%252Bcardiac%252Bfunction%252Bin%252Bex%252Bvivo%252Bischemia%2525E2%252580%252593reperfusion%252Binjury%26aulast%3DShimada%26aufirst%3DBriana%2BK.%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John C.  Charpentier</span>, <span class="hlFld-ContribAuthor ">Di  Chen</span>, <span class="hlFld-ContribAuthor ">Philip E.  Lapinski</span>, <span class="hlFld-ContribAuthor ">Jackson  Turner</span>, <span class="hlFld-ContribAuthor ">Irina  Grigorova</span>, <span class="hlFld-ContribAuthor ">Joel A.  Swanson</span>, <span class="hlFld-ContribAuthor ">Philip D.  King</span>. </span><span class="cited-content_cbyCitation_article-title">Macropinocytosis drives T cell growth by sustaining the activation of mTORC1. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-13997-3" title="DOI URL">https://doi.org/10.1038/s41467-019-13997-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-13997-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-13997-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMacropinocytosis%252Bdrives%252BT%252Bcell%252Bgrowth%252Bby%252Bsustaining%252Bthe%252Bactivation%252Bof%252BmTORC1%26aulast%3DCharpentier%26aufirst%3DJohn%2BC.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Insup  Choi</span>, <span class="hlFld-ContribAuthor ">Yuanxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven P.  Seegobin</span>, <span class="hlFld-ContribAuthor ">Mathilde  Pruvost</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Kerry  Purtell</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenyu  Yue</span>. </span><span class="cited-content_cbyCitation_article-title">Microglia clear neuron-released Î±-synuclein via selective autophagy and prevent neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-15119-w" title="DOI URL">https://doi.org/10.1038/s41467-020-15119-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-15119-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-15119-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMicroglia%252Bclear%252Bneuron-released%252B%2525CE%2525B1-synuclein%252Bvia%252Bselective%252Bautophagy%252Band%252Bprevent%252Bneurodegeneration%26aulast%3DChoi%26aufirst%3DInsup%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wouter Laurentius  Smit</span>, <span class="hlFld-ContribAuthor ">Claudia Nanette  Spaan</span>, <span class="hlFld-ContribAuthor ">Ruben  Johannes de Boer</span>, <span class="hlFld-ContribAuthor ">Prashanthi  Ramesh</span>, <span class="hlFld-ContribAuthor ">TÃ¢nia  Martins Garcia</span>, <span class="hlFld-ContribAuthor ">Bartolomeus Joannes  Meijer</span>, <span class="hlFld-ContribAuthor ">Jacqueline Ludovicus Maria  Vermeulen</span>, <span class="hlFld-ContribAuthor ">Marco  Lezzerini</span>, <span class="hlFld-ContribAuthor ">Alyson Winfried  MacInnes</span>, <span class="hlFld-ContribAuthor ">Jan  Koster</span>, <span class="hlFld-ContribAuthor ">Jan Paul  Medema</span>, <span class="hlFld-ContribAuthor ">Gijs Robert  van den Brink</span>, <span class="hlFld-ContribAuthor ">Vanesa  Muncan</span>, <span class="hlFld-ContribAuthor ">Jarom  Heijmans</span>. </span><span class="cited-content_cbyCitation_article-title">Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (41)
                                     , 25560-25570. <a href="https://doi.org/10.1073/pnas.1912772117" title="DOI URL">https://doi.org/10.1073/pnas.1912772117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1912772117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1912772117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDriver%252Bmutations%252Bof%252Bthe%252Badenoma-carcinoma%252Bsequence%252Bgovern%252Bthe%252Bintestinal%252Bepithelial%252Bglobal%252Btranslational%252Bcapacity%26aulast%3DSmit%26aufirst%3DWouter%2BLaurentius%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D41%26spage%3D25560%26epage%3D25570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annamaria  Martorana</span>, <span class="hlFld-ContribAuthor ">Gabriele  La Monica</span>, <span class="hlFld-ContribAuthor ">Antonino  Lauria</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4279. <a href="https://doi.org/10.3390/molecules25184279" title="DOI URL">https://doi.org/10.3390/molecules25184279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184279%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DQuinoline-Based%252BMolecules%252BTargeting%252Bc-Met%25252C%252BEGF%25252C%252Band%252BVEGF%252BReceptors%252Band%252Bthe%252BProteins%252BInvolved%252Bin%252BRelated%252BCarcinogenic%252BPathways%26aulast%3DMartorana%26aufirst%3DAnnamaria%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Xu</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112391. <a href="https://doi.org/10.1016/j.ejmech.2020.112391" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112391%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BmTOR%252Bfor%252Bfighting%252Bdiseases%25253A%252BA%252Brevisited%252Breview%252Bof%252BmTOR%252Binhibitors%26aulast%3DXu%26aufirst%3DTian%26date%3D2020%26volume%3D199%26spage%3D112391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruslana  Bryk</span>, <span class="hlFld-ContribAuthor ">Shashirekha  Mundhra</span>, <span class="hlFld-ContribAuthor ">Xiuju  Jiang</span>, <span class="hlFld-ContribAuthor ">Madeleine  Wood</span>, <span class="hlFld-ContribAuthor ">Daniel  Pfau</span>, <span class="hlFld-ContribAuthor ">Elaina  Weber</span>, <span class="hlFld-ContribAuthor ">Suna  Park</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Colin  Wilson</span>, <span class="hlFld-ContribAuthor ">Renier  Van der Westhuyzen</span>, <span class="hlFld-ContribAuthor ">Leslie  Street</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Matthew  Zimmerman</span>, <span class="hlFld-ContribAuthor ">VÃ©ronique  Dartois</span>, <span class="hlFld-ContribAuthor ">Nunzia  Pastore</span>, <span class="hlFld-ContribAuthor ">Andrea  Ballabio</span>, <span class="hlFld-ContribAuthor ">Natalie  Hawryluk</span>, <span class="hlFld-ContribAuthor ">Stacie  Canan</span>, <span class="hlFld-ContribAuthor ">Vikram  Khetani</span>, <span class="hlFld-ContribAuthor ">Joseph  Camardo</span>, <span class="hlFld-ContribAuthor ">Carl  Nathan</span>, . </span><span class="cited-content_cbyCitation_article-title">Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2020,</strong> <em>16 </em>
                                    (6)
                                     , e1008567. <a href="https://doi.org/10.1371/journal.ppat.1008567" title="DOI URL">https://doi.org/10.1371/journal.ppat.1008567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1008567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1008567%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DPotentiation%252Bof%252Brifampin%252Bactivity%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Btuberculosis%252Bby%252Bactivation%252Bof%252Bhost%252Btranscription%252Bfactor%252BEB%26aulast%3DBryk%26aufirst%3DRuslana%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D6%26spage%3De1008567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chetan V.  Jawale</span>, <span class="hlFld-ContribAuthor ">Kritika  Ramani</span>, <span class="hlFld-ContribAuthor ">De-dong  Li</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Coleman</span>, <span class="hlFld-ContribAuthor ">Rohan S.  Oberoi</span>, <span class="hlFld-ContribAuthor ">Saran  Kupul</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>, <span class="hlFld-ContribAuthor ">Jigar V.  Desai</span>, <span class="hlFld-ContribAuthor ">Greg M.  Delgoffe</span>, <span class="hlFld-ContribAuthor ">Michail S.  Lionakis</span>, <span class="hlFld-ContribAuthor ">Filitsa H.  Bender</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Prokopienko</span>, <span class="hlFld-ContribAuthor ">Thomas D.  Nolin</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Gaffen</span>, <span class="hlFld-ContribAuthor ">Partha S.  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2020,</strong> <em>12 </em>
                                    (548)
                                     , eaay5691. <a href="https://doi.org/10.1126/scitranslmed.aay5691" title="DOI URL">https://doi.org/10.1126/scitranslmed.aay5691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aay5691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aay5691%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DRestoring%252Bglucose%252Buptake%252Brescues%252Bneutrophil%252Bdysfunction%252Band%252Bprotects%252Bagainst%252Bsystemic%252Bfungal%252Binfection%252Bin%252Bmouse%252Bmodels%252Bof%252Bkidney%252Bdisease%26aulast%3DJawale%26aufirst%3DChetan%2BV.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D548%26spage%3Deaay5691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mouna  Triki</span>, <span class="hlFld-ContribAuthor ">Gianmarco  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Melanie  Planque</span>, <span class="hlFld-ContribAuthor ">Dorien  Broekaert</span>, <span class="hlFld-ContribAuthor ">Alina M.  Winkelkotte</span>, <span class="hlFld-ContribAuthor ">Carina R.  Maier</span>, <span class="hlFld-ContribAuthor ">Sudha  Janaki Raman</span>, <span class="hlFld-ContribAuthor ">Anke  Vandekeere</span>, <span class="hlFld-ContribAuthor ">Joke  Van Elsen</span>, <span class="hlFld-ContribAuthor ">Martin F.  Orth</span>, <span class="hlFld-ContribAuthor ">Thomas G.P.  GrÃ¼newald</span>, <span class="hlFld-ContribAuthor ">Almut  Schulze</span>, <span class="hlFld-ContribAuthor ">Sarah-Maria  Fendt</span>. </span><span class="cited-content_cbyCitation_article-title">mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2020,</strong> <em>31 </em>
                                    (12)
                                     , 107806. <a href="https://doi.org/10.1016/j.celrep.2020.107806" title="DOI URL">https://doi.org/10.1016/j.celrep.2020.107806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2020.107806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2020.107806%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DmTOR%252BSignaling%252Band%252BSREBP%252BActivity%252BIncrease%252BFADS2%252BExpression%252Band%252BCan%252BActivate%252BSapienate%252BBiosynthesis%26aulast%3DTriki%26aufirst%3DMouna%26date%3D2020%26volume%3D31%26issue%3D12%26spage%3D107806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyeongmin  Kim</span>, <span class="hlFld-ContribAuthor ">Songyeon  Choi</span>, <span class="hlFld-ContribAuthor ">Myeounghoon  Cha</span>, <span class="hlFld-ContribAuthor ">Bae Hwan  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of mTOR inhibitors on neuropathic pain revealed by optical imaging of the insular cortex in rats. </span><span class="cited-content_cbyCitation_journal-name">Brain Research</span><span> <strong>2020,</strong> <em>1733 </em>, 146720. <a href="https://doi.org/10.1016/j.brainres.2020.146720" title="DOI URL">https://doi.org/10.1016/j.brainres.2020.146720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainres.2020.146720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainres.2020.146720%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%26atitle%3DEffects%252Bof%252BmTOR%252Binhibitors%252Bon%252Bneuropathic%252Bpain%252Brevealed%252Bby%252Boptical%252Bimaging%252Bof%252Bthe%252Binsular%252Bcortex%252Bin%252Brats%26aulast%3DKim%26aufirst%3DKyeongmin%26date%3D2020%26volume%3D1733%26spage%3D146720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyu  Chen</span>, <span class="hlFld-ContribAuthor ">Xiufang  Xiong</span>, <span class="hlFld-ContribAuthor ">Danrui  Cui</span>, <span class="hlFld-ContribAuthor ">Fei  Yang</span>, <span class="hlFld-ContribAuthor ">Dongping  Wei</span>, <span class="hlFld-ContribAuthor ">Haomin  Li</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Shu</span>, <span class="hlFld-ContribAuthor ">Yanli  Bi</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Dai</span>, <span class="hlFld-ContribAuthor ">Longyuan  Gong</span>, <span class="hlFld-ContribAuthor ">Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Yongchao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (7)
                                     , 1557-1571. <a href="https://doi.org/10.1038/s41388-019-1085-y" title="DOI URL">https://doi.org/10.1038/s41388-019-1085-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-019-1085-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-019-1085-y%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DDEPTOR%252Bis%252Ban%252Bin%252Bvivo%252Btumor%252Bsuppressor%252Bthat%252Binhibits%252Bprostate%252Btumorigenesis%252Bvia%252Bthe%252Binactivation%252Bof%252BmTORC1%25252F2%252Bsignals%26aulast%3DChen%26aufirst%3DXiaoyu%26date%3D2020%26date%3D2019%26volume%3D39%26issue%3D7%26spage%3D1557%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel  Datan</span>, <span class="hlFld-ContribAuthor ">Shaima  Salman</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagic cell death in viral infection: Do TAM receptors play a role?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 123-168. <a href="https://doi.org/10.1016/bs.ircmb.2020.10.001" title="DOI URL">https://doi.org/10.1016/bs.ircmb.2020.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.ircmb.2020.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.ircmb.2020.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DAutophagic%252Bcell%252Bdeath%252Bin%252Bviral%252Binfection%25253A%252BDo%252BTAM%252Breceptors%252Bplay%252Ba%252Brole%25253F%26aulast%3DDatan%26aufirst%3DEmmanuel%26date%3D2020%26spage%3D123%26epage%3D168%26pub%3DElsevier%26atitle%3DTAM%252BReceptors%252Bin%252BHealth%252Band%252BDisease%26date%3D2020%26volume%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sameer S.  Chopra</span>, <span class="hlFld-ContribAuthor ">Anne  Jenney</span>, <span class="hlFld-ContribAuthor ">Adam  Palmer</span>, <span class="hlFld-ContribAuthor ">Mario  Niepel</span>, <span class="hlFld-ContribAuthor ">Mirra  Chung</span>, <span class="hlFld-ContribAuthor ">Caitlin  Mills</span>, <span class="hlFld-ContribAuthor ">Sindhu Carmen  Sivakumaren</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Clarence  Yapp</span>, <span class="hlFld-ContribAuthor ">John M.  Asara</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>. </span><span class="cited-content_cbyCitation_article-title">Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cell Systems</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 66-81.e11. <a href="https://doi.org/10.1016/j.cels.2019.11.001" title="DOI URL">https://doi.org/10.1016/j.cels.2019.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cels.2019.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cels.2019.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Systems%26atitle%3DTorin2%252BExploits%252BReplication%252Band%252BCheckpoint%252BVulnerabilities%252Bto%252BCause%252BDeath%252Bof%252BPI3K-Activated%252BTriple-Negative%252BBreast%252BCancer%252BCells%26aulast%3DChopra%26aufirst%3DSameer%2BS.%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D66%26epage%3D81.e11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Louis F.  Amorosa</span>, <span class="hlFld-ContribAuthor ">Anna  Petrova</span>, <span class="hlFld-ContribAuthor ">Susette  Coyle</span>, <span class="hlFld-ContribAuthor ">Marie  Macor</span>, <span class="hlFld-ContribAuthor ">Mohan  Nair</span>, <span class="hlFld-ContribAuthor ">Leonard Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Beatrice  Haimovich</span>. </span><span class="cited-content_cbyCitation_article-title">TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-43347-8" title="DOI URL">https://doi.org/10.1038/s41598-019-43347-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-43347-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-43347-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTLR4%252Bcounteracts%252BBVRA%252Bsignaling%252Bin%252Bhuman%252Bleukocytes%252Bvia%252Bdifferential%252Bregulation%252Bof%252BAMPK%25252C%252BmTORC1%252Band%252BmTORC2%26aulast%3DZhang%26aufirst%3DZhiyong%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Tyagi</span>, <span class="hlFld-ContribAuthor ">Mostafa A.  Elfawal</span>, <span class="hlFld-ContribAuthor ">Scott A.  Wildman</span>, <span class="hlFld-ContribAuthor ">Jon  Helander</span>, <span class="hlFld-ContribAuthor ">Christina A.  Bulman</span>, <span class="hlFld-ContribAuthor ">Judy  Sakanari</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Rosa</span>, <span class="hlFld-ContribAuthor ">Paul J.  Brindley</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Raffi V.  Aroian</span>, <span class="hlFld-ContribAuthor ">Makedonka  Mitreva</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-45548-7" title="DOI URL">https://doi.org/10.1038/s41598-019-45548-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-45548-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-45548-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Bof%252Bsmall%252Bmolecule%252Benzyme%252Binhibitors%252Bas%252Bbroad-spectrum%252Banthelmintics%26aulast%3DTyagi%26aufirst%3DRahul%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James Won Suk  Jahng</span>, <span class="hlFld-ContribAuthor ">Reham Musaibeh  Alsaadi</span>, <span class="hlFld-ContribAuthor ">Rengasamy  Palanivel</span>, <span class="hlFld-ContribAuthor ">Erfei  Song</span>, <span class="hlFld-ContribAuthor ">Victoria Emily Barbosa  Hipolito</span>, <span class="hlFld-ContribAuthor ">Hye Kyoung  Sung</span>, <span class="hlFld-ContribAuthor ">Roberto Jorge  Botelho</span>, <span class="hlFld-ContribAuthor ">Ryan Charles  Russell</span>, <span class="hlFld-ContribAuthor ">Gary  Sweeney</span>. </span><span class="cited-content_cbyCitation_article-title">Iron overload inhibits late stage autophagic flux leading to insulin resistance. </span><span class="cited-content_cbyCitation_journal-name">EMBO reports</span><span> <strong>2019,</strong> <em>20 </em>
                                    (10)
                                     <a href="https://doi.org/10.15252/embr.201947911" title="DOI URL">https://doi.org/10.15252/embr.201947911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embr.201947911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembr.201947911%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520reports%26atitle%3DIron%252Boverload%252Binhibits%252Blate%252Bstage%252Bautophagic%252Bflux%252Bleading%252Bto%252Binsulin%252Bresistance%26aulast%3DJahng%26aufirst%3DJames%2BWon%2BSuk%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blair P.  Curless</span>, <span class="hlFld-ContribAuthor ">Nne E.  Uko</span>, <span class="hlFld-ContribAuthor ">Diane F.  Matesic</span>. </span><span class="cited-content_cbyCitation_article-title">Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2019,</strong> <em>37 </em>
                                    (5)
                                     , 902-911. <a href="https://doi.org/10.1007/s10637-018-0705-7" title="DOI URL">https://doi.org/10.1007/s10637-018-0705-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-018-0705-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-018-0705-7%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DModulator%252Bof%252Bthe%252BPI3K%25252FAkt%252Boncogenic%252Bpathway%252Baffects%252BmTOR%252Bcomplex%252B2%252Bin%252Bhuman%252Badenocarcinoma%252Bcells%26aulast%3DCurless%26aufirst%3DBlair%2BP.%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D5%26spage%3D902%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ozge  Alvur</span>, <span class="hlFld-ContribAuthor ">Onur  Tokgun</span>, <span class="hlFld-ContribAuthor ">Yasemin  Baygu</span>, <span class="hlFld-ContribAuthor ">Nilgun  Kabay</span>, <span class="hlFld-ContribAuthor ">Yasar  Gok</span>, <span class="hlFld-ContribAuthor ">Hakan  Akca</span>. </span><span class="cited-content_cbyCitation_article-title">The triazole linked galactose substituted dicyano compound can induce autophagy in NSCLC cell lines. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2019,</strong> <em>712 </em>, 143935. <a href="https://doi.org/10.1016/j.gene.2019.06.025" title="DOI URL">https://doi.org/10.1016/j.gene.2019.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2019.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2019.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DThe%252Btriazole%252Blinked%252Bgalactose%252Bsubstituted%252Bdicyano%252Bcompound%252Bcan%252Binduce%252Bautophagy%252Bin%252BNSCLC%252Bcell%252Blines%26aulast%3DAlvur%26aufirst%3DOzge%26date%3D2019%26volume%3D712%26spage%3D143935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donna  Episcopio</span>, <span class="hlFld-ContribAuthor ">Sarah  Aminov</span>, <span class="hlFld-ContribAuthor ">Shawna  Benjamin</span>, <span class="hlFld-ContribAuthor ">Gabrielle  Germain</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Datan</span>, <span class="hlFld-ContribAuthor ">Joselyn  Landazuri</span>, <span class="hlFld-ContribAuthor ">Richard A.  Lockshin</span>, <span class="hlFld-ContribAuthor ">Zahra  Zakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2019,</strong> <em>33 </em>
                                    (8)
                                     , 9516-9525. <a href="https://doi.org/10.1096/fj.201900428RR" title="DOI URL">https://doi.org/10.1096/fj.201900428RR</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.201900428RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.201900428RR%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DAtorvastatin%252Brestricts%252Bthe%252Bability%252Bof%252Binfluenza%252Bvirus%252Bto%252Bgenerate%252Blipid%252Bdroplets%252Band%252Bseverely%252Bsuppresses%252Bthe%252Breplication%252Bof%252Bthe%252Bvirus%26aulast%3DEpiscopio%26aufirst%3DDonna%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D8%26spage%3D9516%26epage%3D9525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara J.  Holditch</span>, <span class="hlFld-ContribAuthor ">Carolyn N.  Brown</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Atwood</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Lombardi</span>, <span class="hlFld-ContribAuthor ">Khoa N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Harrison W.  Toll</span>, <span class="hlFld-ContribAuthor ">Katharina  Hopp</span>, <span class="hlFld-ContribAuthor ">Charles L.  Edelstein</span>. </span><span class="cited-content_cbyCitation_article-title">A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
              Pkd1
              mouse model of autosomal dominant polycystic kidney disease. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Renal Physiology</span><span> <strong>2019,</strong> <em>317 </em>
                                    (1)
                                     , F187-F196. <a href="https://doi.org/10.1152/ajprenal.00051.2019" title="DOI URL">https://doi.org/10.1152/ajprenal.00051.2019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajprenal.00051.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajprenal.00051.2019%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Renal%2520Physiology%26atitle%3DA%252Bstudy%252Bof%252Bsirolimus%252Band%252BmTOR%252Bkinase%252Binhibitor%252Bin%252Ba%252Bhypomorphic%252BPkd1%252Bmouse%252Bmodel%252Bof%252Bautosomal%252Bdominant%252Bpolycystic%252Bkidney%252Bdisease%26aulast%3DHolditch%26aufirst%3DSara%2BJ.%26date%3D2019%26volume%3D317%26issue%3D1%26spage%3DF187%26epage%3DF196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junfang  Wu</span>, <span class="hlFld-ContribAuthor ">Marta M.  Lipinski</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagy in Neurotrauma: Good, Bad, or Dysregulated. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (7)
                                     , 693. <a href="https://doi.org/10.3390/cells8070693" title="DOI URL">https://doi.org/10.3390/cells8070693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8070693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8070693%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DAutophagy%252Bin%252BNeurotrauma%25253A%252BGood%25252C%252BBad%25252C%252Bor%252BDysregulated%26aulast%3DWu%26aufirst%3DJunfang%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D7%26spage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Li  Shen</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Liu</span>, <span class="hlFld-ContribAuthor ">Shuyu  Zhan</span>, <span class="hlFld-ContribAuthor ">Baoyue  Ding</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 4-Acrylamido-Quinoline Derivatives as Potent PI3K/mTOR Dual Inhibitors: The Design, Synthesis, and in vitro and in vivo Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00236" title="DOI URL">https://doi.org/10.3389/fchem.2019.00236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00236%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DNovel%252B4-Acrylamido-Quinoline%252BDerivatives%252Bas%252BPotent%252BPI3K%25252FmTOR%252BDual%252BInhibitors%25253A%252BThe%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252BBiological%252BEvaluation%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-HÃ©lÃ¨ne  MontanÃ©</span>, <span class="hlFld-ContribAuthor ">BenoÃ®t  Menand</span>. </span><span class="cited-content_cbyCitation_article-title">TOR inhibitors: from mammalian outcomes to pharmacogenetics in plants and algae. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Botany</span><span> <strong>2019,</strong> <em>70 </em>
                                    (8)
                                     , 2297-2312. <a href="https://doi.org/10.1093/jxb/erz053" title="DOI URL">https://doi.org/10.1093/jxb/erz053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jxb/erz053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjxb%2Ferz053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Botany%26atitle%3DTOR%252Binhibitors%25253A%252Bfrom%252Bmammalian%252Boutcomes%252Bto%252Bpharmacogenetics%252Bin%252Bplants%252Band%252Balgae%26aulast%3DMontan%25C3%25A9%26aufirst%3DMarie-H%25C3%25A9l%25C3%25A8ne%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D8%26spage%3D2297%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lianpin  Wu</span>, <span class="hlFld-ContribAuthor ">Baozhu  Yi</span>, <span class="hlFld-ContribAuthor ">Shi  Wei</span>, <span class="hlFld-ContribAuthor ">Dapeng  Rao</span>, <span class="hlFld-ContribAuthor ">Youhua  He</span>, <span class="hlFld-ContribAuthor ">Gurudatta  Naik</span>, <span class="hlFld-ContribAuthor ">Sejong  Bae</span>, <span class="hlFld-ContribAuthor ">Xiaoguang M.  Liu</span>, <span class="hlFld-ContribAuthor ">Wei-Hsiung  Yang</span>, <span class="hlFld-ContribAuthor ">Guru  Sonpavde</span>, <span class="hlFld-ContribAuthor ">Runhua  Liu</span>, <span class="hlFld-ContribAuthor ">Lizhong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (7)
                                     , 1413-1425. <a href="https://doi.org/10.1158/0008-5472.CAN-18-2049" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-2049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-2049%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DLoss%252Bof%252BFOXP3%252Band%252BTSC1%252BAccelerates%252BProstate%252BCancer%252BProgression%252Bthrough%252BSynergistic%252BTranscriptional%252Band%252BPosttranslational%252BRegulation%252Bof%252Bc-MYC%26aulast%3DWu%26aufirst%3DLianpin%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D7%26spage%3D1413%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linxuan  Li</span>, <span class="hlFld-ContribAuthor ">Tingting  Zhu</span>, <span class="hlFld-ContribAuthor ">Yun  Song</span>, <span class="hlFld-ContribAuthor ">Xiumei  Luo</span>, <span class="hlFld-ContribAuthor ">Li  Feng</span>, <span class="hlFld-ContribAuthor ">Fengping  Zhuo</span>, <span class="hlFld-ContribAuthor ">Fuguang  Li</span>, <span class="hlFld-ContribAuthor ">Maozhi  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Characterization of Target of Rapamycin Signaling in Verticillium dahliae. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fmicb.2019.00501" title="DOI URL">https://doi.org/10.3389/fmicb.2019.00501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2019.00501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2019.00501%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DFunctional%252BCharacterization%252Bof%252BTarget%252Bof%252BRapamycin%252BSignaling%252Bin%252BVerticillium%252Bdahliae%26aulast%3DLi%26aufirst%3DLinxuan%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Poluzzi</span>, <span class="hlFld-ContribAuthor ">Madalina-Viviana  Nastase</span>, <span class="hlFld-ContribAuthor ">Jinyang  Zeng-Brouwers</span>, <span class="hlFld-ContribAuthor ">Heiko  Roedig</span>, <span class="hlFld-ContribAuthor ">Louise Tzung-Harn  Hsieh</span>, <span class="hlFld-ContribAuthor ">Jonas B.  Michaelis</span>, <span class="hlFld-ContribAuthor ">Eva Miriam  Buhl</span>, <span class="hlFld-ContribAuthor ">Flavia  Rezende</span>, <span class="hlFld-ContribAuthor ">Yosif  Manavski</span>, <span class="hlFld-ContribAuthor ">AndrÃ©  Bleich</span>, <span class="hlFld-ContribAuthor ">Peter  Boor</span>, <span class="hlFld-ContribAuthor ">Ralf P.  Brandes</span>, <span class="hlFld-ContribAuthor ">Josef  Pfeilschifter</span>, <span class="hlFld-ContribAuthor ">Ernst H.K.  Stelzer</span>, <span class="hlFld-ContribAuthor ">Christian  MÃ¼nch</span>, <span class="hlFld-ContribAuthor ">Ivan  Dikic</span>, <span class="hlFld-ContribAuthor ">Christian  Brandts</span>, <span class="hlFld-ContribAuthor ">Renato V.  Iozzo</span>, <span class="hlFld-ContribAuthor ">Malgorzata  Wygrecka</span>, <span class="hlFld-ContribAuthor ">Liliana  Schaefer</span>. </span><span class="cited-content_cbyCitation_article-title">Biglycan evokes autophagy in macrophages via aÂ novel CD44/Toll-like receptor 4 signaling axisÂ inÂ ischemia/reperfusion injury. </span><span class="cited-content_cbyCitation_journal-name">Kidney International</span><span> <strong>2019,</strong> <em>95 </em>
                                    (3)
                                     , 540-562. <a href="https://doi.org/10.1016/j.kint.2018.10.037" title="DOI URL">https://doi.org/10.1016/j.kint.2018.10.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.kint.2018.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.kint.2018.10.037%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%26atitle%3DBiglycan%252Bevokes%252Bautophagy%252Bin%252Bmacrophages%252Bvia%252Ba%2525C2%2525A0novel%252BCD44%25252FToll-like%252Breceptor%252B4%252Bsignaling%252Baxis%2525C2%2525A0in%2525C2%2525A0ischemia%25252Freperfusion%252Binjury%26aulast%3DPoluzzi%26aufirst%3DChiara%26date%3D2019%26volume%3D95%26issue%3D3%26spage%3D540%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niina  Vuokila</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Lukasiuk</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Bot</span>, <span class="hlFld-ContribAuthor ">Erwin A.  van Vliet</span>, <span class="hlFld-ContribAuthor ">Eleonora  Aronica</span>, <span class="hlFld-ContribAuthor ">Asla  PitkÃ¤nen</span>, <span class="hlFld-ContribAuthor ">Noora  Puhakka</span>. </span><span class="cited-content_cbyCitation_article-title">miR-124-3p is a chronic regulator of gene expression after brain injury. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2018,</strong> <em>75 </em>
                                    (24)
                                     , 4557-4581. <a href="https://doi.org/10.1007/s00018-018-2911-z" title="DOI URL">https://doi.org/10.1007/s00018-018-2911-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-018-2911-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-018-2911-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DmiR-124-3p%252Bis%252Ba%252Bchronic%252Bregulator%252Bof%252Bgene%252Bexpression%252Bafter%252Bbrain%252Binjury%26aulast%3DVuokila%26aufirst%3DNiina%26date%3D2018%26date%3D2018%26volume%3D75%26issue%3D24%26spage%3D4557%26epage%3D4581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Lixia  Xia</span>, <span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Lingren  Zhou</span>, <span class="hlFld-ContribAuthor ">Qingyu  Weng</span>, <span class="hlFld-ContribAuthor ">Zhouyang  Li</span>, <span class="hlFld-ContribAuthor ">Yinfang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Mao</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanping  Wu</span>, <span class="hlFld-ContribAuthor ">Miao  Li</span>, <span class="hlFld-ContribAuthor ">Songmin  Ying</span>, <span class="hlFld-ContribAuthor ">Zhihua  Chen</span>, <span class="hlFld-ContribAuthor ">Huahao  Shen</span>, <span class="hlFld-ContribAuthor ">Wen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">mTOR complexes differentially orchestrates eosinophil development in allergy. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-25358-z" title="DOI URL">https://doi.org/10.1038/s41598-018-25358-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-25358-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-25358-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DmTOR%252Bcomplexes%252Bdifferentially%252Borchestrates%252Beosinophil%252Bdevelopment%252Bin%252Ballergy%26aulast%3DZhu%26aufirst%3DChen%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin H.  Song</span>, <span class="hlFld-ContribAuthor ">Neha  Singh</span>, <span class="hlFld-ContribAuthor ">Libia A.  Luevano</span>, <span class="hlFld-ContribAuthor ">Sathish K.R.  Padi</span>, <span class="hlFld-ContribAuthor ">Koichi  Okumura</span>, <span class="hlFld-ContribAuthor ">Virginie  Olive</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Black</span>, <span class="hlFld-ContribAuthor ">Noel A.  Warfel</span>, <span class="hlFld-ContribAuthor ">David W.  Goodrich</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Kraft</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (12)
                                     , 2710-2721. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0374" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0374%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMechanisms%252BBehind%252BResistance%252Bto%252BPI3K%252BInhibitor%252BTreatment%252BInduced%252Bby%252Bthe%252BPIM%252BKinase%26aulast%3DSong%26aufirst%3DJin%2BH.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D12%26spage%3D2710%26epage%3D2721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Buerger</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fimmu.2018.02786" title="DOI URL">https://doi.org/10.3389/fimmu.2018.02786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2018.02786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2018.02786%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DEpidermal%252BmTORC1%252BSignaling%252BContributes%252Bto%252Bthe%252BPathogenesis%252Bof%252BPsoriasis%252Band%252BCould%252BServe%252Bas%252Ba%252BTherapeutic%252BTarget%26aulast%3DBuerger%26aufirst%3DClaudia%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">AndrÃ©s  Norambuena</span>, <span class="hlFld-ContribAuthor ">Horst  Wallrabe</span>, <span class="hlFld-ContribAuthor ">Rui  Cao</span>, <span class="hlFld-ContribAuthor ">Dora Bigler  Wang</span>, <span class="hlFld-ContribAuthor ">Antonia  Silva</span>, <span class="hlFld-ContribAuthor ">Zdenek  Svindrych</span>, <span class="hlFld-ContribAuthor ">Ammasi  Periasamy</span>, <span class="hlFld-ContribAuthor ">Song  Hu</span>, <span class="hlFld-ContribAuthor ">Rudolph E  Tanzi</span>, <span class="hlFld-ContribAuthor ">Doo Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">George S  Bloom</span>. </span><span class="cited-content_cbyCitation_article-title">A novel lysosomeâtoâmitochondria signaling pathway disrupted by amyloidâÎ² oligomers. </span><span class="cited-content_cbyCitation_journal-name">The EMBO Journal</span><span> <strong>2018,</strong> <em>37 </em>
                                    (22)
                                     <a href="https://doi.org/10.15252/embj.2018100241" title="DOI URL">https://doi.org/10.15252/embj.2018100241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embj.2018100241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembj.2018100241%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520EMBO%2520Journal%26atitle%3DA%252Bnovel%252Blysosome%2525E2%252580%252590to%2525E2%252580%252590mitochondria%252Bsignaling%252Bpathway%252Bdisrupted%252Bby%252Bamyloid%2525E2%252580%252590%2525CE%2525B2%252Boligomers%26aulast%3DNorambuena%26aufirst%3DAndr%25C3%25A9s%26date%3D2018%26date%3D2018%26volume%3D37%26issue%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magda  Descorbeth</span>, <span class="hlFld-ContribAuthor ">Karen  Figueroa</span>, <span class="hlFld-ContribAuthor ">Miguel  Serrano-IllÃ¡n</span>, <span class="hlFld-ContribAuthor ">Marino  De LeÃ³n</span>. </span><span class="cited-content_cbyCitation_article-title">Protective effect of docosahexaenoic acid on lipotoxicity-mediated cell death in Schwann cells: Implication of PI3K/AKT and mTORC2 pathways. </span><span class="cited-content_cbyCitation_journal-name">Brain and Behavior</span><span> <strong>2018,</strong> <em>8 </em>
                                    (11)
                                     , e01123. <a href="https://doi.org/10.1002/brb3.1123" title="DOI URL">https://doi.org/10.1002/brb3.1123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/brb3.1123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbrb3.1123%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520and%2520Behavior%26atitle%3DProtective%252Beffect%252Bof%252Bdocosahexaenoic%252Bacid%252Bon%252Blipotoxicity-mediated%252Bcell%252Bdeath%252Bin%252BSchwann%252Bcells%25253A%252BImplication%252Bof%252BPI3K%25252FAKT%252Band%252BmTORC2%252Bpathways%26aulast%3DDescorbeth%26aufirst%3DMagda%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D11%26spage%3De01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher M.  Dower</span>, <span class="hlFld-ContribAuthor ">Neema  Bhat</span>, <span class="hlFld-ContribAuthor ">Melat T.  Gebru</span>, <span class="hlFld-ContribAuthor ">Longgui  Chen</span>, <span class="hlFld-ContribAuthor ">Carson A.  Wills</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Miller</span>, <span class="hlFld-ContribAuthor ">Hong-Gang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Inhibition of ULK1 Promotes Apoptosis and Suppresses Tumor Growth and Metastasis in Neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (11)
                                     , 2365-2376. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0176" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0176%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTargeted%252BInhibition%252Bof%252BULK1%252BPromotes%252BApoptosis%252Band%252BSuppresses%252BTumor%252BGrowth%252Band%252BMetastasis%252Bin%252BNeuroblastoma%26aulast%3DDower%26aufirst%3DChristopher%2BM.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D11%26spage%3D2365%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Amanda Marie  Shaw</span>, <span class="hlFld-ContribAuthor ">Howard  Goldfine</span>, <span class="hlFld-ContribAuthor ">Junqiang  Tian</span>, <span class="hlFld-ContribAuthor ">Jiyang  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing TFEB-Mediated Cellular Degradation Pathways by the mTORC1 Inhibitor Quercetin. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2018,</strong> <em>2018 </em>, 1-9. <a href="https://doi.org/10.1155/2018/5073420" title="DOI URL">https://doi.org/10.1155/2018/5073420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/5073420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F5073420%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DEnhancing%252BTFEB-Mediated%252BCellular%252BDegradation%252BPathways%252Bby%252Bthe%252BmTORC1%252BInhibitor%252BQuercetin%26aulast%3DHuang%26aufirst%3DYi%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhadeep  Palit</span>, <span class="hlFld-ContribAuthor ">Sanghamitra  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Sougata  Niyogi</span>, <span class="hlFld-ContribAuthor ">Anindyajit  Banerjee</span>, <span class="hlFld-ContribAuthor ">Dipendu  Patra</span>, <span class="hlFld-ContribAuthor ">Amit  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Saikat  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">Partha  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">Sanjay  Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline-Glycomimetic Conjugates Reducing Lipogenesis and Lipid Accumulation in Hepatocytes. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2018,</strong> <em>19 </em>
                                    (16)
                                     , 1720-1726. <a href="https://doi.org/10.1002/cbic.201800271" title="DOI URL">https://doi.org/10.1002/cbic.201800271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201800271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201800271%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DQuinoline-Glycomimetic%252BConjugates%252BReducing%252BLipogenesis%252Band%252BLipid%252BAccumulation%252Bin%252BHepatocytes%26aulast%3DPalit%26aufirst%3DSubhadeep%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D16%26spage%3D1720%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Felices</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Lenvik</span>, <span class="hlFld-ContribAuthor ">Ron  McElmurry</span>, <span class="hlFld-ContribAuthor ">Sami  Chu</span>, <span class="hlFld-ContribAuthor ">Peter  Hinderlie</span>, <span class="hlFld-ContribAuthor ">Laura  Bendzick</span>, <span class="hlFld-ContribAuthor ">Melissa A.  Geller</span>, <span class="hlFld-ContribAuthor ">Jakub  Tolar</span>, <span class="hlFld-ContribAuthor ">Bruce R.  Blazar</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2018,</strong> <em>3 </em>
                                    (3)
                                     <a href="https://doi.org/10.1172/jci.insight.96219" title="DOI URL">https://doi.org/10.1172/jci.insight.96219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.96219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.96219%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DContinuous%252Btreatment%252Bwith%252BIL-15%252Bexhausts%252Bhuman%252BNK%252Bcells%252Bvia%252Ba%252Bmetabolic%252Bdefect%26aulast%3DFelices%26aufirst%3DMartin%26date%3D2018%26volume%3D3%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi Wen  Fan</span>, <span class="hlFld-ContribAuthor ">Theodore P.  Nicolaides</span>, <span class="hlFld-ContribAuthor ">William A.  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting 4EBP1 in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2018,</strong> <em>24 </em>
                                    (1)
                                     , 14-21. <a href="https://doi.org/10.1158/1078-0432.CCR-17-0042" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-0042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-0042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-0042%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DInhibiting%252B4EBP1%252Bin%252BGlioblastoma%26aulast%3DFan%26aufirst%3DQi%2BWen%26date%3D2018%26date%3D2017%26volume%3D24%26issue%3D1%26spage%3D14%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrrs  Norambuena</span>, <span class="hlFld-ContribAuthor ">Horst  Wallrabe</span>, <span class="hlFld-ContribAuthor ">Rui  Cao</span>, <span class="hlFld-ContribAuthor ">Dora Bigler  Wang</span>, <span class="hlFld-ContribAuthor ">Antonia  Silva</span>, <span class="hlFld-ContribAuthor ">Zdenek  Svindrych</span>, <span class="hlFld-ContribAuthor ">Ammasi  Periasamy</span>, <span class="hlFld-ContribAuthor ">Song  Hu</span>, <span class="hlFld-ContribAuthor ">Doo Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Rudolph E.  Tanzi</span>, <span class="hlFld-ContribAuthor ">George S.  Bloom</span>. </span><span class="cited-content_cbyCitation_article-title">Nutrient-induced Mitochondrial Activation (NiMA): A Novel Lysosome-to-Mitochondria Signaling Pathway Disrupted by Amyloid-- Oligomers. </span><span class="cited-content_cbyCitation_journal-name">SSRN Electronic Journal</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.2139/ssrn.3188445" title="DOI URL">https://doi.org/10.2139/ssrn.3188445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2139/ssrn.3188445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2139%2Fssrn.3188445%26sid%3Dliteratum%253Aachs%26jtitle%3DSSRN%2520Electronic%2520Journal%26atitle%3DNutrient-induced%252BMitochondrial%252BActivation%252B%252528NiMA%252529%25253A%252BA%252BNovel%252BLysosome-to-Mitochondria%252BSignaling%252BPathway%252BDisrupted%252Bby%252BAmyloid%25252D%25252D%252BOligomers%26aulast%3DNorambuena%26aufirst%3DAndrrs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashok K.  Shetty</span>, <span class="hlFld-ContribAuthor ">Maheedhar  Kodali</span>, <span class="hlFld-ContribAuthor ">Raghavendra  Upadhya</span>, <span class="hlFld-ContribAuthor ">Leelavathi N.  Madhu</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Anti-Aging Strategies - Scientific Basis and Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Aging and disease</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 1165. <a href="https://doi.org/10.14336/AD.2018.1026" title="DOI URL">https://doi.org/10.14336/AD.2018.1026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14336/AD.2018.1026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14336%2FAD.2018.1026%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%2520and%2520disease%26atitle%3DEmerging%252BAnti-Aging%252BStrategies%252B-%252BScientific%252BBasis%252Band%252BEfficacy%26aulast%3DShetty%26aufirst%3DAshok%2BK.%26date%3D2018%26volume%3D9%26issue%3D6%26spage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bill X.  Huang</span>, <span class="hlFld-ContribAuthor ">Kenny  Newcomer</span>, <span class="hlFld-ContribAuthor ">Karl  Kevala</span>, <span class="hlFld-ContribAuthor ">Elena  Barnaeva</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Samarjit  Patnaik</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Juan  Marugan</span>, <span class="hlFld-ContribAuthor ">Marc  Ferrer</span>, <span class="hlFld-ContribAuthor ">Hee-Yong  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-11870-1" title="DOI URL">https://doi.org/10.1038/s41598-017-11870-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-11870-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-11870-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Bof%252B4-phenylquinolin-2%2525281H%252529-one%252Bas%252Ba%252Bspecific%252Ballosteric%252Binhibitor%252Bof%252BAkt%26aulast%3DHuang%26aufirst%3DBill%2BX.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tijmen H.  Booij</span>, <span class="hlFld-ContribAuthor ">Hester  Bange</span>, <span class="hlFld-ContribAuthor ">Wouter N.  Leonhard</span>, <span class="hlFld-ContribAuthor ">Kuan  Yan</span>, <span class="hlFld-ContribAuthor ">Michiel  Fokkelman</span>, <span class="hlFld-ContribAuthor ">Steven J.  Kunnen</span>, <span class="hlFld-ContribAuthor ">Johannes G.  Dauwerse</span>, <span class="hlFld-ContribAuthor ">Yu  Qin</span>, <span class="hlFld-ContribAuthor ">Bob  van de Water</span>, <span class="hlFld-ContribAuthor ">Gerard J. P.  van Westen</span>, <span class="hlFld-ContribAuthor ">Dorien J. M.  Peters</span>, <span class="hlFld-ContribAuthor ">Leo S.  Price</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2017,</strong> <em>22 </em>
                                    (8)
                                     , 974-984. <a href="https://doi.org/10.1177/2472555217716056" title="DOI URL">https://doi.org/10.1177/2472555217716056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555217716056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555217716056%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DHigh-Throughput%252BPhenotypic%252BScreening%252Bof%252BKinase%252BInhibitors%252Bto%252BIdentify%252BDrug%252BTargets%252Bfor%252BPolycystic%252BKidney%252BDisease%26aulast%3DBooij%26aufirst%3DTijmen%2BH.%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D8%26spage%3D974%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang-Oh  Yoon</span>, <span class="hlFld-ContribAuthor ">Sejeong  Shin</span>, <span class="hlFld-ContribAuthor ">Florian A.  Karreth</span>, <span class="hlFld-ContribAuthor ">Gwen R.  Buel</span>, <span class="hlFld-ContribAuthor ">Mark P.  Jedrychowski</span>, <span class="hlFld-ContribAuthor ">David R.  Plas</span>, <span class="hlFld-ContribAuthor ">Shoukat  Dedhar</span>, <span class="hlFld-ContribAuthor ">Steven P.  Gygi</span>, <span class="hlFld-ContribAuthor ">Philippe P.  Roux</span>, <span class="hlFld-ContribAuthor ">Noah  Dephoure</span>, <span class="hlFld-ContribAuthor ">John  Blenis</span>. </span><span class="cited-content_cbyCitation_article-title">Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2017,</strong> <em>67 </em>
                                    (3)
                                     , 512-527.e4. <a href="https://doi.org/10.1016/j.molcel.2017.06.033" title="DOI URL">https://doi.org/10.1016/j.molcel.2017.06.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2017.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2017.06.033%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DFocal%252BAdhesion-%252Band%252BIGF1R-Dependent%252BSurvival%252Band%252BMigratory%252BPathways%252BMediate%252BTumor%252BResistance%252Bto%252BmTORC1%25252F2%252BInhibition%26aulast%3DYoon%26aufirst%3DSang-Oh%26date%3D2017%26volume%3D67%26issue%3D3%26spage%3D512%26epage%3D527.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianna  HÃ¶sel</span>, <span class="hlFld-ContribAuthor ">Anke  Huber</span>, <span class="hlFld-ContribAuthor ">Susanne  Bohlen</span>, <span class="hlFld-ContribAuthor ">Julie  Lucifora</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Ronzitti</span>, <span class="hlFld-ContribAuthor ">Francesco  Puzzo</span>, <span class="hlFld-ContribAuthor ">Florence  Boisgerault</span>, <span class="hlFld-ContribAuthor ">Ulrich T.  Hacker</span>, <span class="hlFld-ContribAuthor ">Wilhelmus J.  Kwanten</span>, <span class="hlFld-ContribAuthor ">Nora  KlÃ¶ting</span>, <span class="hlFld-ContribAuthor ">Matthias  BlÃ¼her</span>, <span class="hlFld-ContribAuthor ">Alexander  Gluschko</span>, <span class="hlFld-ContribAuthor ">Michael  Schramm</span>, <span class="hlFld-ContribAuthor ">Olaf  UtermÃ¶hlen</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Bloch</span>, <span class="hlFld-ContribAuthor ">Federico  Mingozzi</span>, <span class="hlFld-ContribAuthor ">Oleg  Krut</span>, <span class="hlFld-ContribAuthor ">Hildegard  BÃ¼ning</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2017,</strong> <em>66 </em>
                                    (1)
                                     , 252-265. <a href="https://doi.org/10.1002/hep.29176" title="DOI URL">https://doi.org/10.1002/hep.29176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.29176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.29176%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DAutophagy%252Bdetermines%252Befficiency%252Bof%252Bliver-directed%252Bgene%252Btherapy%252Bwith%252Badeno-associated%252Bviral%252Bvectors%26aulast%3DH%25C3%25B6sel%26aufirst%3DMarianna%26date%3D2017%26date%3D2017%26volume%3D66%26issue%3D1%26spage%3D252%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karine Rech  Begnini</span>, <span class="hlFld-ContribAuthor ">Wladimir R.  Duarte</span>, <span class="hlFld-ContribAuthor ">Liziane Pereira  da Silva</span>, <span class="hlFld-ContribAuthor ">Julieti H.  Buss</span>, <span class="hlFld-ContribAuthor ">Bruna S.  Goldani</span>, <span class="hlFld-ContribAuthor ">Mariana  Fronza</span>, <span class="hlFld-ContribAuthor ">NatÃ¡lia Vieira  Segatto</span>, <span class="hlFld-ContribAuthor ">Diego  Alves</span>, <span class="hlFld-ContribAuthor ">Lucielli  Savegnago</span>, <span class="hlFld-ContribAuthor ">Fabiana KÃ¶mmling  Seixas</span>, <span class="hlFld-ContribAuthor ">Tiago  Collares</span>. </span><span class="cited-content_cbyCitation_article-title">Apoptosis induction by 7-chloroquinoline-1,2,3-triazoyl carboxamides in triple negative breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2017,</strong> <em>91 </em>, 510-516. <a href="https://doi.org/10.1016/j.biopha.2017.04.098" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.04.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.04.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.04.098%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DApoptosis%252Binduction%252Bby%252B7-chloroquinoline-1%25252C2%25252C3-triazoyl%252Bcarboxamides%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%252Bcells%26aulast%3DBegnini%26aufirst%3DKarine%2BRech%26date%3D2017%26volume%3D91%26spage%3D510%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuchao  Gu</span>, <span class="hlFld-ContribAuthor ">Claudio P.  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Daniel  Braas</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Genaro R.  Villa</span>, <span class="hlFld-ContribAuthor ">Junfeng  Bi</span>, <span class="hlFld-ContribAuthor ">Shiro  Ikegami</span>, <span class="hlFld-ContribAuthor ">Kenta  Masui</span>, <span class="hlFld-ContribAuthor ">Beatrice  Gini</span>, <span class="hlFld-ContribAuthor ">Huijun  Yang</span>, <span class="hlFld-ContribAuthor ">Timothy C.  Gahman</span>, <span class="hlFld-ContribAuthor ">Andrew K.  Shiau</span>, <span class="hlFld-ContribAuthor ">Timothy F.  Cloughesy</span>, <span class="hlFld-ContribAuthor ">Heather R.  Christofk</span>, <span class="hlFld-ContribAuthor ">Huilin  Zhou</span>, <span class="hlFld-ContribAuthor ">Kun-Liang  Guan</span>, <span class="hlFld-ContribAuthor ">Paul S.  Mischel</span>. </span><span class="cited-content_cbyCitation_article-title">mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2017,</strong> <em>67 </em>
                                    (1)
                                     , 128-138.e7. <a href="https://doi.org/10.1016/j.molcel.2017.05.030" title="DOI URL">https://doi.org/10.1016/j.molcel.2017.05.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2017.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2017.05.030%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DmTORC2%252BRegulates%252BAmino%252BAcid%252BMetabolism%252Bin%252BCancer%252Bby%252BPhosphorylation%252Bof%252Bthe%252BCystine-Glutamate%252BAntiporter%252BxCT%26aulast%3DGu%26aufirst%3DYuchao%26date%3D2017%26volume%3D67%26issue%3D1%26spage%3D128%26epage%3D138.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Kissing</span>, <span class="hlFld-ContribAuthor ">SÃ¶nke  Rudnik</span>, <span class="hlFld-ContribAuthor ">Markus  Damme</span>, <span class="hlFld-ContribAuthor ">Renate  LÃ¼llmann-Rauch</span>, <span class="hlFld-ContribAuthor ">Atsuhiro  Ichihara</span>, <span class="hlFld-ContribAuthor ">Uwe  Kornak</span>, <span class="hlFld-ContribAuthor ">Eeva-Liisa  Eskelinen</span>, <span class="hlFld-ContribAuthor ">Sabrina  Jabs</span>, <span class="hlFld-ContribAuthor ">JÃ¶rg  Heeren</span>, <span class="hlFld-ContribAuthor ">Jef K.  De Brabander</span>, <span class="hlFld-ContribAuthor ">Albert  Haas</span>, <span class="hlFld-ContribAuthor ">Paul  Saftig</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of the vacuolar-type H
              +
              -ATPase complex in liver causes MTORC1-independent accumulation of autophagic vacuoles and lysosomes. </span><span class="cited-content_cbyCitation_journal-name">Autophagy</span><span> <strong>2017,</strong> <em>13 </em>
                                    (4)
                                     , 670-685. <a href="https://doi.org/10.1080/15548627.2017.1280216" title="DOI URL">https://doi.org/10.1080/15548627.2017.1280216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15548627.2017.1280216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15548627.2017.1280216%26sid%3Dliteratum%253Aachs%26jtitle%3DAutophagy%26atitle%3DDisruption%252Bof%252Bthe%252Bvacuolar-type%252BH%252B%25252B%252B-ATPase%252Bcomplex%252Bin%252Bliver%252Bcauses%252BMTORC1-independent%252Baccumulation%252Bof%252Bautophagic%252Bvacuoles%252Band%252Blysosomes%26aulast%3DKissing%26aufirst%3DSandra%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D4%26spage%3D670%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomofumi  Naruse</span>, <span class="hlFld-ContribAuthor ">Souichi  Yanamoto</span>, <span class="hlFld-ContribAuthor ">Kohei  Okuyama</span>, <span class="hlFld-ContribAuthor ">Kentaro  Yamashita</span>, <span class="hlFld-ContribAuthor ">Keisuke  Omori</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakao</span>, <span class="hlFld-ContribAuthor ">Shin-ichi  Yamada</span>, <span class="hlFld-ContribAuthor ">Masahiro  Umeda</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic implication of mTORC2 in oral squamous cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oral Oncology</span><span> <strong>2017,</strong> <em>65 </em>, 23-32. <a href="https://doi.org/10.1016/j.oraloncology.2016.12.012" title="DOI URL">https://doi.org/10.1016/j.oraloncology.2016.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.oraloncology.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.oraloncology.2016.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Oncology%26atitle%3DTherapeutic%252Bimplication%252Bof%252BmTORC2%252Bin%252Boral%252Bsquamous%252Bcell%252Bcarcinoma%26aulast%3DNaruse%26aufirst%3DTomofumi%26date%3D2017%26volume%3D65%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiandong  Sun</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Tran</span>, <span class="hlFld-ContribAuthor ">Patrick  OâNeal</span>, <span class="hlFld-ContribAuthor ">Michel  Baudry</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Bi</span>. </span><span class="cited-content_cbyCitation_article-title">mTORC1âS6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2016,</strong> <em>73 </em>
                                    (22)
                                     , 4303-4314. <a href="https://doi.org/10.1007/s00018-016-2269-z" title="DOI URL">https://doi.org/10.1007/s00018-016-2269-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-016-2269-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-016-2269-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DmTORC1%2525E2%252580%252593S6K1%252Binhibition%252Bor%252BmTORC2%252Bactivation%252Bimproves%252Bhippocampal%252Bsynaptic%252Bplasticity%252Band%252Blearning%252Bin%252BAngelman%252Bsyndrome%252Bmice%26aulast%3DSun%26aufirst%3DJiandong%26date%3D2016%26date%3D2016%26volume%3D73%26issue%3D22%26spage%3D4303%26epage%3D4314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei Shi  Ong</span>, <span class="hlFld-ContribAuthor ">Louis Z.  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Dai</span>, <span class="hlFld-ContribAuthor ">Sheng Hsuan  Tseng</span>, <span class="hlFld-ContribAuthor ">Shang Jun  Loo</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>. </span><span class="cited-content_cbyCitation_article-title">Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2016,</strong> <em>7 </em><a href="https://doi.org/10.3389/fphar.2016.00395" title="DOI URL">https://doi.org/10.3389/fphar.2016.00395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2016.00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2016.00395%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DJudicious%252BToggling%252Bof%252BmTOR%252BActivity%252Bto%252BCombat%252BInsulin%252BResistance%252Band%252BCancer%25253A%252BCurrent%252BEvidence%252Band%252BPerspectives%26aulast%3DOng%26aufirst%3DPei%2BShi%26date%3D2016%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta P.  Carrasco</span>, <span class="hlFld-ContribAuthor ">Marta  Machado</span>, <span class="hlFld-ContribAuthor ">LÃ­dia  GonÃ§alves</span>, <span class="hlFld-ContribAuthor ">Moni  Sharma</span>, <span class="hlFld-ContribAuthor ">Jiri  Gut</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Lukens</span>, <span class="hlFld-ContribAuthor ">Dyann F.  Wirth</span>, <span class="hlFld-ContribAuthor ">VÃ¢nia  AndrÃ©</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Duarte</span>, <span class="hlFld-ContribAuthor ">Rita C.  Guedes</span>, <span class="hlFld-ContribAuthor ">Daniel J. V. A.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Ralph  Mazitschek</span>, <span class="hlFld-ContribAuthor ">Miguel  PrudÃªncio</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (19)
                                     , 2194-2204. <a href="https://doi.org/10.1002/cmdc.201600327" title="DOI URL">https://doi.org/10.1002/cmdc.201600327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600327%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DProbing%252Bthe%252BAzaaurone%252BScaffold%252Bagainst%252Bthe%252BHepatic%252Band%252BErythrocytic%252BStages%252Bof%252BMalaria%252BParasites%26aulast%3DCarrasco%26aufirst%3DMarta%2BP.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D19%26spage%3D2194%26epage%3D2204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">StanleyÂ Ching-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">AmberÂ M.  Smith</span>, <span class="hlFld-ContribAuthor ">Bart  Everts</span>, <span class="hlFld-ContribAuthor ">Marco  Colonna</span>, <span class="hlFld-ContribAuthor ">ErikaÂ L.  Pearce</span>, <span class="hlFld-ContribAuthor ">JoelÂ D.  Schilling</span>, <span class="hlFld-ContribAuthor ">EdwardÂ J.  Pearce</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation. </span><span class="cited-content_cbyCitation_journal-name">Immunity</span><span> <strong>2016,</strong> <em>45 </em>
                                    (4)
                                     , 817-830. <a href="https://doi.org/10.1016/j.immuni.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.immuni.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.immuni.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.immuni.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunity%26atitle%3DMetabolic%252BReprogramming%252BMediated%252Bby%252Bthe%252BmTORC2-IRF4%252BSignaling%252BAxis%252BIs%252BEssential%252Bfor%252BMacrophage%252BAlternative%252BActivation%26aulast%3DHuang%26aufirst%3DStanley%25C2%25A0Ching-Cheng%26date%3D2016%26volume%3D45%26issue%3D4%26spage%3D817%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lynsey  Vaughan</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Karen  Barker</span>, <span class="hlFld-ContribAuthor ">Yvan  Chanthery</span>, <span class="hlFld-ContribAuthor ">Clay W.  Gustafson</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Tucker</span>, <span class="hlFld-ContribAuthor ">Jane  Renshaw</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Xiaodun  Li</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Yann  Jamin</span>, <span class="hlFld-ContribAuthor ">Simon P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Andrew  Pearson</span>, <span class="hlFld-ContribAuthor ">Michel  Maira</span>, <span class="hlFld-ContribAuthor ">William A.  Weiss</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Louis  Chesler</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (36)
                                     , 57525-57544. <a href="https://doi.org/10.18632/oncotarget.10544" title="DOI URL">https://doi.org/10.18632/oncotarget.10544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10544%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252BmTOR-kinase%252Bdestabilizes%252BMYCN%252Band%252Bis%252Ba%252Bpotential%252Btherapy%252Bfor%252BMYCN-dependent%252Btumors%26aulast%3DVaughan%26aufirst%3DLynsey%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D36%26spage%3D57525%26epage%3D57544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lanying  Shi</span>, <span class="hlFld-ContribAuthor ">Xuhong  Gong</span>, <span class="hlFld-ContribAuthor ">Mengjie  Jiang</span>, <span class="hlFld-ContribAuthor ">Yaoxue  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Yin</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Chihiro  Emori</span>, <span class="hlFld-ContribAuthor ">Koji  Sugiura</span>, <span class="hlFld-ContribAuthor ">John J.  Eppig</span>, <span class="hlFld-ContribAuthor ">You-Qiang  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Oocyte-dependent activation of MTOR in cumulus cells controls the development and survival of cumulusâoocyte complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Science</span><span> <strong>2016,</strong> <em>129 </em>
                                    (16)
                                     , 3091-3103. <a href="https://doi.org/10.1242/jcs.182642" title="DOI URL">https://doi.org/10.1242/jcs.182642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/jcs.182642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fjcs.182642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Science%26atitle%3DOocyte-dependent%252Bactivation%252Bof%252BMTOR%252Bin%252Bcumulus%252Bcells%252Bcontrols%252Bthe%252Bdevelopment%252Band%252Bsurvival%252Bof%252Bcumulus%2525E2%252580%252593oocyte%252Bcomplexes%26aulast%3DGuo%26aufirst%3DJing%26date%3D2016%26date%3D2016%26volume%3D129%26issue%3D16%26spage%3D3091%26epage%3D3103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susana  Llanos</span>, <span class="hlFld-ContribAuthor ">Juana M.  GarcÃ­a-Pedrero</span>. </span><span class="cited-content_cbyCitation_article-title">A new mechanism of regulation of p21 by the mTORC1/4E-BP1 pathway predicts clinical outcome of head and neck cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Oncology</span><span> <strong>2016,</strong> <em>3 </em>
                                    (4)
                                     , e1159275. <a href="https://doi.org/10.1080/23723556.2016.1159275" title="DOI URL">https://doi.org/10.1080/23723556.2016.1159275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/23723556.2016.1159275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F23723556.2016.1159275%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Oncology%26atitle%3DA%252Bnew%252Bmechanism%252Bof%252Bregulation%252Bof%252Bp21%252Bby%252Bthe%252BmTORC1%25252F4E-BP1%252Bpathway%252Bpredicts%252Bclinical%252Boutcome%252Bof%252Bhead%252Band%252Bneck%252Bcancer%26aulast%3DLlanos%26aufirst%3DSusana%26date%3D2016%26date%3D2016%26volume%3D3%26issue%3D4%26spage%3De1159275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Eunice Eunkyeong  Kim</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-substituted-2-anilinoquinolines with 3-(morpholino or 4-methylpiperazin-1-yl)propoxy moiety as broad spectrum antiproliferative agents: Synthesis, cell based assays and kinase screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (14)
                                     , 3307-3312. <a href="https://doi.org/10.1016/j.bmcl.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252B5-substituted-2-anilinoquinolines%252Bwith%252B3-%252528morpholino%252Bor%252B4-methylpiperazin-1-yl%252529propoxy%252Bmoiety%252Bas%252Bbroad%252Bspectrum%252Bantiproliferative%252Bagents%25253A%252BSynthesis%25252C%252Bcell%252Bbased%252Bassays%252Band%252Bkinase%252Bscreening%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2016%26volume%3D26%26issue%3D14%26spage%3D3307%26epage%3D3312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Durga  Udayakumar</span>, <span class="hlFld-ContribAuthor ">Raj K.  Pandita</span>, <span class="hlFld-ContribAuthor ">Nobuo  Horikoshi</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Clayton R.  Hunt</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">John D.  Minna</span>, <span class="hlFld-ContribAuthor ">Tej K.  Pandita</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westoverâ</span>. </span><span class="cited-content_cbyCitation_article-title">Torin2 Suppresses Ionizing Radiation-Induced DNA Damage Repair. </span><span class="cited-content_cbyCitation_journal-name">Radiation Research</span><span> <strong>2016,</strong> <em>185 </em>
                                    (5)
                                     , 527-538. <a href="https://doi.org/10.1667/RR14373.1" title="DOI URL">https://doi.org/10.1667/RR14373.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1667/RR14373.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1667%2FRR14373.1%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiation%2520Research%26atitle%3DTorin2%252BSuppresses%252BIonizing%252BRadiation-Induced%252BDNA%252BDamage%252BRepair%26aulast%3DUdayakumar%26aufirst%3DDurga%26date%3D2016%26volume%3D185%26issue%3D5%26spage%3D527%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohsine  Driowya</span>, <span class="hlFld-ContribAuthor ">Aziza  Saber</span>, <span class="hlFld-ContribAuthor ">Hamid  Marzag</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>, <span class="hlFld-ContribAuthor ">Khalid  Bougrin</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-Assisted Synthesis of Bioactive Six-Membered Heterocycles and Their Fused Analogues. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 492. <a href="https://doi.org/10.3390/molecules21040492" title="DOI URL">https://doi.org/10.3390/molecules21040492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21040492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21040492%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMicrowave-Assisted%252BSynthesis%252Bof%252BBioactive%252BSix-Membered%252BHeterocycles%252Band%252BTheir%252BFused%252BAnalogues%26aulast%3DDriowya%26aufirst%3DMohsine%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kexuan  Deng</span>, <span class="hlFld-ContribAuthor ">Lihua  Yu</span>, <span class="hlFld-ContribAuthor ">Xianzhe  Zheng</span>, <span class="hlFld-ContribAuthor ">Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanjing  Wang</span>, <span class="hlFld-ContribAuthor ">Pan  Dong</span>, <span class="hlFld-ContribAuthor ">Jiankui  Zhang</span>, <span class="hlFld-ContribAuthor ">Maozhi  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Target of Rapamycin Is a Key Player for Auxin Signaling Transduction in Arabidopsis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Plant Science</span><span> <strong>2016,</strong> <em>7 </em><a href="https://doi.org/10.3389/fpls.2016.00291" title="DOI URL">https://doi.org/10.3389/fpls.2016.00291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpls.2016.00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpls.2016.00291%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Plant%2520Science%26atitle%3DTarget%252Bof%252BRapamycin%252BIs%252Ba%252BKey%252BPlayer%252Bfor%252BAuxin%252BSignaling%252BTransduction%252Bin%252BArabidopsis%26aulast%3DDeng%26aufirst%3DKexuan%26date%3D2016%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher A  Lamb</span>, <span class="hlFld-ContribAuthor ">Stefanie  NÃ¼hlen</span>, <span class="hlFld-ContribAuthor ">Delphine  Judith</span>, <span class="hlFld-ContribAuthor ">David  Frith</span>, <span class="hlFld-ContribAuthor ">Ambrosius P  Snijders</span>, <span class="hlFld-ContribAuthor ">Christian  Behrends</span>, <span class="hlFld-ContribAuthor ">Sharon A  Tooze</span>. </span><span class="cited-content_cbyCitation_article-title">TBC
              1D14 regulates autophagy via the
              TRAPP
              complex and
              ATG
              9 traffic. </span><span class="cited-content_cbyCitation_journal-name">The EMBO Journal</span><span> <strong>2016,</strong> <em>35 </em>
                                    (3)
                                     , 281-301. <a href="https://doi.org/10.15252/embj.201592695" title="DOI URL">https://doi.org/10.15252/embj.201592695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embj.201592695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembj.201592695%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520EMBO%2520Journal%26atitle%3DTBC%252B1D14%252Bregulates%252Bautophagy%252Bvia%252Bthe%252BTRAPP%252Bcomplex%252Band%252BATG%252B9%252Btraffic%26aulast%3DLamb%26aufirst%3DChristopher%2BA%26date%3D2016%26date%3D2015%26volume%3D35%26issue%3D3%26spage%3D281%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vunnam  Venkateswarlu</span>, <span class="hlFld-ContribAuthor ">Anup Singh  Pathania</span>, <span class="hlFld-ContribAuthor ">K.A.  Aravinda Kumar</span>, <span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Fayaz A.  Malik</span>, <span class="hlFld-ContribAuthor ">Sanghapal D.  Sawant</span>. </span><span class="cited-content_cbyCitation_article-title">4-(N-Phenyl-Nâ²-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4237-4247. <a href="https://doi.org/10.1016/j.bmc.2015.06.046" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D4-%252528N-Phenyl-N%2525E2%252580%2525B2-substituted%252Bbenzenesulfonyl%252529-6-%2525284-hydroxyphenyl%252529quinolines%252Bas%252Binhibitors%252Bof%252Bmammalian%252Btarget%252Bof%252Brapamycin%26aulast%3DVenkateswarlu%26aufirst%3DVunnam%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4237%26epage%3D4247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P  Torres-Ayuso</span>, <span class="hlFld-ContribAuthor ">M  Tello-Lafoz</span>, <span class="hlFld-ContribAuthor ">I  MÃ©rida</span>, <span class="hlFld-ContribAuthor ">A  Ãvila-Flores</span>. </span><span class="cited-content_cbyCitation_article-title">Diacylglycerol kinase-Î¶ regulates mTORC1 and lipogenic metabolism in cancer cells through SREBP-1. </span><span class="cited-content_cbyCitation_journal-name">Oncogenesis</span><span> <strong>2015,</strong> <em>4 </em>
                                    (8)
                                     , e164-e164. <a href="https://doi.org/10.1038/oncsis.2015.22" title="DOI URL">https://doi.org/10.1038/oncsis.2015.22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/oncsis.2015.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Foncsis.2015.22%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogenesis%26atitle%3DDiacylglycerol%252Bkinase-%2525CE%2525B6%252Bregulates%252BmTORC1%252Band%252Blipogenic%252Bmetabolism%252Bin%252Bcancer%252Bcells%252Bthrough%252BSREBP-1%26aulast%3DTorres-Ayuso%26aufirst%3DP%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D8%26spage%3De164%26epage%3De164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Hallaj  Neishabouri</span>, <span class="hlFld-ContribAuthor ">S. M.  Hutson</span>, <span class="hlFld-ContribAuthor ">J.  Davoodi</span>. </span><span class="cited-content_cbyCitation_article-title">Chronic activation of mTOR complex 1 by branched chain amino acids and organ hypertrophy. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2015,</strong> <em>47 </em>
                                    (6)
                                     , 1167-1182. <a href="https://doi.org/10.1007/s00726-015-1944-y" title="DOI URL">https://doi.org/10.1007/s00726-015-1944-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-015-1944-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-015-1944-y%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DChronic%252Bactivation%252Bof%252BmTOR%252Bcomplex%252B1%252Bby%252Bbranched%252Bchain%252Bamino%252Bacids%252Band%252Borgan%252Bhypertrophy%26aulast%3DNeishabouri%26aufirst%3DS.%2BHallaj%26date%3D2015%26date%3D2015%26volume%3D47%26issue%3D6%26spage%3D1167%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Obaid  Afzal</span>, <span class="hlFld-ContribAuthor ">Suresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Md Rafi  Haider</span>, <span class="hlFld-ContribAuthor ">Md Rahmat  Ali</span>, <span class="hlFld-ContribAuthor ">Rajiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Manu  Jaggi</span>, <span class="hlFld-ContribAuthor ">Sandhya  Bawa</span>. </span><span class="cited-content_cbyCitation_article-title">A review on anticancer potential of bioactive heterocycle quinoline. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 871-910. <a href="https://doi.org/10.1016/j.ejmech.2014.07.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Banticancer%252Bpotential%252Bof%252Bbioactive%252Bheterocycle%252Bquinoline%26aulast%3DAfzal%26aufirst%3DObaid%26date%3D2015%26volume%3D97%26spage%3D871%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcel  Tiebe</span>, <span class="hlFld-ContribAuthor ">Marilena  Lutz</span>, <span class="hlFld-ContribAuthor ">Adriana  DeÂ LaÂ Garza</span>, <span class="hlFld-ContribAuthor ">Tina  Buechling</span>, <span class="hlFld-ContribAuthor ">Michael  Boutros</span>, <span class="hlFld-ContribAuthor ">AurelioÂ A.  Teleman</span>. </span><span class="cited-content_cbyCitation_article-title">REPTOR and REPTOR-BP Regulate Organismal Metabolism and Transcription Downstream of TORC1. </span><span class="cited-content_cbyCitation_journal-name">Developmental Cell</span><span> <strong>2015,</strong> <em>33 </em>
                                    (3)
                                     , 272-284. <a href="https://doi.org/10.1016/j.devcel.2015.03.013" title="DOI URL">https://doi.org/10.1016/j.devcel.2015.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.devcel.2015.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.devcel.2015.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopmental%2520Cell%26atitle%3DREPTOR%252Band%252BREPTOR-BP%252BRegulate%252BOrganismal%252BMetabolism%252Band%252BTranscription%252BDownstream%252Bof%252BTORC1%26aulast%3DTiebe%26aufirst%3DMarcel%26date%3D2015%26volume%3D33%26issue%3D3%26spage%3D272%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luisa  Speranza</span>, <span class="hlFld-ContribAuthor ">Teresa  Giuliano</span>, <span class="hlFld-ContribAuthor ">Floriana  Volpicelli</span>, <span class="hlFld-ContribAuthor ">M. Egle  De Stefano</span>, <span class="hlFld-ContribAuthor ">Loredana  Lombardi</span>, <span class="hlFld-ContribAuthor ">Angela  Chambery</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Gian C.  Bellenchi</span>, <span class="hlFld-ContribAuthor ">Umberto  di Porzio</span>, <span class="hlFld-ContribAuthor ">Marianna  Crispino</span>, <span class="hlFld-ContribAuthor ">Carla  Perrone-Capano</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Behavioral Neuroscience</span><span> <strong>2015,</strong> <em>9 </em><a href="https://doi.org/10.3389/fnbeh.2015.00062" title="DOI URL">https://doi.org/10.3389/fnbeh.2015.00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnbeh.2015.00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnbeh.2015.00062%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Behavioral%2520Neuroscience%26atitle%3DActivation%252Bof%252B5-HT7%252Breceptor%252Bstimulates%252Bneurite%252Belongation%252Bthrough%252BmTOR%25252C%252BCdc42%252Band%252Bactin%252Bfilaments%252Bdynamics%26aulast%3DSperanza%26aufirst%3DLuisa%26date%3D2015%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Unselective Autophagy of Cellular Aggregates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 95-133. <a href="https://doi.org/10.1016/B978-0-12-801944-3.00004-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-801944-3.00004-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801944-3.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801944-3.00004-7%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BUnselective%252BAutophagy%252Bof%252BCellular%252BAggregates%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2015%26spage%3D95%26epage%3D133%26pub%3DElsevier%26atitle%3DChemical%252BModulators%252Bof%252BProtein%252BMisfolding%252Band%252BNeurodegenerative%252BDisease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gemma  Triola</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical tools for modulating autophagy. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (3)
                                     , 387-406. <a href="https://doi.org/10.1016/j.tet.2014.10.057" title="DOI URL">https://doi.org/10.1016/j.tet.2014.10.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.10.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.10.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DChemical%252Btools%252Bfor%252Bmodulating%252Bautophagy%26aulast%3DTriola%26aufirst%3DGemma%26date%3D2015%26volume%3D71%26issue%3D3%26spage%3D387%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E  Weisberg</span>, <span class="hlFld-ContribAuthor ">A  Nonami</span>, <span class="hlFld-ContribAuthor ">Z  Chen</span>, <span class="hlFld-ContribAuthor ">F  Liu</span>, <span class="hlFld-ContribAuthor ">J  Zhang</span>, <span class="hlFld-ContribAuthor ">M  Sattler</span>, <span class="hlFld-ContribAuthor ">E  Nelson</span>, <span class="hlFld-ContribAuthor ">K  Cowens</span>, <span class="hlFld-ContribAuthor ">A L  Christie</span>, <span class="hlFld-ContribAuthor ">C  Mitsiades</span>, <span class="hlFld-ContribAuthor ">K-K  Wong</span>, <span class="hlFld-ContribAuthor ">Q  Liu</span>, <span class="hlFld-ContribAuthor ">N  Gray</span>, <span class="hlFld-ContribAuthor ">J D  Griffin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2015,</strong> <em>29 </em>
                                    (1)
                                     , 27-37. <a href="https://doi.org/10.1038/leu.2014.149" title="DOI URL">https://doi.org/10.1038/leu.2014.149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/leu.2014.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fleu.2014.149%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DIdentification%252Bof%252BWee1%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bfor%252Bmutant%252BRAS-driven%252Bacute%252Bleukemia%252Band%252Bother%252Bmalignancies%26aulast%3DWeisberg%26aufirst%3DE%26date%3D2015%26date%3D2014%26volume%3D29%26issue%3D1%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Ravichandran</span>, <span class="hlFld-ContribAuthor ">I.  Zafar</span>, <span class="hlFld-ContribAuthor ">A.  Ozkok</span>, <span class="hlFld-ContribAuthor ">C. L.  Edelstein</span>. </span><span class="cited-content_cbyCitation_article-title">An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease. </span><span class="cited-content_cbyCitation_journal-name">Nephrology Dialysis Transplantation</span><span> <strong>2015,</strong> <em>30 </em>
                                    (1)
                                     , 45-53. <a href="https://doi.org/10.1093/ndt/gfu296" title="DOI URL">https://doi.org/10.1093/ndt/gfu296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ndt/gfu296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fndt%2Fgfu296%26sid%3Dliteratum%253Aachs%26jtitle%3DNephrology%2520Dialysis%2520Transplantation%26atitle%3DAn%252BmTOR%252Bkinase%252Binhibitor%252Bslows%252Bdisease%252Bprogression%252Bin%252Ba%252Brat%252Bmodel%252Bof%252Bpolycystic%252Bkidney%252Bdisease%26aulast%3DRavichandran%26aufirst%3DK.%26date%3D2015%26date%3D2014%26volume%3D30%26issue%3D1%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JinXiang  Dai</span>, <span class="hlFld-ContribAuthor ">Kathryn K.  Bercury</span>, <span class="hlFld-ContribAuthor ">Wendy B.  Macklin</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. </span><span class="cited-content_cbyCitation_journal-name">Glia</span><span> <strong>2014,</strong> <em>62 </em>
                                    (12)
                                     , 2096-2109. <a href="https://doi.org/10.1002/glia.22729" title="DOI URL">https://doi.org/10.1002/glia.22729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/glia.22729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fglia.22729%26sid%3Dliteratum%253Aachs%26jtitle%3DGlia%26atitle%3DInteraction%252Bof%252BmTOR%252Band%252BErk1%25252F2%252Bsignaling%252Bto%252Bregulate%252Boligodendrocyte%252Bdifferentiation%26aulast%3DDai%26aufirst%3DJinXiang%26date%3D2014%26date%3D2014%26volume%3D62%26issue%3D12%26spage%3D2096%26epage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enrique  Rozengurt</span>, <span class="hlFld-ContribAuthor ">Heloisa P.  Soares</span>, <span class="hlFld-ContribAuthor ">James  Sinnet-Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2014,</strong> <em>13 </em>
                                    (11)
                                     , 2477-2488. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0330" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0330%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSuppression%252Bof%252BFeedback%252BLoops%252BMediated%252Bby%252BPI3K%25252FmTOR%252BInduces%252BMultiple%252BOveractivation%252Bof%252BCompensatory%252BPathways%25253A%252BAn%252BUnintended%252BConsequence%252BLeading%252Bto%252BDrug%252BResistance%26aulast%3DRozengurt%26aufirst%3DEnrique%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D11%26spage%3D2477%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dubek  Kazyken</span>, <span class="hlFld-ContribAuthor ">Yelimbek  Kaz</span>, <span class="hlFld-ContribAuthor ">Vladimir  Kiyan</span>, <span class="hlFld-ContribAuthor ">Assylbek A.  Zhylkibayev</span>, <span class="hlFld-ContribAuthor ">Chien-Hung  Chen</span>, <span class="hlFld-ContribAuthor ">Nitin K.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Dos D.  Sarbassov</span>. </span><span class="cited-content_cbyCitation_article-title">The nuclear import of ribosomal proteins is regulated by mTOR. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2014,</strong> <em>5 </em>
                                    (20)
                                     , 9577-9593. <a href="https://doi.org/10.18632/oncotarget.2473" title="DOI URL">https://doi.org/10.18632/oncotarget.2473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2473%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bnuclear%252Bimport%252Bof%252Bribosomal%252Bproteins%252Bis%252Bregulated%252Bby%252BmTOR%26aulast%3DKazyken%26aufirst%3DDubek%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D20%26spage%3D9577%26epage%3D9593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta P.  Carrasco</span>, <span class="hlFld-ContribAuthor ">Ana S.  Newton</span>, <span class="hlFld-ContribAuthor ">LÃ­dia  GonÃ§alves</span>, <span class="hlFld-ContribAuthor ">Ana  GÃ³is</span>, <span class="hlFld-ContribAuthor ">Marta  Machado</span>, <span class="hlFld-ContribAuthor ">Jiri  Gut</span>, <span class="hlFld-ContribAuthor ">FÃ¡tima  Nogueira</span>, <span class="hlFld-ContribAuthor ">Thomas  HÃ¤nscheid</span>, <span class="hlFld-ContribAuthor ">Rita C.  Guedes</span>, <span class="hlFld-ContribAuthor ">Daniel J.V.A.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the aurone scaffold against Plasmodium falciparum: Design, synthesis and antimalarial activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>80 </em>, 523-534. <a href="https://doi.org/10.1016/j.ejmech.2014.04.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProbing%252Bthe%252Baurone%252Bscaffold%252Bagainst%252BPlasmodium%252Bfalciparum%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bantimalarial%252Bactivity%26aulast%3DCarrasco%26aufirst%3DMarta%2BP.%26date%3D2014%26volume%3D80%26spage%3D523%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Grabiner</span>, <span class="hlFld-ContribAuthor ">Valentina  Nardi</span>, <span class="hlFld-ContribAuthor ">KÄ±vanÃ§  Birsoy</span>, <span class="hlFld-ContribAuthor ">Richard  Possemato</span>, <span class="hlFld-ContribAuthor ">Kuang  Shen</span>, <span class="hlFld-ContribAuthor ">Sumi  Sinha</span>, <span class="hlFld-ContribAuthor ">Alexander  Jordan</span>, <span class="hlFld-ContribAuthor ">Andrew H.  Beck</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>. </span><span class="cited-content_cbyCitation_article-title">A Diverse Array of Cancer-Associated
              MTOR
              Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2014,</strong> <em>4 </em>
                                    (5)
                                     , 554-563. <a href="https://doi.org/10.1158/2159-8290.CD-13-0929" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-13-0929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-13-0929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-13-0929%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DA%252BDiverse%252BArray%252Bof%252BCancer-Associated%252BMTOR%252BMutations%252BAre%252BHyperactivating%252Band%252BCan%252BPredict%252BRapamycin%252BSensitivity%26aulast%3DGrabiner%26aufirst%3DBrian%2BC.%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D5%26spage%3D554%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm101144f&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm101144f%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=145&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of reported ATP-competitive mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening flowchart for development of mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (1) appropriate aniline, 1,4-dioxane, 100 Â°C, 4â12 h; (2) appropriate boronic acid, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, <i>t</i>-Bu-Xphos, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 Â°C, 6 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model demonstration of compound <b>18</b> binding with mTOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (1) aniline (R<sub>2</sub>NH<sub>2</sub>), 1,4-dioxane, 100 Â°C, 4 h; (2) LAH, THF, 0 Â°Cârt, 4 h; (3) (a) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 6 h, (b) triethyl phosphonoacetate, K<sub>2</sub>CO<sub>3</sub>, EtOH, 100 Â°C, 12 h; (4) R<sub>1</sub>B(OH)<sub>2</sub>, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, <i>t</i>-Bu-Xphos, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 Â°C, 12 h.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative structures of variations of R1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative structures of variations of R2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic inhibition of Akt S473 and S6 S235/236 phosphorylation in lung and liver of mice treated with a single intraperitoneal dose of 20 mg/kg <b>37</b>. Six-week-old male C57BL/6 mice were fasted overnight prior to treatment with <b>37</b> as a suspension in 20% <i>N</i>-methyl-2-pyrrolidone/40% PEG400/40% water or with vehicle by IP injection. Tissues were collected and analyzed at 2, 6, and 10 h after dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/medium/jm-2010-01144f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo efficacy of <b>37</b> in U87MG xenografts. Mice model was established with six-week-old immunodeficient mice by subcutaneous injection of U87MG cells. <b>37</b> as a solution/suspension in vehicle (20% <i>N</i>-methyl-2-pyrrolidone, 40% PEG400, and 40% water) or vehicle was delivered by intraperitoneal injection once daily after the tumor reached 1 cm<sup>3</sup> in size and continued for 10 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm101144f/production/images/large/jm-2010-01144f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101144f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-kinase related kinases: âbigâ players in stress-induced signaling pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-kinase+related+kinases%3A+%E2%80%9Cbig%E2%80%9D+players+in+stress-induced+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-kinase%2520related%2520kinases%253A%2520%25E2%2580%259Cbig%25E2%2580%259D%2520players%2520in%2520stress-induced%2520signaling%2520pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Targeting mTOR globally in cancer: thinking beyond rapamycin</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3831</span><span class="NLM_x">â</span> <span class="NLM_lpage">3837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.4161%2Fcc.8.23.10070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19901542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlWrtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3831-3837&author=B.+Shorauthor=J%2C+J.+Gibbonsauthor=R%2C+T.+Abrahamauthor=K.+Yu&title=Targeting+mTOR+globally+in+cancer%3A+thinking+beyond+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mTOR globally in cancer: thinking beyond rapamycin</span></div><div class="casAuthors">Shor, Boris; Gibbons, James J.; Abraham, Robert T.; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3831-3837</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is centrally involved in growth, survival and metab.  In cancer, mTOR is frequently hyperactivated and is a clin. validated target for drug development.  Until recently, we have relied largely on the use of rapamycin to study mTOR function and its anticancer potential.  Recent insights now indicate that rapamycin is a partial inhibitor of mTOR through allosteric inhibition of mTOR complex-1 (mTORC1) but not mTOR complex-2 (mTORC2).  Both the mechanism of action and the cellular response to mTORC1 inhibition by rapamycin and related drugs may limit the effectiveness of these compds. as antitumor agents.  We and others have recently reported the discovery of second-generation ATP-competitive mTOR kinase inhibitors (TKIs) that bind to the active sites of mTORC1 and mTORC2, thereby targeting mTOR signaling function globally (reviewed in refs. 1-4).  The discovery of specific, active-site mTOR inhibitors has opened a new chapter in the 40-plus year old odyssey that began with the discovery of rapamycin from a soil sample collected on Easter Island.  Here, we discuss recent studies that highlight the emergence of rapamycin-resistant mTOR function in protein synthesis, cell growth, survival and metab.  It is shown that these rapamycin-resistant mTOR functions are profoundly inhibited by TKIs.  A more complete suppression of mTOR global signaling network by the new inhibitors is expected to yield a deeper and broader antitumor response in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9EP_1DwoGrVg90H21EOLACvtfcHk0ljmVr7lyJx5Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlWrtL4%253D&md5=4dab0a66742fadd9087aa2c439704f27</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.23.10070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.23.10070%26sid%3Dliteratum%253Aachs%26aulast%3DShor%26aufirst%3DB.%26aulast%3DGibbons%26aufirst%3DJ%252C%2BJ.%26aulast%3DAbraham%26aufirst%3DR%252C%2BT.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DTargeting%2520mTOR%2520globally%2520in%2520cancer%253A%2520thinking%2520beyond%2520rapamycin%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D3831%26epage%3D3837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">mTOR mediated anti-cancer drug discovery</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.ddstr.2009.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=20622997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=47-55&author=Q.+Liuauthor=C.+Thoreenauthor=J.+Wangauthor=D.+Sabatiniauthor=N.+S.+Gray&title=mTOR+mediated+anti-cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR mediated anti-cancer drug discovery</span></div><div class="casAuthors">Liu, Qingsong; Thoreen, Carson; Wang, Jinhua; Sabatini, David; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase and the founding member of a signaling pathway that regulates many fundamental features of cell growth and division.  In cells, mTOR acts as the catalytic subunit of two functionally distinct complexes, called mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2).  Together, these complexes coordinate a variety of processes that include protein translation, autophagy, proliferation, survival and metab. in response to nutrient, energy and growth factor signals.  Consistent with its role as a growth-promoting pathway, numerous studies have found that mTOR signaling is hyper-activated in a broad spectrum of human cancers.  In particular, mTORC2 is considered a primary effector of the phosphatidylinositol-3-kinase (PI3K) signaling pathway, which is mutated in a majority of human cancers, in part through its ability to phosphorylate and regulate the proto-oncogene Akt/PKB.  Many biol. functions of mTOR have been pharmacol. explored using the natural product rapamycin, an allosteric inhibitor that has been reviewed extensively elsewhere.  This review will focus specifically on the development of small mol. ATP-competitive inhibitors of mTOR and their prospects as a targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo708zVFEp5VLVg90H21EOLACvtfcHk0ljmVr7lyJx5Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D&md5=93364d568c3a23dd0fcf0c3980841e7e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2009.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2009.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DThoreen%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSabatini%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DmTOR%2520mediated%2520anti-cancer%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2009%26volume%3D6%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">â</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-168&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=S.+Senguptaauthor=J.+H.+Sheenauthor=P.+P.+Hsuauthor=A.+F.+Bagleyauthor=A.+L.+Markhardauthor=D.+M.+Sabatini&title=Prolonged+rapamycin+treatment+inhibits+mTORC2+assembly+and+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSheen%26aufirst%3DJ.%2BH.%26aulast%3DHsu%26aufirst%3DP.%2BP.%26aulast%3DBagley%26aufirst%3DA.%2BF.%26aulast%3DMarkhard%26aufirst%3DA.%2BL.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DProlonged%2520rapamycin%2520treatment%2520inhibits%2520mTORC2%2520assembly%2520and%2520Akt%252FPKB%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuleux, M.</span><span> </span><span class="NLM_article-title">Optimal targeting of the mTORC1 kinase in human cancer</span> <span class="citation_source-journal">Curr. Opin. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.ceb.2009.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19233631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=219-229&author=H.+A.+Laneauthor=M.+Breuleux&title=Optimal+targeting+of+the+mTORC1+kinase+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal targeting of the mTORC1 kinase in human cancer</span></div><div class="casAuthors">Lane, Heidi A.; Breuleux, Madlaina</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A central sensor of the availability of growth factors, nutrients, and energy sources, the mammalian target of rapamycin complex 1 (mTORC1) kinase plays a key role in tumor biol.  Consequently, mTORC1 inhibitors were shown to have broad antitumor activity pre-clin. in exptl. tumor models as well as clin. in cancer patients.  Strikingly, certain tumor types appear to be predisposed to respond to mTORC1 inhibition, a phenomenon related to deregulation of crit. elements of the PI3K/mTORC1 pathway.  In this review we address optimization of clin. development in the context of mTORC1 inhibitor-induced activation of survival pathways, crosstalk between different signaling modules involved in malignant transformation, definition of rational target combination scenarios and biol. based dosing and patient stratification strategies.  Emphasis is given where possible to mTORC1 drug development decisions based on full clin. publications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kA5ODdrLmrVg90H21EOLACvtfcHk0ljmVr7lyJx5Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7o%253D&md5=cdacb3486d406d929dc4d1a0d06478c8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DBreuleux%26aufirst%3DM.%26atitle%3DOptimal%2520targeting%2520of%2520the%2520mTORC1%2520kinase%2520in%2520human%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">â</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-Competitive+Mammalian+Target+of+Rapamycin+Inhibitor+Reveals+Rapamycin-Resistant+Functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lhuSfdtHbe21Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Inhibitor%2520Reveals%2520Rapamycin-Resistant%2520Functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinght, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of  mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Kinghtauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-Site+Inhibitors+of+mTOR+Target+Rapamycin-Resistant+Outputs+of++mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKinght%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-Site%2520Inhibitors%2520of%2520mTOR%2520Target%2520Rapamycin-Resistant%2520Outputs%2520of%2520%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Garcia-martinez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garcia-martinezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-martinez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T., S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">â</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-kaloustianauthor=T.%2C+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+Cellular%2C+and+in+Vivo+Activity+of+Novel+ATP-Competitive+and+Selective+Inhibitors+of+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%252C%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520Cellular%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Novel%2520ATP-Competitive%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DCancer.%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Barr, S.; Russo, S.; Buck, E.; Epstein, D.; Miglarese, M.</span><span> </span><span class="NLM_article-title">Co-targeting mTOR and IGF-1R/IR results in synergistic activity against a broad array of tumor cell lines, independent of KRAS mutation status</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington, DC</span>, <span class="NLM_conf-date">April, 2010</span>, p  <span class="NLM_fpage">1632</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Barr%2C+S.%3B+Russo%2C+S.%3B+Buck%2C+E.%3B+Epstein%2C+D.%3B+Miglarese%2C+M.+Co-targeting+mTOR+and+IGF-1R%2FIR+results+in+synergistic+activity+against+a+broad+array+of+tumor+cell+lines%2C+independent+of+KRAS+mutation+status.+AACR+101st+Annual+Meeting%2C+Washington%2C+DC%2C+April%2C+2010%2C+p+1632."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DS.%26atitle%3DCo-targeting%2520mTOR%2520and%2520IGF-1R%252FIR%2520results%2520in%2520synergistic%2520activity%2520against%2520a%2520broad%2520array%2520of%2520tumor%2520cell%2520lines%252C%2520independent%2520of%2520KRAS%2520mutation%2520status%26spage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellsonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+Is+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+ATP-Competitive+Mammalian+Target+of+Rapamycin+Kinase+Inhibitor+with+in+Vitro+and+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllson%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520Is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Kinase%2520Inhibitor%2520with%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and optimization of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">â</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+optimization+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6830</span><span class="NLM_x">â</span> <span class="NLM_lpage">6835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6830-6835&author=D.+J.+Richardauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=J.+Lucasauthor=K.+Yuauthor=A.+Zask&title=Incorporation+of+water-solubilizing+groups+in+pyrazolopyrimidine+mTOR+inhibitors%3A+discovery+of+highly+potent+and+selective+analogs+with+improved+human+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DIncorporation%2520of%2520water-solubilizing%2520groups%2520in%2520pyrazolopyrimidine%2520mTOR%2520inhibitors%253A%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520analogs%2520with%2520improved%2520human%2520microsomal%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6830%26epage%3D6835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viguie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">PI-103, a dual inhibitor of class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">â</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1698-1706&author=S.+Parkauthor=N.+Chapuisauthor=V.+Bardetauthor=J.+Tamburiniauthor=N.+Gallayauthor=L.+Willemsauthor=Z.+A.+Knightauthor=K.+M.+Shokatauthor=N.+Azarauthor=F.+Viguieauthor=N.+Ifrahauthor=F+Dreyfusauthor=P.+Mayeuxauthor=C.+Lacombeauthor=D.+Bouscary&title=PI-103%2C+a+dual+inhibitor+of+class+IA+phosphatidylinositide+3-kinase+and+mTOR%2C+has+antileukemic+activity+in+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DN.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DAzar%26aufirst%3DN.%26aulast%3DViguie%26aufirst%3DF.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DPI-103%252C%2520a%2520dual%2520inhibitor%2520of%2520class%2520IA%2520phosphatidylinositide%25203-kinase%2520and%2520mTOR%252C%2520has%2520antileukemic%2520activity%2520in%2520AML%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1698%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llonch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8022</span><span class="NLM_x">â</span> <span class="NLM_lpage">8030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F0008-5472.CAN-08-1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18829560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8022-8030&author=V.+Serraauthor=B.+Markmanauthor=M.+Scaltritiauthor=P.+J.+A.+Eichhornauthor=V.+Valeroauthor=M.+Guzmanauthor=M.+L.+Boteroauthor=E.+Llonchauthor=F.+Atzoriauthor=S.+D.+Cosimoauthor=M.+Mairaauthor=C.+Garcia-Echeverriaauthor=J.+L.+Parraauthor=J.+Arribasauthor=J.+Baselga&title=NVP-BEZ235%2C+a+Dual+PI3K%2FmTOR+Inhibitor%2C+Prevents+PI3K+Signaling+and+Inhibits+the+Growth+of+Cancer+Cells+with+Activating+PI3K+Mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span></div><div class="casAuthors">Serra, Violeta; Markman, Ben; Scaltriti, Maurizio; Eichhorn, Pieter J. A.; Valero, Vanesa; Guzman, Marta; Botero, Maria Luisa; Llonch, Elisabeth; Atzori, Francesco; Di Cosimo, Serena; Maira, Michel; Garcia-Echeverria, Carlos; Parra, Josep Lluis; Arribas, Joaquin; Baselga, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8022-8030</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homolog deleted from chromosome 10 or activating mutations of p110-Î±.  These hotspot mutations result in oncogenic activity of the enzyme and contribute to therapeutic resistance to the anti-HER2 antibody trastuzumab.  The PI3K pathway is, therefore, an attractive target for cancer therapy.  We have studied NVP-BEZ235, a dual inhibitor of the PI3K and the downstream mammalian target of rapamycin (mTOR).  NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breast cancer cells.  The antiproliferative activity of NVP-BEZ235 was superior to the allosteric selective mTOR complex inhibitor everolimus in a panel of 21 cancer cell lines of different origin and mutation status.  The described Akt activation due to mTOR inhibition was prevented by higher doses of NVP-BEZ235.  NVP-BEZ235 reversed the hyperactivation of the PI3K/mTOR pathway caused by the oncogenic mutations of p110-Î±, E545K, and H1047R, and inhibited the proliferation of HER2-amplified BT474 cells exogenously expressing these mutations that render them resistant to trastuzumab.  In trastuzumab-resistant BT474 H1047R breast cancer xenografts, NVP-BEZ235 inhibited PI3K signaling and had potent antitumor activity.  In treated animals, there was complete inhibition of PI3K signaling in the skin at pharmacol. active doses, suggesting that skin may serve as surrogate tissue for pharmacodynamic studies.  In summary, NVP-BEZ235 inhibits the PI3K/mTOR axis and results in antiproliferative and antitumoral activity in cancer cells with both wild-type and mutated p110-Î±.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlC_vqzWMDk7Vg90H21EOLACvtfcHk0lhG5G82u5kEzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK&md5=b5d08e989c1b619e3c0ee9437002afd7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1385%26sid%3Dliteratum%253Aachs%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DBotero%26aufirst%3DM.%2BL.%26aulast%3DLlonch%26aufirst%3DE.%26aulast%3DAtzori%26aufirst%3DF.%26aulast%3DCosimo%26aufirst%3DS.%2BD.%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DNVP-BEZ235%252C%2520a%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%252C%2520Prevents%2520PI3K%2520Signaling%2520and%2520Inhibits%2520the%2520Growth%2520of%2520Cancer%2520Cells%2520with%2520Activating%2520PI3K%2520Mutations%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8022%26epage%3D8030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span> </span><span class="NLM_article-title">Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dostonauthor=A.+Folkesauthor=L.+Freidmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.+Zhu&title=Discovery+of+%28Thienopyrimidin-2-yl%29aminopyrimidines+as+Potent%2C+Selective%2C+and+Orally+Available+Pan-PI3-Kinase+and+Dual+Pan-PI3-Kinase%2FmTOR+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDoston%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFreidman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Pan-PI3-Kinase%2520and%2520Dual%2520Pan-PI3-Kinase%252FmTOR%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">â</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase Î± (PI3KÎ±) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3KÎ± and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0lgRHnLtKeaQIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sancak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaul, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peled, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1496</span><span class="NLM_x">â</span> <span class="NLM_lpage">1501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1126%2Fscience.1157535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18497260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVWqsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2008&pages=1496-1501&author=Y.+Sancakauthor=T.+R.+Petersonauthor=Y.+D.+Shaulauthor=R.+A.+Lindquistauthor=C.+C.+Thoreenauthor=L.+B.+Peledauthor=D.+M.+Sabatini&title=The+Rag+GTPases+Bind+Raptor+and+Mediate+Amino+Acid+Signaling+to+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1</span></div><div class="casAuthors">Sancak, Yasemin; Peterson, Timothy R.; Shaul, Yoav D.; Lindquist, Robert A.; Thoreen, Carson C.; Bar-Peled, Liron; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">5882</span>),
    <span class="NLM_cas:pages">1496-1501</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The multiprotein mTORC1 protein kinase complex is the central component of a pathway that promotes growth in response to insulin, energy levels, and amino acids and is deregulated in common cancers.  We find that the Rag proteins-a family of four related small guanosine triphosphatases (GTPases)-interact with mTORC1 in an amino acid-sensitive manner and are necessary for the activation of the mTORC1 pathway by amino acids.  A Rag mutant that is constitutively bound to guanosine triphosphate interacted strongly with mTORC1, and its expression within cells made the mTORC1 pathway resistant to amino acid deprivation.  Conversely, expression of a guanosine diphosphate-bound Rag mutant prevented stimulation of mTORC1 by amino acids.  The Rag proteins do not directly stimulate the kinase activity of mTORC1, but, like amino acids, promote the intracellular localization of mTOR to a compartment that also contains its activator Rheb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmWxESH6HwgLVg90H21EOLACvtfcHk0lgRHnLtKeaQIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVWqsr4%253D&md5=e5df88ef594f04671eb9cc61a602e6f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1157535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1157535%26sid%3Dliteratum%253Aachs%26aulast%3DSancak%26aufirst%3DY.%26aulast%3DPeterson%26aufirst%3DT.%2BR.%26aulast%3DShaul%26aufirst%3DY.%2BD.%26aulast%3DLindquist%26aufirst%3DR.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DPeled%26aufirst%3DL.%2BB.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Rag%2520GTPases%2520Bind%2520Raptor%2520and%2520Mediate%2520Amino%2520Acid%2520Signaling%2520to%2520mTORC1%26jtitle%3DScience%26date%3D2008%26volume%3D320%26spage%3D1496%26epage%3D1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A combinatorial scaffold approach toward kinase-directed heterocycle libraries</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1594</span><span class="NLM_x">â</span> <span class="NLM_lpage">1596</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0170302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1594-1596&author=S.+Dingauthor=N.+S.+Grayauthor=X.+Wuauthor=Q.+Dingauthor=P.+G.+Schultz&title=A+combinatorial+scaffold+approach+toward+kinase-directed+heterocycle+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja0170302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0170302%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520combinatorial%2520scaffold%2520approach%2520toward%2520kinase-directed%2520heterocycle%2520libraries%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1594%26epage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord., E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F0008-5472.CAN-03-2868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=15173008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3958-3965&author=S.+K.+Rabindranauthor=C.+M.+Discafaniauthor=E.+C.+Rosfjord.author=M+Baxterauthor=M.+B.+Floydauthor=J.+Golasauthor=W.+A.+Hallettauthor=B.+D.+Johnsonauthor=R.+Nilakantanauthor=E.+Overbeekauthor=M.+F.+Reichauthor=R.+Shenauthor=X.+Shiauthor=H.+R.+Tsouauthor=Y.+F.+Wangauthor=A.+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase</span></div><div class="casAuthors">Rabindran, Sridhar K.; Discafani, Carolyn M.; Rosfjord, Edward C.; Baxter, Michelle; Floyd, M. Brawner; Golas, Jonathan; Hallett, William A.; Johnson, Bernard D.; Nilakantan, Ramaswamy; Overbeek, Elsebe; Reich, Marvin F.; Shen, Ru; Shi, Xiaoqing; Tsou, Hwei-Ru; Wang, Yu-Fen; Wissner, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3958-3965</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HER-2 belongs to the ErbB family of receptor tyrosine kinases, which has been implicated in a variety of cancers.  Overexpression of HER-2 is seen in 25-30% of breast cancer patients and predicts a poor outcome in patients with primary disease.  Trastuzumab (Herceptin), a monoclonal antibody to HER-2, is specifically approved for HER-2-pos. breast cancer but is active only in a subset of these tumors.  Blocking HER-2 function by a small mol. kinase inhibitor, therefore, represents an attractive alternate strategy to inhibit the growth of HER-2-pos. tumors.  HKI-272 is a potent inhibitor of HER-2 and is highly active against HER-2-overexpressing human breast cancer cell lines in vitro.  It also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.  HKI-272 reduces HER-2 receptor autophosphorylation in cells at doses consistent with inhibition of cell proliferation and functions as an irreversible binding inhibitor, most likely by targeting a cysteine residue in the ATP-binding pocket of the receptor.  In agreement with the predicted effects of HER-2 inactivation, HKI-272 treatment of cells results in inhibition of downstream signal transduction events and cell cycle regulatory pathways.  This leads to arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle, ultimately resulting in decreased cell proliferation.  In vivo, HKI-272 is active in HER-2- and EGFR-dependent tumor xenograft models when dosed orally on a once daily schedule.  On the basis of its favorable preclin. pharmacol. profile, HKI-272 has been selected as a candidate for addnl. development as an antitumor agent in breast and other HER-2-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xeLXlAwWvbVg90H21EOLACvtfcHk0liag7GDtu4hQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D&md5=60accd0599b7c489e4c3753d4f39cab4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-2868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-2868%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DRosfjord.%26aufirst%3DE.%2BC.%26aulast%3DBaxter%26aufirst%3DM%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3958%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusanak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">â</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusanakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0liag7GDtu4hQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusanak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellacosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">The Akt kinase: molecular determinants of oncogenicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">14950</span><span class="NLM_x">â</span> <span class="NLM_lpage">14955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=14950-14955&author=M.+Aokiauthor=O.+Batistaauthor=A.+Bellacosaauthor=P.+Tsichlisauthor=P.+K.+Vogt&title=The+Akt+kinase%3A+molecular+determinants+of+oncogenicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DO.%26aulast%3DBellacosa%26aufirst%3DA.%26aulast%3DTsichlis%26aufirst%3DP.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DThe%2520Akt%2520kinase%253A%2520molecular%2520determinants%2520of%2520oncogenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D14950%26epage%3D14955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stowasser, F.; Banziger, M.; Garad, S. D.</span><span> </span><span class="NLM_article-title">Salts and crystalline forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydroimidazo[4,5-<i>c</i>]quinolin-1-yl)-phenyl]propionitrile</span>. PCT. Int. Appl. WO2008064093,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+Stowasser&author=M.+Banziger&author=S.+D.+Garad&title=Salts+and+crystalline+forms+of+2-methyl-2-%5B4-%283-methyl-2-oxo-8-quinolin-3-yl-2%2C3-dihydroimidazo%5B4%2C5-c%5Dquinolin-1-yl%29-phenyl%5Dpropionitrile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStowasser%26aufirst%3DF.%26atitle%3DSalts%2520and%2520crystalline%2520forms%2520of%25202-methyl-2-%255B4-%25283-methyl-2-oxo-8-quinolin-3-yl-2%252C3-dihydroimidazo%255B4%252C5-c%255Dquinolin-1-yl%2529-phenyl%255Dpropionitrile%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Capraro, H.; Furet, P.</span><span> </span><span class="NLM_article-title">1H-imidazo[4,5-<i>c</i>]quinoline derivatives in the treatment of protein kinase dependent diseases.</span> PCT. Int. Appl. WO03097641,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Garcia-Echeverria&author=H.+Capraro&author=P.+Furet&title=1H-imidazo%5B4%2C5-c%5Dquinoline+derivatives+in+the+treatment+of+protein+kinase+dependent+diseases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D1H-imidazo%255B4%252C5-c%255Dquinoline%2520derivatives%2520in%2520the%2520treatment%2520of%2520protein%2520kinase%2520dependent%2520diseases.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Let.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">â</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.bmcl.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18248814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathway</span></div><div class="casAuthors">Stauffer, Frederic; Maira, Sauveur-Michel; Furet, Pascal; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1027-1030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Imidazo[4,5-c]quinoline derivs. have been discovered and developed as potent and effective modulators of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) pathway to lead to clin. development candidates.  The SAR data of representative examples of this compd. class and their biol. profiling in cellular and in vivo settings are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGWVPHweBID7Vg90H21EOLACvtfcHk0ljISyLppwQlCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWlsbw%253D&md5=1266a6fd4ee3e6cd57eb34b84713a3ae</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Let.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Blocking the PI3K/PKB pathway in tumor cells.</span> <span class="citation_source-journal">Curr. Med. Chem.âAnti-Cancer Agents.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">â</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.2174%2F1568011054866937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=16178772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovV2rsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=449-462&author=F.+Staufferauthor=P.+Holzerauthor=C.+Garcia-Echeverria&title=Blocking+the+PI3K%2FPKB+pathway+in+tumor+cells."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking the PI3K/PKB pathway in tumor cells</span></div><div class="casAuthors">Stauffer, Frederic; Holzer, Philipp; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-462</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A substantial no. of exptl. and epidemiol. studies support an important role for the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) pathway in the biol. of human cancers.  Components of this signaling cascade have been deregulated in a wide range of solid tumors and hematol. malignancies, and extensive anti-cancer therapeutic programs are now devoted to the identification of agents that specifically block this mol. pathway.  This article focuses on the current knowledge of the alterations of the PI3K/PKB pathway in cancer cells and ongoing drug discovery efforts to therapeutically target it.  Particular emphasis is placed on medicinal chem. activities to identify and develop compds. able to modulate the kinase activity of its main mol. components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDY3kHBWG1bVg90H21EOLACvtfcHk0ljISyLppwQlCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovV2rsrk%253D&md5=d05e06c8872a3a868b26844ad918d148</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.2174%2F1568011054866937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011054866937%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DBlocking%2520the%2520PI3K%252FPKB%2520pathway%2520in%2520tumor%2520cells.%26jtitle%3DCurr.%2520Med.%2520Chem.%25E2%2588%2592Anti-Cancer%2520Agents.%26date%3D2005%26volume%3D5%26spage%3D449%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950692f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=918-928&author=G.+W.+Rewcastleauthor=B.+D.+Palmerauthor=A.+J.+Bridgesauthor=H.+D.+H.+Showalterauthor=L.+Sunauthor=J.+Nelsonauthor=A.+McMichaelauthor=A.+J.+Krakerauthor=D.+W.+Fryauthor=W.+A.+Denny&title=Tyrosine+Kinase+Inhibitors.+9.+Synthesis+and+Evaluation+of+Fused+Tricyclic+Quinazoline+Analogues+as+ATP+Site+Inhibitors+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm950692f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950692f%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DNelson%26aufirst%3DJ.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%25209.%2520Synthesis%2520and%2520Evaluation%2520of%2520Fused%2520Tricyclic%2520Quinazoline%2520Analogues%2520as%2520ATP%2520Site%2520Inhibitors%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D918%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gazit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohmer, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoblom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltenberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golomb, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tricyclic Quinoxalines as Potent Kinase Inhibitors of PDGFR Kinase, Flt3 and Kit</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">â</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2007-2018&author=A.+Gazitauthor=K.+Yeeauthor=A.+Ueckerauthor=F.+D.+Bohmerauthor=T.+Sjoblomauthor=A.+Ostmanauthor=J.+Waltenbergerauthor=G.+Golombauthor=S.+Banaiauthor=M.+C.+Heinrichauthor=A.+Levitzki&title=Tricyclic+Quinoxalines+as+Potent+Kinase+Inhibitors+of+PDGFR+Kinase%2C+Flt3+and+Kit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DYee%26aufirst%3DK.%26aulast%3DUecker%26aufirst%3DA.%26aulast%3DBohmer%26aufirst%3DF.%2BD.%26aulast%3DSjoblom%26aufirst%3DT.%26aulast%3DOstman%26aufirst%3DA.%26aulast%3DWaltenberger%26aufirst%3DJ.%26aulast%3DGolomb%26aufirst%3DG.%26aulast%3DBanai%26aufirst%3DS.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTricyclic%2520Quinoxalines%2520as%2520Potent%2520Kinase%2520Inhibitors%2520of%2520PDGFR%2520Kinase%252C%2520Flt3%2520and%2520Kit%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2007%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H.</span><span> </span><span class="NLM_article-title">Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4<i>H</i>-pyrazolo-[1,5-<i>a</i>]pyrrolo[3,4-<i>d</i>]pyrimidine-5,8-dione scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1623</span><span class="NLM_x">â</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1623-1627&author=M.+S.+Coumarauthor=J.+Wuauthor=J.+Leouauthor=U.+Tanauthor=C.+Changauthor=T.+Changauthor=W.+Linauthor=J.+T.+Hsuauthor=Y.+Chaoauthor=S.+Wuauthor=H.+Hsieh&title=Aurora+kinase+A+inhibitors%3A+identification%2C+SAR+exploration+and+molecular+modeling+of+6%2C7-dihydro-4H-pyrazolo-%5B1%2C5-a%5Dpyrrolo%5B3%2C4-d%5Dpyrimidine-5%2C8-dione+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLeou%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DU.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DH.%26atitle%3DAurora%2520kinase%2520A%2520inhibitors%253A%2520identification%252C%2520SAR%2520exploration%2520and%2520molecular%2520modeling%2520of%25206%252C7-dihydro-4H-pyrazolo-%255B1%252C5-a%255Dpyrrolo%255B3%252C4-d%255Dpyrimidine-5%252C8-dione%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1623%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catarzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span> </span><span class="NLM_article-title">Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 inhibitors</span> <span class="citation_source-journal">Lett. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=281-284&author=S.+Moroauthor=F.+Varanoauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=G.+Zagottoauthor=A.+Chilinauthor=A.+Guiottoauthor=D.+Catarziauthor=V.+Calottaauthor=L.+A.+Pinnaauthor=F.+Meggio&title=Pyrazoloquinazoline+Tricyclic+System+as+Novel+Scaffold+to+Design+New+Kinase+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DVarano%26aufirst%3DF.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DChilin%26aufirst%3DA.%26aulast%3DGuiotto%26aufirst%3DA.%26aulast%3DCatarzi%26aufirst%3DD.%26aulast%3DCalotta%26aufirst%3DV.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26atitle%3DPyrazoloquinazoline%2520Tricyclic%2520System%2520as%2520Novel%2520Scaffold%2520to%2520Design%2520New%2520Kinase%2520CK2%2520inhibitors%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2006%26volume%3D3%26spage%3D281%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kempson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesnelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langevine, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattoli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang-Iverson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, W. J.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Inhibitors of IKB Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">â</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8015816" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1994-2005&author=J.+Kempsonauthor=S.+H.+Spergelauthor=J.+Guoauthor=C.+Quesnelleauthor=P.+Gillauthor=D.+Belangerauthor=A.+J.+Dyckmanauthor=T.+Liauthor=S.+H.+Wattersonauthor=C.+M.+Langevineauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+A.+Furchauthor=A.+Marinierauthor=M.+Dodierauthor=A.+Martelauthor=D.+Nirschlauthor=K.+V.+Kirkauthor=J.+R.+Burkeauthor=M.+A.+Pattoliauthor=K.+Gilloolyauthor=K.+W.+McIntyreauthor=L.+Chenauthor=Z.+Yangauthor=P.+H.+Maratheauthor=D.+Wang-Iversonauthor=H.+H.+Doddauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=W.+J.+Pitts&title=Novel+Tricyclic+Inhibitors+of+IKB+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1021%2Fjm8015816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8015816%26sid%3Dliteratum%253Aachs%26aulast%3DKempson%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DQuesnelle%26aufirst%3DC.%26aulast%3DGill%26aufirst%3DP.%26aulast%3DBelanger%26aufirst%3DD.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DMarinier%26aufirst%3DA.%26aulast%3DDodier%26aufirst%3DM.%26aulast%3DMartel%26aufirst%3DA.%26aulast%3DNirschl%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DK.%2BV.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DWang-Iverson%26aufirst%3DD.%26aulast%3DDodd%26aufirst%3DH.%2BH.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26atitle%3DNovel%2520Tricyclic%2520Inhibitors%2520of%2520IKB%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1994%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Maira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pover, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C. G.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">â</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+D.+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+G.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lj8tXr4gs-jgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DPover%26aufirst%3DA.%2BD.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%2BG.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110Î± in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101144f&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101144f&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101144f&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110Î± in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110Î³ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110Î± is the primary insulin-responsive PI3-K in cultured cells, whereas p110Î² is dispensable but sets a phenotypic threshold for p110Î± activity.  Compds. targeting p110Î± block the acute effects of insulin treatment in vivo, whereas a p110Î² inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lj3iVi3NBBceQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yip, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span> </span><span class="NLM_article-title">Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=768-774&author=C.+K.+Yipauthor=K.+Murataauthor=T.+Walzauthor=D.+M.+Sabatiniauthor=S.+A.+Kang&title=Structure+of+the+Human+mTOR+Complex+I+and+Its+Implications+for+Rapamycin+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DC.%2BK.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DKang%26aufirst%3DS.%2BA.%26atitle%3DStructure%2520of%2520the%2520Human%2520mTOR%2520Complex%2520I%2520and%2520Its%2520Implications%2520for%2520Rapamycin%2520Inhibition%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D5%26spage%3D768%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS','PDB','3DBS'); return false;">PDB: 3DBS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm101144f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00621"></div></div></div></div></div><hr /></hr><p class="last">Spectral data of <b>16</b>â<b>17</b>, <b>19</b>â<b>36</b>, <b>38</b>â<b>47</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101144f/suppl_file/jm101144f_si_001.pdf">jm101144f_si_001.pdf (76.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101144f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm101144f%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101144f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999e84cf8e3d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
